Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,retinoid binding (GO:0005501),0.8491536642952291,2.227382220924157,0.0,0.0,0.0,6/22,4.68%,CYP26B1;ALDH1A2;NR2F2;RBP4;ABCA4;RBP1
prerank,aldehyde dehydrogenase [NAD(P)+] activity (GO:0004030),0.8842989540999947,2.075337226128211,0.0,0.00442812989181016,0.008,4/15,2.65%,ALDH1A1;ALDH1A2;ALDH4A1;ALDH7A1
prerank,cadherin binding (GO:0045296),-0.45393509801272325,-2.061871349036314,0.0,0.004075807487714036,0.004,100/315,12.29%,DOCK9;FMNL2;PTPRB;SPTBN1;STXBP6;BSG;COBLL1;PTPRJ;MRTFB;PTPRM;TJP2;ITGA6;FXYD5;PROM1;LRRFIP1;ESYT2;STK38;HSPA8;KDR;PKP4;FNBP1L;CDH1;CTNND2;IQGAP1;TES;HSP90AB1;CBL;CDH11;HNRNPK;ITGB1;CDH2;EHD4;RPL6;AHNAK;F11R;EEF2;PLEC;SLK;NOTCH3;DAB2IP;CLINT1;RACK1;PKM;TAGLN2;RPL34;SH3GLB1;BMPR2;PACSIN2;SHTN1;CHMP5;RPL24;EPS8L2;FLNA;RPL23A;PPME1;CHMP2B;TRIM25;NCK1;EEF1D;YWHAB;MPP7;CTNNB1;EHD1;SLC3A2;ATXN2L;TJP1;CEMIP2;BAIAP2L1;RPL14;PCMT1;CTNNA3;RPS2;MYH9;TRPC4;RPL29;PAICS;LASP1;SEPTIN9;PLCB3;RTN4;PAK2;APC;CD2AP;RPL7A;RANBP1;PPP1CA;HSPA5;LYPLA2;TXNDC9;RSL1D1;PTPN1;PSMB6;CDH13;RAB1A;RANGAP1;DBNL;TBC1D10A;EPN2;EEF1G;MARK2
prerank,aldehyde dehydrogenase (NAD+) activity (GO:0004029),0.8996858987540406,2.0368092509619298,0.0,0.008200240540389184,0.024,4/13,2.65%,ALDH1A1;ALDH1A2;ALDH4A1;ALDH7A1
prerank,retinoic acid binding (GO:0001972),0.8745750391674367,1.9924236883888085,0.0,0.016728490702393937,0.056,2/12,1.08%,CYP26B1;NR2F2
prerank,MHC class II protein complex binding (GO:0023026),-0.8059063087638153,-1.9091843937817299,0.0,0.057061304827996505,0.099,7/11,12.71%,HSPA8;HSP90AA1;HSP90AB1;ATP1B1;PKM;CD74;CD81
prerank,organic cation transmembrane transporter activity (GO:0015101),0.7468046722565141,1.8012406440648403,0.005905511811023622,0.2550602817682652,0.668,2/16,0.72%,SLC22A4;SLC22A2
prerank,amino acid:sodium symporter activity (GO:0005283),0.7810110806590782,1.7963272461501758,0.0041841004184100415,0.22534261004989478,0.684,4/11,3.87%,SLC6A13;SLC6A12;SLC1A3;SLC6A1
prerank,monocarboxylate:sodium symporter activity (GO:0140161),0.8182929464529566,1.7907569113418738,0.004132231404958678,0.2060837594093236,0.709,3/10,3.87%,SLC6A13;SLC6A12;SLC6A1
prerank,transmembrane-ephrin receptor activity (GO:0005005),0.7199528463570867,1.7768271181428328,0.006172839506172839,0.19232297480726102,0.767,4/17,3.90%,EPHA7;EPHA3;EPHA8;EPHA4
prerank,ephrin receptor activity (GO:0005003),0.7199528463570867,1.7768271181428328,0.006172839506172839,0.19232297480726102,0.767,4/17,3.90%,EPHA7;EPHA3;EPHA8;EPHA4
prerank,anion channel activity (GO:0005253),-0.5022595022104894,-1.7669259863219573,0.0,0.2849668735160063,0.54,18/61,15.81%,SLC26A7;LRRC8C;ANO1;ANO4;LRRC8D;CLIC4;LRRC8B;GABRB3;GABRB1;CLCN5;TTYH3;ANO3;LRRC8A;GABRG3;SLC1A4;ANO2;CFTR;GLRA3
prerank,translation elongation factor activity (GO:0003746),-0.6858879824755217,-1.7502752121586027,0.001937984496124031,0.26620117654132297,0.628,11/14,28.41%,EEF1A1;EEF2;GFM1;EEF1B2;EEFSEC;EIF5A;EIF5AL1;GTPBP2;TUFM;EEF1A2;GTPBP1
prerank,LRR domain binding (GO:0030275),0.7418966395773234,1.7396650738307722,0.006012024048096192,0.26312931846000814,0.878,2/14,0.81%,ROBO1;PAWR
prerank,monocarboxylic acid binding (GO:0033293),0.6904106497740378,1.7370194476522811,0.008,0.245738844703081,0.884,3/18,6.35%,CYP26B1;NR2F2;NAPEPLD
prerank,amyloid-beta binding (GO:0001540),-0.4536743492339095,-1.723429864167167,0.002564102564102564,0.29019749312523935,0.72,43/79,33.38%,APBB2;COL25A1;TGFB2;CST3;ITM2B;FZD4;FZD6;ITM2A;APBB1;CRYAB;GRIN1;ATP1A3;APBB3;CD74;ADRB2;CLU;APBA3;C1QA;CACNA1B;GRIA2;IAPP;ITM2C;PFDN6;PFDN5;INSR;MAPK8IP2;AGER;FCGR2B;SORL1;APBA2;PFDN4;CLSTN1;ITGB2;TLR4;APBA1;TREM2;GRIA1;GRIN2B;TLR6;BCHE;CD36;ACHE;NGFR
prerank,phospholipid transfer activity (GO:0120014),-0.6052698533929187,-1.7151838055773487,0.00796812749003984,0.26645591450930506,0.765,11/21,19.36%,PITPNC1;CERT1;PLTP;PITPNM2;TNFAIP8L3;GLTP;ABCA3;PRELID3B;PITPNA;MTTP;PITPNB
prerank,nucleoside-diphosphatase activity (GO:0017110),-0.7285649938664107,-1.7149203692384292,0.003861003861003861,0.2289730420776492,0.765,4/12,12.85%,ENTPD1;ENTPD7;ENTPD2;SLC25A42
prerank,intracellular calcium activated chloride channel activity (GO:0005229),-0.6447562678124795,-1.7109197522890525,0.004032258064516129,0.1859021081896235,0.779,7/16,19.77%,ANO1;ANO4;TTYH3;TTYH2;ANO3;ANO2;ANO8
prerank,intracellular chloride channel activity (GO:0061778),-0.6447562678124795,-1.7109197522890525,0.004032258064516129,0.1859021081896235,0.779,7/16,19.77%,ANO1;ANO4;TTYH3;TTYH2;ANO3;ANO2;ANO8
prerank,NADH dehydrogenase (ubiquinone) activity (GO:0008137),-0.5287238979622565,-1.6781972757189474,0.009195402298850575,0.21527674094198676,0.88,15/34,19.18%,NDUFC2;NDUFA7;NDUFA5;NDUFA6;NDUFB5;NDUFA12;NDUFV1;NDUFB7;NDUFA4;NDUFA13;NDUFS1;NDUFB10;NDUFA1;NDUFB4;NDUFS7
prerank,NADH dehydrogenase (quinone) activity (GO:0050136),-0.5287238979622565,-1.6781972757189474,0.009195402298850575,0.21527674094198676,0.88,15/34,19.18%,NDUFC2;NDUFA7;NDUFA5;NDUFA6;NDUFB5;NDUFA12;NDUFV1;NDUFB7;NDUFA4;NDUFA13;NDUFS1;NDUFB10;NDUFA1;NDUFB4;NDUFS7
prerank,chloride transmembrane transporter activity (GO:0015108),-0.6448927790254281,-1.6772742766305404,0.01006036217303823,0.1998843922099758,0.884,6/16,15.12%,SLC26A7;SLC26A2;SLC1A1;SLC4A8;SLC26A6;CFTR
prerank,quaternary ammonium group transmembrane transporter activity (GO:0015651),0.7320342227750267,1.6613614179907823,0.021653543307086614,0.4678237228292029,0.985,1/11,0.28%,SLC22A4
prerank,CoA-ligase activity (GO:0016405),0.70151134871715,1.6612623672852733,0.010040160642570281,0.4323671443080279,0.985,2/14,1.94%,ACSS3;ACSL1
prerank,bicarbonate transmembrane transporter activity (GO:0015106),-0.653960828685415,-1.6605946544849783,0.004081632653061225,0.22017198524978315,0.924,6/15,15.12%,SLC26A7;SLC26A2;SLC39A8;SLC4A8;SLC26A6;CFTR
prerank,fatty acid synthase activity (GO:0004312),-0.719381021701317,-1.6456213069723473,0.0108499095840868,0.23807082664843948,0.944,4/10,13.30%,ELOVL7;ELOVL5;ELOVL6;ELOVL1
prerank,"oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor (GO:0016620)",0.6637730060070679,1.6429069265026393,0.03076923076923077,0.4729664451109614,0.995,2/18,0.21%,ALDH1A1;ALDH1A2
prerank,semaphorin receptor binding (GO:0030215),-0.5741240566456287,-1.6357056701397712,0.020179372197309416,0.2454994710099754,0.956,10/23,11.12%,SEMA6A;SEMA7A;SEMA6D;SEMA3C;SEMA4D;SEMA3E;SEMA4B;SEMA5B;SEMA6C;SEMA3G
prerank,transmembrane receptor protein phosphatase activity (GO:0019198),-0.6416772779665787,-1.6296955689480084,0.01016260162601626,0.22890454111146913,0.964,5/16,6.18%,PTPRB;PTPRG;PTPRM;PTPRN2;PTPRC
prerank,transmembrane receptor protein tyrosine phosphatase activity (GO:0005001),-0.6416772779665787,-1.6296955689480084,0.01016260162601626,0.22890454111146913,0.964,5/16,6.18%,PTPRB;PTPRG;PTPRM;PTPRN2;PTPRC
prerank,oxidoreduction-driven active transmembrane transporter activity (GO:0015453),-0.4618418581901998,-1.628556711085856,0.005050505050505051,0.21822552590468897,0.965,31/57,30.86%,COX4I1;NDUFC2;NDUFA7;NDUFA5;NDUFA6;NDUFB5;NDUFA12;NDUFV1;NDUFB7;NDUFA4;UQCRH;COX6A1;NDUFA13;NDUFS1;UQCR11;COX8A;NDUFB10;COX5A;NDUFA1;UQCRQ;NDUFB4;NDUFS7;UQCRC1;UQCR10;NDUFA4L2;COX15;COX4I2;CYB561D2;NDUFC1;NDUFS2;NDUFS5
prerank,rRNA binding (GO:0019843),-0.4993164923470578,-1.6263710550509278,0.013793103448275862,0.20963594038781797,0.967,20/42,25.98%,RPL11;CAVIN1;RPL23;RPS9;RPS3;RPS14;RPL5;RCC1L;RPLP0;ERAL1;RPS5;RPL12;NOP53;ANG;PPAN;MRPS11;MRPS27;MRPS18C;MRPL11;MRPL18
prerank,sialyltransferase activity (GO:0008373),-0.5867260175352658,-1.6211081645184486,0.018036072144288578,0.2092417669005193,0.97,8/20,8.96%,ST3GAL4;ST6GALNAC3;ST3GAL6;ST6GAL1;ST8SIA4;ST6GALNAC5;ST8SIA1;ST8SIA6
prerank,poly(U) RNA binding (GO:0008266),0.6469525773114793,1.6165214207419392,0.02394106813996317,0.552040193179,0.999,7/20,5.80%,ATXN1;RBMS1;RBMS3;HNRNPC;PABPC4L;HNRNPH1;RBMS2
prerank,acetyltransferase activity (GO:0016407),0.5832236237178988,1.6158813576813962,0.018050541516245487,0.5205512695039055,0.999,15/31,20.56%,PAFAH2;NAA80;PAFAH1B3;SPHK1;DBT;KAT8;KAT6B;SMARCE1;SAT2;CREBBP;ESCO1;NAT8;NAT14;NAA50;KAT2B
prerank,metallopeptidase activity (GO:0008237),0.4551800083151688,1.6107605214298533,0.001524390243902439,0.5093217636344785,0.999,16/113,8.42%,ADAMTS12;ADAMTS9;PAPPA;ADAM12;TRABD2B;ADAMTS5;THSD4;ADAMTS10;ADAMTS15;MMP2;ADAMTS7;ACE;NRDC;MMP19;MMP9;ADAMTSL4
prerank,phosphatidylcholine transporter activity (GO:0008525),-0.6008956760831142,-1.5977871348264083,0.024761904761904763,0.24843017067971263,0.989,5/17,1.74%,ATP10A;PITPNC1;ATP8B1;PLTP;PITPNM2
prerank,calcium:sodium antiporter activity (GO:0005432),0.7321510203957413,1.5879915460683167,0.0430327868852459,0.5775156071244756,1.0,3/10,3.10%,SLC24A3;SLC8A3;SLC8A1
prerank,sodium:proton antiporter activity (GO:0015385),-0.6707982569765321,-1.5859431471051653,0.026415094339622643,0.2643716947712694,0.991,3/11,5.74%,SLC9A2;SLC9B2;SLC9A8
prerank,diacylglycerol kinase activity (GO:0004143),-0.6669175646961971,-1.5797136260841071,0.024344569288389514,0.2683387603596078,0.993,7/11,23.52%,DGKH;DGKB;DGKI;DGKZ;DGKG;DGKQ;DGKE
prerank,amino acid transmembrane transporter activity (GO:0015171),0.5021188249064984,1.5678480610906786,0.02680067001675042,0.6349575727905562,1.0,10/47,7.55%,SLC7A11;SLC22A4;SLC6A13;SLC22A2;SLC38A3;PDPN;SLC6A1;SLC38A9;SLC43A1;SLC1A5
prerank,metalloendopeptidase activity (GO:0004222),0.47334669994127093,1.5677047616081181,0.0110062893081761,0.6037017085834517,1.0,13/76,8.42%,ADAMTS12;ADAMTS9;TRABD2B;ADAMTS5;THSD4;ADAMTS10;ADAMTS15;MMP2;ADAMTS7;NRDC;MMP19;MMP9;ADAMTSL4
prerank,acylglycerol lipase activity (GO:0047372),-0.6600990499057559,-1.5668045465121498,0.023076923076923078,0.2890426810037203,0.997,3/11,9.03%,ABHD2;MGLL;LIPE
prerank,translation initiation factor activity (GO:0003743),-0.4871637407551794,-1.5617921178280434,0.020689655172413793,0.2899937027508536,0.998,19/36,24.80%,EIF3F;EIF1B;EIF3I;EIF4G3;EIF4G1;EIF3D;EIF3B;EIF2B5;EIF3C;EIF2B2;EIF1;EIF2A;EIF5B;EIF2D;EIF3A;EIF3G;EIF4E;EIF5;EIF3K
prerank,outward rectifier potassium channel activity (GO:0015271),0.696460398533179,1.5571346651013673,0.054466230936819175,0.618907297471202,1.0,4/11,4.29%,KCNK2;KCNA5;KCNT2;KCND3
prerank,cAMP-dependent protein kinase regulator activity (GO:0008603),0.6995118753725118,1.5539073654923807,0.04246284501061571,0.6047751946178299,1.0,1/10,0.09%,PRKAG2
prerank,protein tyrosine kinase activator activity (GO:0030296),-0.5678462825720795,-1.5531435269928366,0.02771855010660981,0.29839613664860254,0.998,9/19,26.83%,EFNA5;GAS6;PAK2;NRG3;GREM1;AFAP1L2;ABI1;DGKQ;ANGPT4
prerank,carboxylic acid transmembrane transporter activity (GO:0046943),0.4849858284910732,1.548071854546418,0.025041736227045076,0.6024823684683157,1.0,14/55,12.73%,SLC22A4;SLC6A13;SLC13A3;SLC16A12;SLC38A3;SLC6A12;PDPN;SLC38A9;SLC16A6;SLC19A2;SLC19A1;SLC36A2;SLC38A7;SLC38A2
prerank,transmembrane receptor protein tyrosine kinase activity (GO:0004714),0.48031069969728607,1.5441494444740413,0.024916943521594685,0.5916883561917816,1.0,18/60,11.64%,EPHA7;EFEMP1;EPHA3;FGFR2;FGFR4;KIT;PDGFRB;EPHA8;PDGFRA;EPHA4;DDR1;IGF1R;DDR2;RYK;MUSK;AXL;EPHA2;ERBB2
prerank,phospholipase activator activity (GO:0016004),0.7120256820561719,1.5428023989130317,0.0410958904109589,0.5731771331959071,1.0,2/10,1.95%,ARHGAP6;PDPK1
prerank,poly-pyrimidine tract binding (GO:0008187),0.5919783142542249,1.5378213862770116,0.05555555555555555,0.5709638251952827,1.0,7/23,5.80%,ATXN1;RBMS1;RBMS3;HNRNPC;PABPC4L;HNRNPH1;RBMS2
prerank,phospholipase binding (GO:0043274),0.6752127895317497,1.5350152222753801,0.06623931623931624,0.5605319978274919,1.0,3/13,1.95%,ARHGAP6;PRKN;PDPK1
prerank,acid-thiol ligase activity (GO:0016878),0.6634985646075843,1.534894975479624,0.0465587044534413,0.5409698684494746,1.0,3/13,8.97%,ACSS3;ACSL1;AASDH
prerank,chloride channel activity (GO:0005254),-0.4302858598136973,-1.5296736245267721,0.027989821882951654,0.350519443943407,1.0,21/59,25.22%,SLC26A7;ANO1;ANO4;CLIC4;GABRB3;GABRB1;CLCN5;TTYH3;TTYH2;ANO3;GABRG3;SLC1A4;ANO2;CFTR;GLRA3;GABRA5;GABRE;CLCN3;BEST1;GABRG2;GLRA1
prerank,L-glutamate transmembrane transporter activity (GO:0005313),0.647593208359801,1.527758158090922,0.05389221556886228,0.5487827183160592,1.0,5/14,11.83%,SLC7A11;SLC1A3;SLC25A18;SLC25A22;SLC38A7
prerank,histone methyltransferase activity (H3-K4 specific) (GO:0042800),0.6269125968923857,1.520406733428987,0.06595744680851064,0.5557467019032558,1.0,4/15,11.04%,KMT2A;ASH2L;SETD1A;KMT2B
prerank,C4-dicarboxylate transmembrane transporter activity (GO:0015556),0.6235732827989321,1.515834852553288,0.05197505197505198,0.5554684227726594,1.0,7/16,11.83%,SLC13A3;SLC25A18;SLC13A5;SLC1A5;SLC25A22;SLC25A11;SLC38A7
prerank,AMP binding (GO:0016208),0.6812578019616198,1.5125567375186344,0.06903765690376569,0.5494263665067509,1.0,3/11,7.55%,PRKAG2;PRKAG3;MPPED2
prerank,cation:chloride symporter activity (GO:0015377),-0.6550685300332116,-1.51110546213251,0.05018587360594796,0.38982187328922097,1.0,5/10,11.42%,SLC12A2;SLC12A7;SLC12A6;SLC12A8;SLC12A4
prerank,MAP kinase activity (GO:0004707),0.6327655691402702,1.5110893064204214,0.07755102040816327,0.5380550556755725,1.0,2/14,4.43%,MAPK4;MAPK9
prerank,GTPase activity (GO:0003924),-0.34842105017285463,-1.5099289682715364,0.0,0.37989336687210473,1.0,77/192,27.46%,DNM3;EEF1A1;RAP1A;RHOJ;KRAS;RAC1;RASL12;EEF2;RAB3C;RAB31;GNAL;ARHGDIB;RAB27A;GCH1;NRAS;RERG;RHOB;GBP4;RHOT1;GNA14;GNAI1;GNA12;MRAS;GFM1;ENTPD7;DNM2;RAB28;NKIRAS1;SEPTIN9;RAB38;GNA11;RHOA;GPN3;BMS1;RALB;ARL8A;RAB3B;GBP5;RHEB;RAB1A;GSPT2;DNM1;AGAP3;GBP3;RABL3;RHOG;TPPP;ATL2;RRAS;GNAZ;RRAGB;GNA13;RAB1B;RIT2;MTG1;RAB8A;MFN2;RAP1GAP;GNAO1;GNG3;TSR1;GEM;RAB3A;RAB14;RAB8B;HRAS;DRG2;RAB6B;RAB5B;RND1;RAB7A;GNB1;RNF112;RAB2A;ATL3;GNB2;EEF1A2
prerank,C-C chemokine receptor activity (GO:0016493),0.5857048332218195,1.5065234899478344,0.04725897920604915,0.537916484765906,1.0,4/21,4.17%,ACKR2;CCR9;CXCR5;CXCR6
prerank,lysine-acetylated histone binding (GO:0070577),0.576466445328009,1.5052911220231613,0.06614785992217899,0.5119136828013622,1.0,9/20,20.05%,KMT2A;DPF2;PSME4;PHIP;TRIM24;ATAD2B;BRD7;CARM1;BRDT
prerank,acetylation-dependent protein binding (GO:0140033),0.576466445328009,1.5052911220231613,0.06614785992217899,0.5119136828013622,1.0,9/20,20.05%,KMT2A;DPF2;PSME4;PHIP;TRIM24;ATAD2B;BRD7;CARM1;BRDT
prerank,insulin-like growth factor receptor binding (GO:0005159),0.6559882113969708,1.5003228251971954,0.06882591093117409,0.5137428535741553,1.0,3/12,3.59%,IGF1;GNAS;IGF2
prerank,cytokine receptor activity (GO:0004896),0.4378232184632261,1.491546856023186,0.022508038585209004,0.5276725310258223,1.0,7/83,4.17%,IL31RA;LEPR;ACKR2;CCR9;CNTFR;IL13RA1;GFRAL
prerank,monovalent cation:proton antiporter activity (GO:0005451),-0.6130200423742491,-1.4912814610463871,0.054820415879017016,0.4231707124119097,1.0,3/12,5.74%,SLC9A2;SLC9B2;SLC9A8
prerank,"hydrolase activity, hydrolyzing N-glycosyl compounds (GO:0016799)",-0.5721474959205728,-1.4899458394990166,0.058823529411764705,0.4136287211725276,1.0,11/16,31.88%,RPS3;CD38;ADPRH;SMUG1;NEIL1;NEIL3;NTHL1;SARM1;MACROD2;NEIL2;BST1
prerank,frizzled binding (GO:0005109),0.5095594041750854,1.4872217578964746,0.05740740740740741,0.5285244264600992,1.0,8/34,10.34%,WNT4;RNF43;WNT6;NDP;ZNRF3;WNT5B;RYK;DVL3
prerank,receptor antagonist activity (GO:0048019),0.6028067043667378,1.4864013841900956,0.07157464212678936,0.5180419958985463,1.0,3/17,2.70%,DKK3;PXDN;DKK1
prerank,sterol binding (GO:0032934),0.46384605475086277,1.4817960213626344,0.04833333333333333,0.5185352103661708,1.0,6/56,3.73%,RORA;SIDT1;OSBPL8;INSIG2;ABCA1;GRAMD1C
prerank,GDP-dissociation inhibitor activity (GO:0005092),-0.6113648528993474,-1.4812980714712078,0.037815126050420166,0.4262721471720921,1.0,7/13,16.80%,SH3BP4;ARHGDIB;ARHGDIA;CCDC88A;RANBP1;GDI2;GDI1
prerank,copper ion binding (GO:0005507),0.4973260434799446,1.481244146722944,0.04823747680890538,0.5077120357435246,1.0,10/42,11.01%,MOXD1;HEPH;SOD3;LOXL3;LACC1;COX17;CCS;DCT;PAM;ATP7B
prerank,nucleoside monophosphate kinase activity (GO:0050145),-0.5400271118308966,-1.4790499540046655,0.05803571428571429,0.42116677373045036,1.0,9/20,18.20%,TJP2;DLG2;MAGI3;CMPK1;GUK1;AK2;CASK;LRGUK;AK6
prerank,lipase activator activity (GO:0060229),0.6732491203847937,1.4730197285300402,0.09555555555555556,0.5199562753065563,1.0,2/10,1.95%,ARHGAP6;PDPK1
prerank,ubiquitin-like protein ligase activity (GO:0061659),0.3843761904178279,1.4706934833463827,0.004026845637583893,0.5150720178700999,1.0,66/232,17.97%,ASB2;PDZRN3;RNF220;TRIM63;RNF43;PRKN;PELI2;TRIM5;MGRN1;NEDD4;NEURL2;KCMF1;RNF138;RNF2;RNF217;ZNRF3;UFL1;LTN1;SH3RF1;FBXO44;RNF181;UBR2;RNF145;TRIM56;RNF152;SIAH2;RNF135;PIAS1;AMFR;WWP2;RNF216;RNF180;RC3H2;MDM2;ITCH;NHLRC1;SMURF2;FBXO6;RNF149;TRIM35;MYCBP2;DTX1;RBBP6;RNF14;SH3RF2;TRIM26;GID4;TRIM43;RCHY1;RNFT2;TRIM24;CBLB;TRIM62;BIRC2;UBR1;RNF122;CBX4;PPIL2;TRIM17;HECTD1;PELI3;TRIM69;DTX3L;NHLRC3;TRIM9;TRIM39
prerank,1-phosphatidylinositol-3-kinase regulator activity (GO:0046935),-0.5734843228973627,-1.4692449211903074,0.05656565656565657,0.4391382876284835,1.0,8/15,23.49%,PIK3R6;SOCS2;SOCS5;PIK3R5;CISH;PIK3R3;CCKBR;SOCS1
prerank,C-C chemokine binding (GO:0019957),0.5650672571583266,1.4680724549839486,0.06439393939393939,0.5120230193419006,1.0,4/22,4.17%,ACKR2;CCR9;CXCR5;CXCR6
prerank,NAD binding (GO:0051287),0.5431271035159128,1.4650900994264744,0.07352941176470588,0.5100264390364146,1.0,9/26,16.53%,ALDH1A1;CRYL1;SORD;NUDT6;PARP9;BDH2;CRYZ;SIRT3;ALDH2
prerank,cAMP response element binding (GO:0035497),0.659578084151185,1.4649970927000544,0.10084033613445378,0.49946792765495585,1.0,1/10,0.08%,CREB5
prerank,pyridoxal phosphate binding (GO:0030170),0.5746710572089533,1.463228917781275,0.05029013539651837,0.4943720015787129,1.0,6/20,13.34%,ABAT;CBS;ACCS;SRR;THNSL2;SHMT1
prerank,"oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor (GO:0016646)",0.6111789898139305,1.4601900995526083,0.08858267716535433,0.49311895461858724,1.0,3/14,5.31%,ALDH4A1;AASS;MTHFR
prerank,poly-purine tract binding (GO:0070717),0.5289191771159771,1.4592961898332102,0.08480565371024736,0.48563792537914446,1.0,6/27,5.80%,ATXN1;RBMS1;RBMS3;RBPMS;PABPC4L;RBMS2
prerank,ubiquitin protein ligase activity (GO:0061630),0.3810687699314145,1.451714105057589,0.009472259810554804,0.4981115524486758,1.0,66/228,18.30%,ASB2;PDZRN3;RNF220;TRIM63;RNF43;PRKN;PELI2;TRIM5;MGRN1;NEDD4;NEURL2;KCMF1;RNF138;RNF2;RNF217;ZNRF3;LTN1;SH3RF1;FBXO44;RNF181;UBR2;RNF145;TRIM56;RNF152;SIAH2;RNF135;AMFR;WWP2;RNF216;RNF180;RC3H2;MDM2;UBE4A;ITCH;NHLRC1;SMURF2;FBXO6;RNF149;TRIM35;MYCBP2;DTX1;RBBP6;RNF14;SH3RF2;TRIM26;GID4;TRIM43;RCHY1;RNFT2;TRIM24;CBLB;TRIM62;BIRC2;UBR1;RNF122;PPIL2;TRIM17;HECTD1;PELI3;TRIM69;DTX3L;NHLRC3;TRIM9;TRIM39;UBE4B;TRAF6
prerank,sulfotransferase activity (GO:0008146),0.506066543113346,1.4470787959538967,0.05935251798561151,0.5019493392318995,1.0,9/33,12.37%,HS3ST3A1;UST;TPST1;GAL3ST2;GAL3ST3;CHST3;CHST15;SULT4A1;HS6ST1
prerank,potassium ion transmembrane transporter activity (GO:0015079),-0.472181407856374,-1.4432439964477108,0.03829787234042553,0.5117176300824972,1.0,10/31,13.37%,SLC12A2;SLC12A7;KCNK5;ABCC9;SLC12A6;SLC12A8;KCNA1;SLC12A4;HCN1;TMEM38B
prerank,enoyl-CoA hydratase activity (GO:0004300),0.6573664688810364,1.4427880901178818,0.11776859504132231,0.5053638051370262,1.0,4/10,11.74%,EHHADH;ECHDC3;ECHDC1;AUH
prerank,histone demethylase activity (H3-K36 specific) (GO:0051864),0.6295190477504324,1.442082268351268,0.12200435729847495,0.497991496639457,1.0,4/10,7.85%,KDM7A;KDM2B;PHF8;KDM2A
prerank,nucleoside-triphosphatase activity (GO:0017111),-0.3244970065707311,-1.4409004643926104,0.0,0.5056265622258578,1.0,104/248,28.67%,DNM3;EEF1A1;RAP1A;RHOJ;KRAS;RAC1;HSP90AA1;MYL6;RASL12;EEF2;RAB3C;RAB31;GNAL;ARHGDIB;RAB27A;GCH1;NRAS;RERG;RHOB;GBP4;SMCHD1;RHOT1;GNA14;GNAI1;GNA12;MRAS;KIF26A;GFM1;ENTPD7;DNM2;ABCB10;MYH9;RAB28;NKIRAS1;SEPTIN9;RAB38;GNA11;TOR1B;RHOA;KIF1A;TOR3A;GPN3;BMS1;RALB;ARL8A;RAB3B;GBP5;RHEB;RAB1A;GSPT2;ATP2B1;DNM1;CLU;AGAP3;GBP3;ABCD2;RABL3;CFTR;RHOG;ABCA3;TPPP;ATL2;DHX29;RRAS;RUVBL1;GNAZ;RRAGB;GNA13;RAB1B;RIT2;MTG1;ATAD1;KIF15;RAB8A;VCP;MFN2;RAP1GAP;GNAO1;GNG3;HSPA1B;TSR1;GEM;RAB3A;RAB14;RAB8B;HRAS;DRG2;RAB6B;RAB5B;RND1;RAB7A;KIF14;GNB1;RNF112;RAB2A;ATL3;GNB2;EEF1A2;KLC1;DYNC1I1;GTPBP1;RAB20;GNG8;ABCB6
prerank,transmembrane receptor protein kinase activity (GO:0019199),0.45343818432527955,1.4387264114883456,0.046875,0.4984195657618078,1.0,17/60,11.64%,EPHA7;EPHA3;FGFR2;FGFR4;KIT;PDGFRB;EPHA8;PDGFRA;EPHA4;DDR1;IGF1R;DDR2;RYK;MUSK;AXL;EPHA2;ERBB2
prerank,store-operated calcium channel activity (GO:0015279),-0.6270015385333337,-1.4380192181811182,0.07198443579766536,0.5016547918662085,1.0,8/10,28.99%,TRPC3;TRPC6;TRPC4;STIM2;TRPC1;ORAI1;TRPC7;ORAI3
prerank,leak channel activity (GO:0022840),0.55889942797288,1.4380170804312935,0.11203319502074689,0.4914521302148673,1.0,3/18,6.27%,KCNK2;NALCN;TMEM175
prerank,phosphatidylinositol 3-kinase activity (GO:0035004),-0.6044968006985136,-1.4374712324151808,0.052123552123552123,0.4903035520582311,1.0,6/12,17.15%,PIK3R6;PIK3C2B;PIK3CD;PIK3C2A;PIK3C3;PIK3R3
prerank,ligand-gated anion channel activity (GO:0099095),-0.5465910199921825,-1.4346388466741542,0.08383233532934131,0.4863796935338749,1.0,9/17,25.22%,GABRB3;GABRB1;GABRG3;CFTR;GLRA3;GABRA5;GABRE;GABRG2;GLRA1
prerank,phosphatidylglycerol binding (GO:1901611),-0.5770309636208635,-1.4306063464511385,0.09108159392789374,0.4882817370281414,1.0,6/13,17.31%,PITPNC1;PLTP;STOML2;PLEKHN1;UQCC3;PITPNA
prerank,histone demethylase activity (GO:0032452),0.5101273451807052,1.428017703549667,0.08349146110056926,0.511815855370354,1.0,13/27,17.42%,KDM7A;JARID2;KDM2B;PHF8;KDM2A;KDM5B;KDM3B;KDM6B;KDM5C;PHF2;KDM6A;RIOX2;KDM4D
prerank,transmembrane receptor protein serine/threonine kinase binding (GO:0070696),0.6287334715716123,1.4273502044691662,0.0970464135021097,0.5048237736812694,1.0,2/13,1.28%,BMP6;BMP7
prerank,BMP receptor binding (GO:0070700),0.6287342676339569,1.4245496010541976,0.10772357723577236,0.5043064540062666,1.0,2/12,1.28%,BMP6;BMP7
prerank,glutamate receptor binding (GO:0035254),-0.5240205935149801,-1.424417885951497,0.06952965235173825,0.49590647932832843,1.0,5/17,8.61%,HIP1;SHANK3;NSF;HOMER1;SYNDIG1
prerank,chemokine receptor activity (GO:0004950),0.5340541766342489,1.4215114313237769,0.09056603773584905,0.5048724095906814,1.0,4/24,4.17%,ACKR2;CCR9;CXCR5;CXCR6
prerank,pyrophosphate hydrolysis-driven proton transmembrane transporter activity (GO:0009678),-0.5146731243259329,-1.418646728067223,0.06170212765957447,0.5032409209384062,1.0,14/22,24.56%,ATP6V0A1;ATP2C1;ATP2A3;ATP2A2;ATP6V1A;ATP6V0C;ATP6V1E1;TCIRG1;ATP6V0A4;ATP5F1B;ATP6V0A2;ATP6V0D2;ATP6V0E2;ATP6V1B2
prerank,"2 iron, 2 sulfur cluster binding (GO:0051537)",-0.5782827488396634,-1.4164387749324863,0.10505836575875487,0.4981963757075574,1.0,7/12,23.32%,CISD2;ISCU;CISD1;XDH;CIAPIN1;ISCA2;ISCA1
prerank,ankyrin binding (GO:0030506),-0.5208251821343723,-1.413477247111093,0.078,0.49657693158552296,1.0,7/19,14.90%,SPTBN1;CDH1;PLEC;NRCAM;PTPRC;SPTBN4;KCNQ2
prerank,"oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen (GO:0016709)",0.5223412948546727,1.4128181326120717,0.11328125,0.5202125054684663,1.0,3/25,1.12%,CYP26B1;MICAL3;CYP27A1
prerank,histone methyltransferase binding (GO:1990226),-0.5934102264988835,-1.4114359533984544,0.08565737051792828,0.49249340476544595,1.0,3/11,6.03%,HSP90AB1;LCORL;CTNNB1
prerank,metal ion:proton antiporter activity (GO:0051139),-0.5683724797843113,-1.410356066470915,0.09864603481624758,0.4848438820167653,1.0,3/13,5.74%,SLC9A2;SLC9B2;SLC9A8
prerank,disordered domain specific binding (GO:0097718),-0.49196745741426556,-1.4071856601590904,0.08008213552361396,0.4838287005495432,1.0,7/23,10.77%,FN1;HSP90AA1;CALM1;HSP90AB1;FYN;GAPDH;KCNA1
prerank,RNA binding (GO:0003723),-0.27984521510188975,-1.4069750015820908,0.0,0.47451314985870746,1.0,399/1321,23.09%,MSI2;SPTBN1;SORBS2;TMSB4X;SYNE1;MBNL1;EEF1A1;ACTN4;LRRFIP1;MSN;HSPA8;RPL37A;TFRC;FAU;RPL41;NOVA2;TPT1;RPL13;RPL11;RPS21;HSP90AA1;RPL27A;CAVIN1;TES;HSP90AB1;RPL17;RPL23;RPS24;RPL19;RPL21;HNRNPK;PPARGC1A;RPS9;TARDBP;ADARB1;RPL38;RPL6;AHNAK;RPS15;CMSS1;EEF2;RPL37;PLEC;SUCLG1;RPL4;RPS8;VIM;MAP4;RPS7;RPL8;RPS23;RPSA;PPIA;RACK1;RPS3;RPS19;ADARB2;PKM;RPS11;RPL34;SMC1A;RPL18A;RPL28;RBFOX1;QKI;PSTK;RPL26;IREB2;UCHL5;CDK11B;RPL24;RBFOX3;RPS14;LUC7L2;FLNA;HSPB1;RPS12;RPS6;ACTN1;RPL23A;RPL18;HNRNPAB;SRSF2;ATP5F1A;G3BP1;RPS20;CKAP4;PABPC1;RBFOX2;SRP9;PINX1;RBM47;RFTN1;YBX3;TRIM25;CALR;RPS18;RTCB;EIF1B;RPS25;RPL3;HSP90B1;RPL32;SARS1;TFB2M;SLC3A2;SRSF1;RPL36;UBC;RPS27A;ATXN2L;LGALS1;SRRM3;TCF20;KCTD12;GNL3;COL14A1;RPL5;RPL14;HNRNPU;GFM1;ARF1;HNRNPA3;PUM2;DCAF13;RPS2;MTHFSD;JUN;SFPQ;CISD2;RPL27;PPIE;MYH9;EIF3I;LARP7;RPS27;YBX1;RCC1L;MRPL32;RPL29;SF3B1;SF3B2;DDX5;RPL31;CPSF7;RALYL;TIAL1;EIF4G3;RBM14;PATL1;PHF5A;GRN;KHDC4;LLPH;STRBP;CPNE3;PPP1R10;DDX52;PYM1;CCDC47;ZC3H12C;RPLP0;STAU1;DDX20;DIDO1;SRSF5;ADAR;RTN4;MAK16;APEH;IMP3;DDX39B;PDAP1;PPIB;RPL35A;PDCD11;ZC3H8;EIF4G1;EIF3D;RPL7A;SSB;ANKHD1;MRPS14;BMS1;MEPCE;RPL7;RPS28;YWHAG;TUBB4B;POP5;LBR;NUDT4;TUBA1B;S100A16;RPS10;RPS17;CPSF3;RPN1;RALY;KIN;CLNS1A;SRSF9;RSL1D1;RPUSD4;PTPN1;RPL30;CWC15;DDX54;STAT3;HNRNPH2;CPSF6;RPS4X;RBM8A;ZFP36L1;YTHDF3;TASOR;DGCR8;RANGAP1;GSPT2;MYBBP1A;MARK2;OAS2;ZRANB2;ERAL1;DHX37;KHDRBS3;STRAP;DNM1;SNRPC;ALDH18A1;HSPD1;EIF4H;MYO5A;WDR3;PRPF40B;RNPS1;EIF3B;SRSF6;ZCCHC9;BUD23;FBL;SRPK1;RPS27L;CANX;RSL24D1;SAMSN1;ALDOA;YARS1;RPP21;NUDT1;GDI2;SF3B5;ALKBH8;MTCL1;HNRNPDL;RPS26;POP4;GRSF1;RPS16;LARP1B;SHFL;RCC2;PPRC1;NUFIP2;FUS;NELFCD;RPF1;RPS5;RIDA;HNRNPA0;MRPL23;IFIH1;GLRX3;DHX32;AKAP8;MRPS5;RPL13A;RTRAF;RBM42;EIF3C;AGFG1;TENT5A;POLR2G;RRBP1;TBL2;IMMT;AKAP1;LIN28B;FASN;SERBP1;CPSF2;DHX29;EIF1;TOP2A;RBM28;ZC3H7A;SAFB2;YTHDC2;N4BP1;COA6;BTF3;EIF2A;CSTF2;RPL36A;ZC3H12A;RPP30;NELFE;UTP18;UTP15;SPEN;TBL3;DSP;RPL12;PCBP1;CSTF2T;ZBED4;EIF5A;SMG5;PCF11;MRPS28;MRPS35;YTHDC1;BST2;FASTKD3;DALRD3;SUPV3L1;RPL9;MRPL13;EBNA1BP2;EDC3;EXOSC10;NOP53;HSPA9;THUMPD1;NOLC1;KRI1;RPL35;MEX3A;FKBP4;R3HDM1;HNRNPLL;ANG;EIF5B;MTREX;ADD1;HNRNPUL1;PTBP1;MAGOH;AGO3;PCBP4;MEX3B;CTNNA1;PPP1CC;TSN;ELP5;METTL3;NKAP;PRKRIP1;MAPRE1;FARSA;DDX24;SNIP1;RBM22;CCDC124;NOC2L;TSNAX;DDX17;RO60;PWP2;PURG;LRRC47;EIF4B;NHP2;EIF3A;CCDC137;EIF3G;MAZ;TRA2B;RPL22;UBA1;SLTM;TRMT10C;PPAN;FMR1;VCP;NTPCR;TRUB2;SNRPG;DUSP11;MRPS23;RBM20;MKI67;EIF4E;PUM3;HUWE1;HSPA1B;TSR1;NOP16;MRM3
prerank,RNA polymerase II transcription regulatory region sequence-specific DNA binding (GO:0000977),0.32897210367974017,1.4063902514697946,0.0,0.5308042154182759,1.0,139/831,13.60%,GLIS3;CREB5;RORA;SOX5;MAF;TCF7L2;TCF4;OSR1;AEBP1;RBPJ;ARNT2;ZIC1;HOXC6;PPARA;EPAS1;HLF;NR2F2;IKZF2;NPAS3;HOXC4;ZEB2;KCNIP3;ZKSCAN2;PRRX1;MEIS1;HOXB4;ESRRG;MXI1;ZEB1;CUX1;MYBL1;PRDM5;SATB1;ZIC2;EBF1;ZBTB20;DMRT1;SCX;NR1I2;ASCL2;SOX6;HOXB3;PAX5;HIF3A;NFYB;ZIC5;BBX;HOXA3;PKNOX2;STAT5B;HOXC5;VSX2;NFAT5;ZFP90;ELF4;TEAD1;HOXA7;FOXD1;ZNF367;MGA;NFIB;TEF;GMEB1;IKZF4;ZNF250;SOX1;GLI3;SALL4;ZFHX2;SIX5;IRF8;HIVEP2;ZNF569;ZBTB32;MYNN;MXD1;ZFP37;TCF7L1;SALL1;THAP1;ZNF23;SMAD3;TEAD3;RFXAP;EN1;PBX4;NR6A1;TCF12;ZKSCAN5;RBL2;ARNT;MITF;NFIA;ZNF628;KDM6B;CEBPG;EBF4;NSD1;IRF3;ZSCAN29;NFYC;BATF2;HDAC1;HOXB6;IRX1;ZIC4;ZBTB11;ZNF8;NEUROD2;ATOH8;ZBTB38;SNAI1;TFAP2A;HOXC8;TFAP2B;ZNF568;NPAS2;ZNF177;RXRA;ZBTB37;MYB;E2F6;ZBTB39;HIVEP1;GLI2;MLXIP;FOXK2;GMEB2;BATF;AR;HSF1;SOX13;NFATC4;KLF5;HOXA6;CLOCK;NR1I3;HOXD4;MEIS2
prerank,phosphatidylinositol 3-kinase regulator activity (GO:0035014),-0.5274595179131079,-1.4051829377558205,0.08315565031982942,0.46998635219298424,1.0,8/18,23.49%,PIK3R6;SOCS2;SOCS5;PIK3R5;CISH;PIK3R3;CCKBR;SOCS1
prerank,N-acetyltransferase activity (GO:0008080),0.5691551141596046,1.402746275293111,0.11538461538461539,0.5328906790789673,1.0,9/19,20.56%,NAA80;AANAT;SMARCE1;SAT2;ESCO1;NAT8;NAT14;NAA50;KAT2B
prerank,leucine zipper domain binding (GO:0043522),0.6302195517094119,1.4015540245154259,0.12896825396825398,0.5275932260679647,1.0,1/10,0.81%,PAWR
prerank,androgen receptor binding (GO:0050681),-0.4801585645020032,-1.4001209438285316,0.06304347826086956,0.47656379050096365,1.0,8/25,9.43%,FOXP1;CALR;KDM4C;KDM3A;DDX5;ARID5A;TMF1;ZBTB7A
prerank,GTPase regulator activity (GO:0030695),0.3630667640190472,1.399475273863869,0.019662921348314606,0.524896135414844,1.0,34/212,9.43%,ARHGAP28;RANBP3L;ALDH1A1;ARHGAP24;ERRFI1;GMIP;NPRL3;RIN2;ARHGAP29;ASAP1;SMAP2;PLCB1;ARHGAP20;ALS2;ARFGAP3;SYDE2;LLGL2;ARHGAP26;CPEB2;NPRL2;LRRK2;WASL;ARHGAP40;HACD3;ASAP3;TBC1D9B;GNAQ;ARHGAP35;ARHGAP9;MYO9B;SIRPA;TBC1D4;ARHGEF10L;GNB5
prerank,ubiquitin-dependent protein binding (GO:0140036),-0.5951113464847779,-1.3978045324216437,0.10128913443830571,0.4745718394885857,1.0,5/10,19.24%,ANKRD13A;IDE;LAPTM5;FAAP20;ANKRD13B
prerank,death receptor binding (GO:0005123),-0.545825959588819,-1.3944170192175056,0.084,0.4763795953548842,1.0,11/15,32.69%,DAB2IP;NGF;EDA;TMBIM1;MADD;CASP8AP2;MYD88;BID;FADD;PIDD1;NTF3
prerank,protein binding involved in heterotypic cell-cell adhesion (GO:0086080),-0.6112863786425471,-1.3922082768772177,0.09900990099009901,0.47415867957307195,1.0,6/10,17.88%,CD200;CXADR;CD47;JUP;DSG2;DSP
prerank,L-amino acid transmembrane transporter activity (GO:0015179),0.4454400689334678,1.3906008921669397,0.06942148760330578,0.5407238612332628,1.0,16/53,13.05%,SLC7A11;SLC22A2;SLC38A3;SLC6A9;SLC1A3;SLC25A18;SLC38A9;SLC43A1;SLC1A5;SLC25A22;SLC36A2;SLC38A7;SLC25A2;SLC38A2;SLC25A38;OCA2
prerank,RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978),0.3264203615046694,1.3896335709954168,0.0011160714285714285,0.5350620235108987,1.0,128/731,13.72%,GLIS3;CREB5;RORA;SOX5;MAF;TCF7L2;TCF4;RBPJ;ARNT2;ZIC1;HOXC6;PPARA;HLF;NR2F2;IKZF2;HOXC4;ZEB2;KCNIP3;ZKSCAN2;PRRX1;MEIS1;HOXB4;ESRRG;MXI1;ZEB1;MYBL1;PRDM5;SATB1;ZIC2;EBF1;ZBTB20;DMRT1;SCX;NR1I2;ASCL2;SOX6;HOXB3;PAX5;HIF3A;NFYB;ZIC5;HOXA3;PKNOX2;STAT5B;HOXC5;NFAT5;ELF4;TEAD1;HOXA7;FOXD1;ZNF367;MGA;NFIB;TEF;GMEB1;IKZF4;ZNF250;SOX1;GLI3;SALL4;ZFHX2;SIX5;IRF8;HIVEP2;ZNF569;ZBTB32;MYNN;MXD1;TCF7L1;SALL1;THAP1;ZNF23;SMAD3;TEAD3;EN1;PBX4;NR6A1;TCF12;ZKSCAN5;ARNT;MITF;NFIA;ZNF628;KDM6B;CEBPG;CREB3L2;EBF4;NSD1;IRF3;ZSCAN29;NFYC;BATF2;HDAC1;HOXB6;IRX1;ZIC4;ZBTB11;ZNF8;NEUROD2;ATOH8;ZBTB38;SNAI1;TFAP2A;TFAP2B;ZNF568;NPAS2;RXRA;ZBTB37;MYB;E2F6;ZBTB39;HIVEP1;GLI2;MLXIP;FOXK2;GMEB2;BATF;AR;HSF1;SOX13;NFATC4;KLF5;HOXA6;CLOCK;NR1I3;HOXD4;MEIS2;HOXB9
prerank,peptidase inhibitor activity (GO:0030414),0.4944913175258856,1.388586727664874,0.09557522123893805,0.5297837756182024,1.0,9/33,11.25%,TFPI;ITIH2;PROS1;SERPIND1;A2ML1;GPC3;SIMC1;CST7;RENBP
prerank,hydro-lyase activity (GO:0016836),0.4693339937218144,1.3846435260423051,0.09090909090909091,0.533229554443742,1.0,12/41,14.37%,GMDS;CBS;HACD1;EHHADH;HACD3;ECHDC3;ECHDC1;L3HYPDH;AUH;ENO2;FAHD2A;ACO2
prerank,phosphatidic acid binding (GO:0070300),-0.510475826981083,-1.384331002502075,0.09381237524950099,0.48926672383767233,1.0,8/19,19.12%,PITPNC1;PLTP;PACSIN2;MARK1;PLEKHN1;ATP13A2;UQCC3;JPH2
prerank,sulfate transmembrane transporter activity (GO:0015116),-0.5525694370381311,-1.383292204300111,0.09561752988047809,0.48402066556371315,1.0,5/14,17.61%,SLC26A7;SLC26A2;SLC26A6;SLC25A30;SLC26A11
prerank,G protein-coupled chemoattractant receptor activity (GO:0001637),0.5681088115080523,1.3817640249385439,0.13070539419087138,0.5340605800627294,1.0,2/15,1.54%,ACKR2;CCR9
prerank,cis-regulatory region sequence-specific DNA binding (GO:0000987),0.3231362641633627,1.3757604000016252,0.002232142857142857,0.5425325340059741,1.0,126/732,13.72%,GLIS3;CREB5;RORA;SOX5;MAF;TCF7L2;TCF4;RBPJ;ARNT2;ZIC1;HOXC6;PPARA;HLF;NR2F2;IKZF2;HOXC4;ZEB2;KCNIP3;ZKSCAN2;PRRX1;MEIS1;HOXB4;ESRRG;MXI1;ZEB1;MYBL1;PRDM5;SATB1;ZIC2;EBF1;ZBTB20;DMRT1;NR1I2;ASCL2;SOX6;HOXB3;PAX5;HIF3A;NFYB;ZIC5;HOXA3;PKNOX2;STAT5B;HOXC5;NFAT5;ELF4;TEAD1;HOXA7;FOXD1;ZNF367;MGA;NFIB;TEF;GMEB1;IKZF4;ZNF250;SOX1;GLI3;SALL4;ZFHX2;SIX5;IRF8;HIVEP2;ZNF569;ZBTB32;MYNN;MXD1;TCF7L1;SALL1;THAP1;ZNF23;SMAD3;TEAD3;EN1;PBX4;NR6A1;TCF12;ZKSCAN5;ARNT;MITF;NFIA;ZNF628;KDM6B;CEBPG;EBF4;NSD1;IRF3;ZSCAN29;NFYC;BATF2;HDAC1;HOXB6;IRX1;ZIC4;ZBTB11;ZNF8;NEUROD2;ATOH8;ZBTB38;SNAI1;TFAP2A;TFAP2B;ZNF568;NPAS2;RXRA;ZBTB37;MYB;E2F6;ZBTB39;HIVEP1;GLI2;MLXIP;FOXK2;GMEB2;BATF;AR;HSF1;SOX13;NFATC4;KLF5;HOXA6;CLOCK;NR1I3;HOXD4;MEIS2;HOXB9
prerank,2-oxoglutarate-dependent dioxygenase activity (GO:0016706),0.46829330431211874,1.3752047096279145,0.11153846153846154,0.5365554056252316,1.0,8/32,8.88%,KDM7A;KDM2B;TET1;PHF8;BBOX1;KDM2A;TMLHE;PHYH
prerank,ion gated channel activity (GO:0022839),-0.4680252259490823,-1.3737936028400983,0.08471074380165289,0.5036351582698071,1.0,9/24,19.77%,ANO1;ANO4;TTYH3;TTYH2;KCNT1;ANO3;ANO2;TRPM4;ANO8
prerank,chemokine binding (GO:0019956),0.4803491785910435,1.3734707068432888,0.1111111111111111,0.5336267215436493,1.0,5/30,4.17%,ACKR2;CCR9;CXCR5;PDPN;CXCR6
prerank,ubiquitin protein ligase binding (GO:0031625),-0.3066120030131827,-1.3704957240691604,0.012195121951219513,0.5044169293018724,1.0,92/254,23.75%,ACTG1;PRR5L;HSPA8;RPL11;HSP90AA1;HSP90AB1;ATXN3;RPL23;PPARGC1A;FBXO7;UBB;NFKBIA;DNAJA1;MID1;TRIB2;FZD4;UBXN1;FZD6;CALR;FAF1;NEDD8;ARRB1;UBC;RPS27A;NKD2;BAG6;RPL5;GSK3B;TNFRSF1B;UCHL1;APBB1;CUL3;JUN;MAP1LC3B;BAG1;SMAD5;DERL1;CHEK2;FOXO1;RBX1;UBE2B;RTN4;APC;ATP6V0C;RALB;HSPA5;TUBA1B;ISG15;CAMLG;HSPD1;OTUB1;CLU;PRKAR1A;ELOB;RNF34;TPI1;CKB;TRAF1;CUL1;ERLIN2;UBA52;UBE2G1;WFS1;CASP8;LAPTM5;SPOPL;PER1;HERC2;AUP1;SMG5;UBE2D1;PINK1;TMBIM6;SCAMP3;ARRB2;HSPA9;CD40;UQCRC1;GABARAPL1;DIO2;KCNH2;HDAC6;CDKN1A;UBOX5;VCP;ARIH1;MFN2;HSPA1B;JAK1;RELA;TRIB3;CUL2
prerank,"phosphotransferase activity, for other substituted phosphate groups (GO:0016780)",-0.5797517051908828,-1.368309835833848,0.09333333333333334,0.50267706743949,1.0,2/11,0.96%,SGMS1;SGMS2
prerank,triglyceride lipase activity (GO:0004806),0.5208077260354855,1.3630941382556494,0.11359404096834265,0.5546731352768329,1.0,4/20,7.82%,CEL;LIPC;LIPH;DAGLB
prerank,GTP binding (GO:0005525),-0.3232252318280555,-1.3618232961573897,0.018867924528301886,0.5138280693833388,1.0,62/172,25.44%,EEF1A1;RAP1A;RHOJ;KRAS;RAC1;RASL12;RAB31;RAB27A;TGM2;GCH1;NRAS;RERG;RHOB;TUBB3;GBP4;ARF5;RHOT1;SCG5;GNAI1;MRAS;GNL3;ARF1;DNM2;RAB28;RAB38;RHOA;ARHGEF5;BMS1;RALB;TUBB4B;ARL8A;GBP5;TUBA1B;RHEB;TUBB2A;GBP3;TUBA1A;RABL3;RHOG;EIF2B2;ATL2;RRAS;TUBB4A;RRAGB;RAB1B;RIT2;RAB39A;INSR;ARFIP2;RAB8A;TUBD1;TSR1;GEM;SEPHS1;RAB14;ARL4A;NUDT16;HRAS;DRG2;TUBB2B;RND1;RAB7A
prerank,FAD binding (GO:0071949),0.5186892458856144,1.3581067607043644,0.10546875,0.5607783694988386,1.0,7/24,12.45%,MICAL3;DDO;SQOR;MTHFR;NDOR1;CRY1;PRODH
prerank,phosphatidylinositol phosphate kinase activity (GO:0016307),-0.5522109797745905,-1.3571848257381238,0.11328125,0.5191559787475754,1.0,4/13,10.44%,PIP5K1B;PIK3C2B;PIK3CD;PIK3C2A
prerank,potassium:proton antiporter activity (GO:0015386),-0.5904434404752144,-1.3533035777901272,0.11753731343283583,0.5223214112021728,1.0,2/10,5.74%,SLC9A2;SLC9A8
prerank,transferrin receptor binding (GO:1990459),-0.5697930961174105,-1.3514635003409907,0.1217564870259481,0.5194518034845867,1.0,5/10,20.99%,IKBKB;CHUK;CD81;SNX1;SNX2
prerank,poly(A) binding (GO:0008143),0.5275319508822963,1.351043072797714,0.13851992409867173,0.5727824858301107,1.0,5/21,5.80%,RBMS1;RBMS3;RBPMS;PABPC4L;RBMS2
prerank,purine ribonucleotide transmembrane transporter activity (GO:0005346),-0.575449941381009,-1.348637919939476,0.1339622641509434,0.5201830175391222,1.0,5/11,15.86%,SLC25A25;LRRC8A;SLC25A42;SLC35B2;SLC17A9
prerank,ATPase binding (GO:0051117),-0.36171123984313125,-1.34222660473198,0.05808080808080808,0.5300619480018102,1.0,26/71,17.54%,CAV1;PDE4D;ESR1;ATXN3;ATP1B1;UBXN1;ATP6V0A1;NKD2;DERL1;S100A1;RALB;PIH1D1;ATP6V1E1;TCIRG1;SVIP;PPP3CA;FBL;NR1H2;BBC3;TRPC1;WFS1;DNAJC10;ATP5IF1;PLN;ATP6V0A4;DNAJB1
prerank,ubiquitin-like protein ligase binding (GO:0044389),-0.29594114488134254,-1.3361920447690623,0.008130081300813009,0.5394174448163075,1.0,94/269,23.75%,ACTG1;PRR5L;HSPA8;RPL11;HSP90AA1;HSP90AB1;ATXN3;RPL23;PPARGC1A;FBXO7;UBB;NFKBIA;DNAJA1;MID1;TRIB2;FZD4;UBXN1;FZD6;CALR;FAF1;NEDD8;ARRB1;UBC;RPS27A;NKD2;BAG6;RPL5;GSK3B;TNFRSF1B;UCHL1;APBB1;CUL3;JUN;MAP1LC3B;BAG1;SMAD5;DERL1;CHEK2;FOXO1;RBX1;UBE2B;RTN4;APC;ATP6V0C;RALB;HSPA5;TUBA1B;ISG15;CAMLG;HGS;HSPD1;OTUB1;CLU;PRKAR1A;ELOB;RNF34;TPI1;CKB;TRAF1;CUL1;ERLIN2;UBA52;UBE2G1;WFS1;CASP8;LAPTM5;SPOPL;PER1;SUMO3;HERC2;AUP1;SMG5;UBE2D1;PINK1;TMBIM6;SCAMP3;ARRB2;HSPA9;CD40;UQCRC1;GABARAPL1;DIO2;KCNH2;HDAC6;CDKN1A;UBOX5;VCP;ARIH1;MFN2;HSPA1B;JAK1;RELA;TRIB3;CUL2
prerank,deubiquitinase activity (GO:0101005),-0.35096461444656335,-1.3360130246402637,0.056451612903225805,0.531676735840515,1.0,39/88,29.36%,USP53;ATXN3;USP38;OTUD7A;MINDY2;PAN2;UCHL5;MINDY1;EIF3F;USP29;USP31;UCHL1;ZRANB1;USP50;USP39;USP37;OTUB1;UCHL3;OTUD3;OTUD1;USP28;USP8;MYSM1;ZC3H12A;USP9X;OTUD6B;OTUD7B;USP5;OTULIN;USP49;JOSD2;TNFAIP3;YOD1;USP33;USP2;USP22;USP32;USP10;USP9Y
prerank,protein serine/threonine phosphatase activity (GO:0004722),0.4163835002710942,1.3340646480384368,0.10918544194107452,0.6126538153344273,1.0,10/60,7.47%,LRRK1;PPM1M;CTDSPL;SSU72;CDC14B;PPM1E;LRRK2;MTMR3;LRRC40;PTEN
prerank,PDZ domain binding (GO:0030165),0.42026281905586876,1.3326330224719598,0.1011608623548922,0.6089246310199458,1.0,11/61,8.36%,TGFBR3;SLC22A4;ARHGAP29;PLEKHA2;PRKN;SDC2;LLGL2;SSTR2;SYNJ2;PTEN;SRR
prerank,protein kinase A catalytic subunit binding (GO:0034236),-0.5370714565618216,-1.3293076709298342,0.118,0.5433750960019954,1.0,5/13,13.15%,CSK;GSK3B;KCNQ1;RYR2;PRKAR1A
prerank,alkali metal ion binding (GO:0031420),0.5668285858301423,1.3284524149168586,0.18548387096774194,0.6134984010163876,1.0,1/13,0.21%,ATP1A2
prerank,Wnt-activated receptor activity (GO:0042813),-0.5202472586779339,-1.3271688723422617,0.15082644628099173,0.5414230740664835,1.0,5/15,6.32%,PKD1;FZD4;FZD6;ROR1;LRP5
prerank,histone methyltransferase activity (H3-K9 specific) (GO:0046974),-0.5765710300937155,-1.3265613052462746,0.13394495412844037,0.5351712440389733,1.0,2/10,4.41%,MECOM;PRDM16
prerank,"4 iron, 4 sulfur cluster binding (GO:0051539)",-0.5221991222269418,-1.325568076771137,0.13465346534653466,0.5305536832578613,1.0,6/14,19.27%,IREB2;ISCU;NDUFS1;RSAD2;RSAD1;ISCA2
prerank,protein tyrosine kinase activity (GO:0004713),0.37387373407411767,1.3237951197348492,0.06842923794712286,0.6192493646480296,1.0,24/108,11.96%,EPHA7;EPHA3;FGFR2;FGFR4;KIT;PDGFRB;FER;EPHA8;PDGFRA;EPHA4;BAZ1B;DDR1;IGF1R;TTK;DDR2;RYK;MUSK;FRK;ABL1;JAK2;AXL;EPHA2;ERBB2;HIPK3
prerank,inorganic anion transmembrane transporter activity (GO:0015103),-0.4393504445022438,-1.3220010572055887,0.11041666666666666,0.5329979376275055,1.0,11/27,18.75%,SLC26A7;SLC26A2;ANO1;SLC39A8;LRRC8A;SLC26A6;SLC25A30;XPR1;SLC26A11;ANKH;SLC39A14
prerank,CARD domain binding (GO:0050700),-0.5214757774652703,-1.3210446359358456,0.15447154471544716,0.5286945004375727,1.0,9/14,31.51%,NOD1;CARD10;CARD14;CARD16;CARD19;CASP1;CARD11;MAVS;NOD2
prerank,GABA-gated chloride ion channel activity (GO:0022851),-0.5502314125313023,-1.3195904565122762,0.15891472868217055,0.5253743768153033,1.0,8/12,35.03%,GABRB3;GABRB1;GABRG3;GABRA5;GABRE;GABRG2;GABRG1;GABRB2
prerank,adenine nucleotide transmembrane transporter activity (GO:0000295),-0.5489619662686315,-1.3189534717607445,0.15917602996254682,0.5201611609996128,1.0,5/12,15.86%,SLC25A25;LRRC8A;SLC25A42;SLC35B2;SLC17A9
prerank,double-stranded RNA binding (GO:0003725),-0.35987139568440973,-1.318396294053092,0.0712401055408971,0.5147473136483646,1.0,20/70,13.03%,MBNL1;LRRFIP1;MSN;TFRC;HSP90AB1;ADARB1;VIM;ADARB2;ACTN1;RFTN1;SLC3A2;HNRNPU;STRBP;ADAR;TUBB4B;TUBA1B;DGCR8;OAS2;HSPD1;EIF4H
prerank,MHC protein binding (GO:0042287),-0.4703757067500979,-1.3167346733937302,0.1349036402569593,0.512318275396476,1.0,7/20,18.17%,ATP5F1A;DERL1;TUBB4B;CD74;CD81;TAPBP;ATP5F1B
prerank,C2H2 zinc finger domain binding (GO:0070742),-0.5429003299769696,-1.3131492044621254,0.1691449814126394,0.5152985180895602,1.0,2/11,5.15%,LEF1;GATA2
prerank,Tat protein binding (GO:0030957),-0.5750961385949189,-1.3098982858082588,0.15818181818181817,0.5179802650491963,1.0,5/10,22.09%,ACTB;DNAJA1;MDFIC;GABARAPL1;DLL1
prerank,P-type ion transporter activity (GO:0015662),-0.5545823103700481,-1.3098450394190617,0.14035087719298245,0.511578330332917,1.0,7/12,19.19%,ATP2C1;ATP2A3;ATP2A2;ATP6V1E1;ATP2B1;ATP2B2;ATP2B4
prerank,protein tyrosine kinase binding (GO:1990782),-0.35209928990484574,-1.30954520375734,0.06476683937823834,0.5061133947868903,1.0,21/71,14.03%,GRB14;TJP2;PITPNM2;GAS6;HSP90AA1;PTPN14;CBL;ITGB1;RACK1;BMPR2;NCK1;TOB1;SOCS5;CEACAM1;CPNE3;CRK;DUSP3;PTPN1;PITPNM3;NEDD9;NRG3
prerank,fibroblast growth factor binding (GO:0017134),0.5030024579282829,1.3091551265750627,0.146484375,0.6541362250329713,1.0,4/21,3.26%,FGFR2;FGFR4;KL;CXCL13
prerank,guanyl ribonucleotide binding (GO:0032561),-0.30449862588786186,-1.3072479045914853,0.029411764705882353,0.5065071379176479,1.0,72/196,27.11%,EEF1A1;RAP1A;RHOJ;KRAS;RAC1;RASL12;RAB31;RAB27A;TGM2;GCH1;NRAS;RERG;RHOB;TUBB3;GBP4;ARF5;RHOT1;SCG5;GNAI1;MRAS;GNL3;PDE2A;ARF1;DNM2;RAB28;RAB38;RHOA;ARHGEF5;BMS1;RALB;TUBB4B;ARL8A;MIEF1;RAB3B;GBP5;TUBA1B;RHEB;TUBB2A;PDE11A;GBP3;TUBA1A;RABL3;RHOG;EIF2B2;ATL2;RRAS;TUBB4A;RRAGB;RAB1B;RIT2;RAB39A;INSR;ARFIP2;RAB8A;TUBD1;TSR1;GEM;SEPHS1;RAB14;ARL4A;NUDT16;RAB8B;HRAS;DRG2;TUBB2B;RAB5B;RND1;RAB7A;RNF112;RAB2A;NME2;ATL3
prerank,GTPase activator activity (GO:0005096),0.3249379069483447,1.3050489700342884,0.034666666666666665,0.6587593236068258,1.0,51/313,9.55%,ARHGAP28;RANBP3L;ALDH1A1;ARHGAP24;ERRFI1;GMIP;NPRL3;RIN2;ARHGAP29;ASAP1;DENND4A;DOCK11;FGD4;SBF2;SMAP2;DENND2A;FNIP1;PLCB1;RAB3IL1;ARHGAP20;ALS2;RAB3IP;ARFGAP3;SYDE2;LLGL2;RCBTB2;IQSEC2;ARHGAP26;AKAP13;NPRL2;LRRK2;ARHGAP40;HACD3;ASAP3;TBC1D9B;RABIF;GNAQ;ARHGEF11;ARHGAP35;RAPGEF4;EPS8L1;ARHGAP9;RGL1;RALGPS1;MYO9B;FARP1;ARFGEF2;TBC1D4;ARHGEF10L;GNB5;ARHGEF18
prerank,neurexin family protein binding (GO:0042043),0.5843726357053912,1.3022539130262885,0.2073170731707317,0.6595008875280421,1.0,3/10,8.79%,CEL;NLGN2;SYTL3
prerank,MHC class I protein binding (GO:0042288),-0.5231187657239281,-1.300780797644713,0.15,0.5170310913073342,1.0,5/13,18.17%,ATP5F1A;DERL1;TUBB4B;TAPBP;ATP5F1B
prerank,sequence-specific DNA binding (GO:0043565),0.30907596409450205,1.2962160125440103,0.018779342723004695,0.6697487888216149,1.0,93/590,13.72%,CREB5;RORA;MAF;TCF7L2;TCF4;OSR1;RBPJ;ARNT2;ZIC1;PPARA;EPAS1;HLF;NR2F2;HOXC4;ZEB2;KMT2A;HOXB4;ESRRG;BCL2;CUX1;PRDM5;SATB1;ZBTB20;DMRT1;SCX;NR1I2;ASCL2;ZIC5;BBX;PKNOX2;VSX2;NFAT5;MYRFL;ELF4;TEAD1;HOXA7;FOXD1;NFIB;TEF;KDM2B;GMEB1;ZNF250;GLI3;IRF8;ACD;TET1;CXXC5;ZBTB32;TCF7L1;THAP1;ZNF23;SMAD3;XRCC5;EN1;PBX4;NR6A1;TCF12;KDM2A;ARNT;KDM5B;CEBPG;IRF3;ZSCAN29;ABL1;HOXB6;IRX1;ZIC4;NEUROD2;ZBTB38;SNAI1;KMT2B;TFAP2A;HOXC8;TFAP2B;NPAS2;ZNF177;RXRA;ZBTB37;HIVEP1;GLI2;FOXK2;GMEB2;BATF;HSF1;SOX13;NFATC4;KLF5;HOXA6;CLOCK;NR1I3;HOXD4;MEIS2;HOXB9
prerank,1-phosphatidylinositol-3-kinase activity (GO:0016303),-0.5731946301178951,-1.293403646600301,0.1532567049808429,0.531549134346513,1.0,5/10,17.15%,PIK3C2B;PIK3CD;PIK3C2A;PIK3C3;PIK3R3
prerank,ephrin receptor binding (GO:0046875),-0.46716682012124133,-1.2856947329238608,0.1545253863134658,0.5467404615662113,1.0,8/21,11.86%,EFNA5;CBL;FYN;CHN1;ANKS1A;CRK;PTPN1;EFNB3
prerank,histone acetyltransferase activity (GO:0004402),0.4643344110392354,1.284122850714021,0.15849056603773584,0.6973754681117704,1.0,11/30,13.55%,BAZ1A;NCOA3;KAT8;KAT6B;BRCA2;TADA2A;EPC2;SRCAP;CLOCK;CREBBP;NAA60
prerank,anion:anion antiporter activity (GO:0015301),-0.48527289447354893,-1.2840007204298793,0.15768463073852296,0.5450913008054262,1.0,6/17,20.16%,SLC26A7;SLC26A2;SLC4A2;SLC26A6;SLC26A11;SLC25A4
prerank,vinculin binding (GO:0017166),-0.5437197047022203,-1.283571468099595,0.170873786407767,0.5398430714032401,1.0,5/11,5.88%,UTRN;CORO2B;ACTN1;PXN;RTCB
prerank,inward rectifier potassium channel activity (GO:0005242),-0.44094920816538224,-1.2825660254537705,0.14549180327868852,0.5364371682536732,1.0,10/24,30.07%,KCNJ2;ABCC9;KCNN2;KCNJ8;KCNJ15;KCNH2;KCNJ6;KCNJ16;KCNJ10;ABCC8
prerank,vascular endothelial growth factor receptor binding (GO:0005172),-0.5329739418929272,-1.2810486140967965,0.1752988047808765,0.5343823618337796,1.0,6/12,18.47%,DAB2IP;ITGA5;CCDC88A;VEGFA;CADM4;GREM1
prerank,glycerophospholipid flippase activity (GO:0140333),-0.5503449122602424,-1.2781169011160562,0.1676190476190476,0.5361633158908314,1.0,7/11,16.05%,ATP10A;ATP8B1;ATP8A1;ATP8A2;ATP11C;ATP11A;ABCA3
prerank,potassium ion leak channel activity (GO:0022841),0.5240751303212339,1.2780268250918267,0.19213973799126638,0.7076197335897046,1.0,2/15,6.27%,KCNK2;TMEM175
prerank,glutathione transferase activity (GO:0004364),0.48845271710270355,1.277549834003914,0.1951219512195122,0.7009565613924674,1.0,3/23,4.82%,GSTM2;GSTT4;GSTT1
prerank,TBP-class protein binding (GO:0017025),-0.4581093582820183,-1.2769317683916546,0.14163090128755365,0.533545843516699,1.0,10/21,36.50%,ESR1;AHR;HHEX;YEATS2;RUVBL1;THRA;TAF11;PSMC1;PSMC5;TAF1B
prerank,flavin adenine dinucleotide binding (GO:0050660),0.40900396096789576,1.274284875399246,0.14839797639123103,0.703222809687266,1.0,12/53,13.19%,MICAL3;DPYD;DDO;SQOR;ACADL;MTHFR;NDOR1;GCDH;CRY1;PRODH;MTO1;ACOX1
prerank,peptidoglycan binding (GO:0042834),-0.5442080622704395,-1.274276316666619,0.1701720841300191,0.5346698009295198,1.0,3/10,6.84%,NOD1;PGLYRP1;HK1
prerank,guanyl-nucleotide exchange factor activity (GO:0005085),-0.30792967675627486,-1.2739672448742774,0.04477611940298507,0.529799595583698,1.0,29/147,6.90%,DOCK9;RAPGEF5;FGD5;ARHGEF28;ELMO1;CYTH3;FGD6;RAP1A;TIAM1;RASGEF1B;CYTH1;DOCK1;RASGRF2;DOCK10;ARHGEF15;PREX1;DENND3;RIN3;EPS8L2;DENND1B;SPATA13;ARHGEF17;ARHGEF6;DENND5B;EEF1D;DOCK2;CCDC88A;ABR;BCR
prerank,calcium activated cation channel activity (GO:0005227),-0.4853391697215686,-1.2729826622519682,0.1710261569416499,0.5266228142391804,1.0,10/17,37.49%,ANO1;KCNMA1;KCNMB4;KCNN2;TRPM4;KCNN4;KCNMB2;TMEM63A;TMEM63B;KCNMB1
prerank,receptor ligand activity (GO:0048018),0.32313232964192046,1.2720065368181592,0.07307171853856563,0.7020216712873765,1.0,29/245,10.36%,IGF1;EPHA7;BMP6;IL34;WNT4;WNT6;IL18;BMP7;SEMA3B;DKK1;CXCL13;IGF2;ARTN;TAFA4;NDP;PTN;FGF1;TAFA5;IL6;NBL1;WNT5B;CSF1;VEGFB;GDF1;APLN;FGF9;IL17D;CCL4;FGF20
prerank,"N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity (GO:0008532)",0.5571750938280694,1.2703278829721854,0.20489977728285078,0.6992399777060128,1.0,1/12,0.68%,B3GALT1
prerank,insulin-like growth factor I binding (GO:0031994),0.5440873757654522,1.2690948873712893,0.20773930753564154,0.6954921373664322,1.0,4/13,5.93%,IGFBP2;IGFBP4;IGF1R;LRP2
prerank,sodium-independent organic anion transmembrane transporter activity (GO:0015347),-0.5514242627622099,-1.269049204655486,0.1896551724137931,0.531426760864842,1.0,4/10,8.33%,SLCO1C1;SLCO2A1;SLCO2B1;SLCO3A1
prerank,metalloexopeptidase activity (GO:0008235),0.41124196356665477,1.2664201968297624,0.1549053356282272,0.6960185904583637,1.0,6/51,7.30%,CPQ;AEBP1;ACE;NPEPPS;CPXM1;AGBL2
prerank,carbohydrate kinase activity (GO:0019200),0.559927590282112,1.2642316762479833,0.20710059171597633,0.6951370358476752,1.0,3/11,8.82%,HK2;GALK2;GALK1
prerank,hormone activity (GO:0005179),0.39965090970387307,1.2637620128084015,0.15532286212914484,0.6889876996675591,1.0,1/54,0.03%,IGF1
prerank,DNA binding (GO:0003677),0.296397940469785,1.2601123187329368,0.01834862385321101,0.6934088873624503,1.0,142/694,16.06%,RORA;TCF7L2;TCF4;RBPJ;DENND4A;APLP2;PPARA;EPAS1;HLF;NR2F2;ZEB2;POLR2D;RBMS1;MEIS1;ARID5B;BCL2;CUX1;PRDM5;SATB1;ZIC2;SCX;SOX6;RAD51B;TSHZ3;NFYB;SSBP2;MYRFL;TEAD1;HOXA7;FOXD1;ZDHHC1;SPHK1;COLEC11;RNF138;NFIB;ARID4A;RAD51AP2;DDB2;KDM2B;CAMTA1;RAD51C;SOX1;TDP2;PDS5B;DMC1;GTF3C5;DDX60;MTERF2;HIVEP2;TET1;CXXC5;ZBTB32;PARP4;TCF7L1;THAP1;SMAD3;XRCC5;BLM;CHD4;RBM5;PBX4;NR6A1;XRCC4;MTF2;ARNT;WDR48;CCNT1;LYAR;POLR2A;AUNIP;FUBP1;SSBP1;KDM5B;NUPR1;RC3H2;MAU2;CEBPG;ZBP1;BRCA2;CLSPN;IRF3;TIGD4;MBD4;NFYC;ABL1;ZMYM4;PRKDC;RFC1;IRX1;ZIC4;DCLRE1A;NHEJ1;ZNF8;TSHZ1;SMARCA5;TFAP2A;TFAP2B;ARID3A;NPAS2;DCLRE1B;PCBP2;MPG;RXRA;GTF3C3;CUL4B;BCLAF3;INO80;CRY1;TRIM26;CGGBP1;GLI2;SMARCB1;FOXK2;BATF;HSF1;SOX13;EZH1;SPO11;CLOCK;CREBBP;MEIS2;MRE11;ZNF148;RAD23B;POLR3C;APEX1;MLH1;BANF2;MCM2;CENPX;BRIP1;PATZ1;SOX12;PHF1;SMARCA2;WRN;BARX2;SMAD4;PSIP1;RAD18;RAD51;SIRT3
prerank,cell adhesion mediator activity (GO:0098631),-0.42775950157400094,-1.259601805555,0.1653061224489796,0.5519072370731931,1.0,15/24,27.83%,BSG;ESAM;ROBO4;BCAM;CNTN6;CD47;NTNG1;DSCAML1;NPTN;PLXNB3;JAM3;VSTM2L;LRRC4C;EMB;CNTN2
prerank,insulin-like growth factor binding (GO:0005520),0.5239580359490607,1.2563906644075098,0.21643286573146292,0.6970204459330805,1.0,4/15,5.93%,IGFBP2;IGFBP4;IGF1R;LRP2
prerank,cation transmembrane transporter activity (GO:0008324),0.40815229810894277,1.2547093929721307,0.1734860883797054,0.6948359694839709,1.0,14/48,13.05%,SLC22A2;SLC38A3;SLC6A9;SLC41A1;MMGT1;CHRNE;SLC38A9;SLC1A5;SLC36A2;SLC38A7;SLC25A2;SLC38A2;SLC25A38;OCA2
prerank,ubiquitin-protein transferase activity (GO:0004842),0.31790269193090975,1.2534012075146044,0.06385696040868455,0.6917722919872316,1.0,86/346,17.97%,ASB2;PDZRN3;RNF220;TRIM63;RNF43;PRKN;PELI2;UBE2E2;TRIM5;MGRN1;NEDD4;RNF213;NEURL2;KCMF1;RNF138;RNF2;DDB2;RNF217;ZNRF3;LTN1;SH3RF1;BCOR;UBE2L3;FBXO44;RNF181;UBR2;RNF145;TTC3;TRIM56;RNF152;SIAH2;RNF135;BIRC6;AMFR;WWP2;RNF216;RNF180;RC3H2;TRAF7;MDM2;ITCH;NHLRC1;SMURF2;FBXO6;RNF149;TRIM35;UBA7;MYCBP2;DTX1;RBBP6;FBXO4;TRIM45;RNF14;CUL4B;SH3RF2;TRIM26;GID4;TRIM43;FBXO11;RNF20;RNF214;RCHY1;RNFT2;TRIM24;CBLB;CHFR;TRIM62;UBE2A;BIRC2;UBR1;RNF122;PPIL2;TRIM17;UBE2H;PML;KLHL13;HECTD1;PELI3;UBE2E1;TRIM69;DTX3L;OBI1;NHLRC3;MIB1;TRIM9;TRIM39
prerank,omega peptidase activity (GO:0008242),-0.32782361502927737,-1.2520405964767043,0.09762532981530343,0.5665266267102517,1.0,38/89,29.36%,USP53;ATXN3;USP38;OTUD7A;PAN2;UCHL5;USP29;USP31;UCHL1;ZRANB1;APEH;USP50;USP39;USP37;OTUB1;UCHL3;OTUD3;OTUD1;USP28;USP8;MYSM1;ZC3H12A;USP9X;OTUD6B;OTUD7B;USP5;GGT1;OTULIN;USP49;JOSD2;TNFAIP3;YOD1;USP33;USP2;USP22;USP32;USP10;USP9Y
prerank,"ATPase activity, coupled to transmembrane movement of ions, rotational mechanism (GO:0044769)",-0.48109400595671636,-1.2517391700736573,0.192,0.555567911966898,1.0,10/16,24.56%,ATP6V0A1;ATP6V1A;ATP6V0C;TCIRG1;ATP6V0A4;ATP5F1B;ATP6V0A2;ATP6V0D2;ATP6V0E2;ATP6V1B2
prerank,"proton-transporting ATPase activity, rotational mechanism (GO:0046961)",-0.48109400595671636,-1.2517391700736573,0.192,0.555567911966898,1.0,10/16,24.56%,ATP6V0A1;ATP6V1A;ATP6V0C;TCIRG1;ATP6V0A4;ATP5F1B;ATP6V0A2;ATP6V0D2;ATP6V0E2;ATP6V1B2
prerank,ubiquitination-like modification-dependent protein binding (GO:0140035),-0.5467089045570986,-1.251435653859494,0.17830882352941177,0.550769217885236,1.0,5/10,19.24%,ANKRD13A;IDE;LAPTM5;FAAP20;ANKRD13B
prerank,microtubule minus-end binding (GO:0051011),0.5373294275366146,1.2501749693683635,0.21711899791231734,0.6944758864441842,1.0,4/13,9.91%,MACF1;HAUS4;TUBGCP6;TUBGCP2
prerank,kinesin binding (GO:0019894),-0.4272993134115559,-1.2484625806292897,0.17130620985010706,0.5530463180079175,1.0,15/27,32.34%,ACTB;AP1AR;TOR1B;ARHGEF10;TTBK2;SPAG9;MAPK8IP2;ATCAY;KIF1B;KLC2;CLSTN1;MAPK8IP3;FAM83D;SPTBN5;MAPK8IP1
prerank,GTPase binding (GO:0051020),-0.2868646722939217,-1.2455701052681223,0.023972602739726026,0.5548142499488754,1.0,52/194,18.31%,SPTBN1;UNC13B;FGD5;CAV1;FGD6;FNBP1L;TBC1D30;HSP90AA1;IQGAP1;RASIP1;SH3BP4;EXOC4;ARHGDIB;NCKAP1;RIN3;RABGAP1L;FLNA;YBX3;SOD1;EHD1;PEX5L;SGSM1;YBX1;CYRIB;PAK1;EPS8;PAK2;EXOC5;RANBP1;LAMTOR1;KCTD13;EVI5;RANGAP1;STOML2;WHAMM;ARHGEF2;MYO5A;PPP6R1;MLPH;DMXL2;IARS1;RCC2;BICD1;BICDL1;CDC42EP5;RAF1;RRAGB;TRIP11;RTKN;CDC42EP2;KIF3B;RABGAP1
prerank,GDP binding (GO:0019003),-0.34676262347594927,-1.2448297592279671,0.1486146095717884,0.5510831374013352,1.0,14/63,11.13%,RAP1A;KRAS;RASL12;RAB31;RAB27A;NRAS;RERG;GNAI1;MRAS;RAB28;RALB;MIEF1;RAB3B;RHEB
prerank,"phosphatidylinositol-4,5-bisphosphate binding (GO:0005546)",0.37928225155664336,1.2435752274277858,0.13513513513513514,0.707221545165325,1.0,10/72,4.76%,FRMPD4;TULP3;ADAP2;SNX21;PARD3;GSDMA;PLCB1;AVIL;TULP1;SNX18
prerank,thiol-dependent deubiquitinase (GO:0004843),-0.3295319916146928,-1.2418332625490205,0.09973753280839895,0.5541713200164194,1.0,36/83,29.36%,USP53;ATXN3;USP38;OTUD7A;PAN2;UCHL5;USP29;USP31;UCHL1;ZRANB1;USP50;USP39;USP37;OTUB1;UCHL3;OTUD3;OTUD1;USP28;USP8;MYSM1;ZC3H12A;USP9X;OTUD6B;OTUD7B;USP5;OTULIN;USP49;JOSD2;TNFAIP3;YOD1;USP33;USP2;USP22;USP32;USP10;USP9Y
prerank,estrogen receptor binding (GO:0030331),-0.39970842912374294,-1.238634769311844,0.17057569296375266,0.5572099121184438,1.0,9/32,13.57%,LEF1;ESR1;RERG;CTNNB1;DCAF13;ARID5A;WBP2;DDX54;NRIP1
prerank,acylglycerol O-acyltransferase activity (GO:0016411),0.48500437128574864,1.2326449207365924,0.2667946257197697,0.7318446753646027,1.0,2/20,1.81%,AGPAT4;LPGAT1
prerank,phospholipase inhibitor activity (GO:0004859),0.5420871049554119,1.2295611743939432,0.24476987447698745,0.7336706974777143,1.0,4/10,18.48%,ANXA1;APOC1;ANXA5;SNCA
prerank,protein tyrosine phosphatase activity (GO:0004725),0.3725525404012237,1.2270457406089301,0.16013071895424835,0.7339040132879496,1.0,11/71,7.47%,EYA4;EYA1;PTPN13;EYA2;PTPN4;CDC14B;PTPRA;MTMR3;PTPN9;PTPRD;PTEN
prerank,ribosome binding (GO:0043022),-0.37123915293666054,-1.22557270586355,0.12826603325415678,0.5877702569425326,1.0,24/46,29.86%,EEF2;RPSA;RACK1;NOMO1;BAG6;PYM1;CCDC47;CPEB1;TMEM147;YTHDF3;SHFL;EIF3C;SERBP1;EIF2A;ZC3H12A;EIF6;GTPBP6;FMR1;NAA16;MRPS27;CPEB3;ETF1;MTIF3;SEC61B
prerank,phosphatidylinositol bisphosphate binding (GO:1902936),0.3551140595946592,1.2235216063564345,0.16614906832298137,0.7376810232587336,1.0,12/91,5.21%,FRMPD4;TULP3;ADAP2;SNX21;PARD3;GSDMA;PLCB1;AVIL;SH3PXD2B;TULP1;SNX18;WIPI1
prerank,endopeptidase regulator activity (GO:0061135),0.41546256024232014,1.2194940653711142,0.20465890183028287,0.7428949344418865,1.0,5/40,3.85%,TFPI;ITIH2;PROS1;SERPIND1;A2ML1
prerank,syntaxin-1 binding (GO:0017075),0.4737211918699461,1.2164431576433525,0.21523809523809523,0.7452161992978209,1.0,3/22,5.17%,UNC13C;DAPK1;LRRK2
prerank,general transcription initiation factor binding (GO:0140296),-0.41797291588197805,-1.216407604785181,0.21258134490238612,0.6071222861062335,1.0,13/25,37.76%,ESR1;AHR;HHEX;YEATS2;RUVBL1;RELA;THRA;THAP7;TAF11;PSMC1;PSMC5;TAF1B;TBP
prerank,DNA-directed DNA polymerase activity (GO:0003887),-0.4297678577559964,-1.216365095510966,0.21030042918454936,0.601562521025457,1.0,12/21,25.99%,REV3L;POLK;POLQ;POLA1;POLE4;POLN;POLE;POLD3;POLB;POLD1;POLI;POLL
prerank,E-box binding (GO:0070888),0.4271843405898439,1.2143570256025664,0.21626617375231053,0.744385648396465,1.0,8/34,10.97%,TCF4;ZEB1;SCX;ASCL2;MITF;NEUROD2;ATOH8;SNAI1
prerank,UDP-galactosyltransferase activity (GO:0035250),0.5519106168845522,1.2106994425833892,0.2443064182194617,0.7488459661483403,1.0,3/10,10.11%,B3GALT1;B4GALT1;B3GALT6
prerank,mRNA 3'-UTR binding (GO:0003730),0.3658352829119924,1.2096188768394376,0.18209876543209877,0.7453973512275015,1.0,10/79,5.80%,CELF2;IGF2BP1;RBMS1;CSDC2;RBMS3;CPEB2;HNRNPC;CPEB4;PABPC4L;RBMS2
prerank,cytokine activity (GO:0005125),0.33170226129796937,1.2076664268163944,0.14457831325301204,0.7443999448226238,1.0,15/131,10.28%,BMP6;IL34;WNT4;WNT6;IL18;BMP7;CXCL13;NDP;IL6;WNT5B;CCL19;CSF1;GDF1;IL17D;CCL4
prerank,dipeptidyl-peptidase activity (GO:0008239),-0.5216561657432577,-1.2050683253953351,0.23629489603024575,0.6272214856093266,1.0,4/10,17.39%,FAP;NAALAD2;DPP4;PRCP
prerank,gated channel activity (GO:0022836),-0.47406907107834556,-1.20144634272267,0.25691699604743085,0.63148841149096,1.0,4/14,10.95%,PIEZO2;PIEZO1;TMC6;TMEM266
prerank,gap junction channel activity (GO:0005243),0.46176238890973154,1.1999159838092333,0.2423076923076923,0.7602199214059828,1.0,3/22,5.22%,GJB6;GJA3;GJA1
prerank,MAP-kinase scaffold activity (GO:0005078),0.5308560101898817,1.1994324877830391,0.2857142857142857,0.7550664343296928,1.0,3/11,6.47%,KSR1;AKAP13;SH3RF1
prerank,pyrophosphatase activity (GO:0016462),-0.3538494801559717,-1.1981113097688072,0.17587939698492464,0.6353350185450968,1.0,13/50,16.49%,ENTPD1;PLPP1;NUDT3;PRUNE1;ENTPD7;ALPL;ENTPD2;BNIP2;NUDT4;NUDT1;PRUNE2;DHX29;DCPS
prerank,RNA polymerase II CTD heptapeptide repeat kinase activity (GO:0008353),0.5203768455453318,1.198056980756453,0.2707509881422925,0.752320545945454,1.0,6/12,18.52%,CDK8;CDK7;CDK1;MAPK1;CDK4;CDK9
prerank,protein phosphatase binding (GO:0019903),-0.3022374065302468,-1.1978201285963523,0.11572700296735905,0.6303823783531769,1.0,38/117,23.78%,MAP3K5;IQGAP1;PTK2;DAB2IP;RACK1;PPP1R16B;PXN;PPME1;CTNNB1;SOD1;HSP90B1;MET;GRIN3A;AKAP11;CEACAM1;KCNQ1;FLT4;FOXO1;CDKN1B;MAP2K7;STAT3;PPP6R1;MASTL;MTMR9;JUP;VRK3;FBXL2;PPP1R16A;BOD1;SMG5;JAK3;ATP2B4;VCP;ANAPC7;PTPRT;STRN4;JAK1;PPP1R15A
prerank,histone acetyltransferase binding (GO:0035035),0.4600777118632896,1.197620453353605,0.2423076923076923,0.7472318135367058,1.0,4/21,10.66%,EPAS1;KANSL1L;GLI3;KANSL1
prerank,heme binding (GO:0020037),0.3681459974629092,1.1945833669935892,0.19197207678883071,0.7497615408312848,1.0,6/65,7.15%,CYP26B1;CYP27A1;CBS;PXDN;FLVCR2;PGRMC1
prerank,DNA polymerase activity (GO:0034061),-0.4190445267172834,-1.1939652348873606,0.21814254859611232,0.6356531101765445,1.0,12/22,25.99%,REV3L;POLK;POLQ;POLA1;POLE4;POLN;POLE;POLD3;POLB;POLD1;POLI;POLL
prerank,cytokine receptor binding (GO:0005126),0.35341701244539786,1.1934816077090402,0.16440677966101694,0.7468185273664579,1.0,11/83,10.25%,TGFBR3;IL34;IL18;PXDN;IL13RA1;IL6;SMAD3;CCL19;CSF1;VEGFB;JAK2
prerank,lipid phosphatase activity (GO:0042577),0.49138621916156083,1.1933832643173157,0.2816326530612245,0.7407214201360163,1.0,6/14,18.86%,PLPP3;EPHX2;SGPP1;PLPP2;PLPPR3;PLPP7
prerank,beta-tubulin binding (GO:0048487),0.4111721474972604,1.1930442836561832,0.22900763358778625,0.7354198096025506,1.0,2/31,1.85%,GJB6;EML4
prerank,glutamate receptor activity (GO:0008066),-0.4398019811721334,-1.191619872638386,0.24342105263157895,0.636646539944854,1.0,7/19,19.44%,GRM3;GRM7;GRIK4;GRM8;GRIA2;GRIK2;GRID2
prerank,wide pore channel activity (GO:0022829),0.45615698687631173,1.1909582469606452,0.2533589251439539,0.7353424439946037,1.0,3/23,5.22%,GJB6;GJA3;GJA1
prerank,anion transmembrane transporter activity (GO:0008509),-0.4932205308843891,-1.189905002933579,0.25226860254083483,0.635575699202565,1.0,4/12,10.86%,ABCG2;SLCO2B1;SLC39A8;SLC4A2
prerank,transcription corepressor binding (GO:0001222),0.4380725845509047,1.1886955710499876,0.2462686567164179,0.7357829829675003,1.0,4/27,8.22%,RORA;USP11;MTF2;PER3
prerank,dicarboxylic acid transmembrane transporter activity (GO:0005310),0.4239121559722959,1.1885510114907176,0.23272727272727273,0.7301331527763382,1.0,9/29,11.83%,SLC13A3;SLC25A18;SLC13A5;ABCC2;SLC1A5;SLC25A22;SLC25A11;SLC19A1;SLC38A7
prerank,amino acid binding (GO:0016597),-0.3872713594027917,-1.184947120586993,0.21308016877637131,0.6438712576460947,1.0,16/31,32.37%,NOS3;GRM7;GRIN3A;DDAH1;NOS1;GRIN1;GLRA3;DDAH2;AARS2;CASTOR1;GLRA1;GLDC;GRIN2B;GNMT;AGXT;NOS2
prerank,SH3 domain binding (GO:0017124),-0.32937458220106575,-1.1846868652164362,0.1658653846153846,0.6391375616671571,1.0,16/62,10.48%,AFAP1L1;SHANK3;ELMO1;SGIP1;CBL;ADAM15;ARHGAP27;DAB2IP;PTPN12;SYNJ1;WIPF1;DNM2;ABI3;MICAL1;CD2AP;CRK
prerank,voltage-gated calcium channel activity (GO:0005245),0.4022510925678461,1.1781625687953805,0.2448210922787194,0.7527820816077271,1.0,6/37,7.01%,CACNA2D3;CACNA1D;CACNB4;CACNG7;TMC2;CACNA2D1
prerank,Hsp90 protein binding (GO:0051879),-0.37295644638290043,-1.177759001135544,0.25675675675675674,0.6533484566844165,1.0,5/33,7.55%,SLC12A2;KDR;RPS3;CHORDC1;AHR
prerank,O-acyltransferase activity (GO:0008374),-0.3787136157123856,-1.1756465193455194,0.2671232876712329,0.6537698832517576,1.0,15/30,30.92%,MBOAT1;LPCAT3;GPAT4;GPAT3;DGAT1;LPCAT1;PLA2G4A;LCAT;GPAM;PRDX6;PIGW;PLAAT1;PLA2G15;LPCAT4;MBOAT2
prerank,chloride channel regulator activity (GO:0017081),-0.46559129735172583,-1.1749548887539552,0.265748031496063,0.6502882345681563,1.0,8/14,17.01%,STX7;STX1A;VAMP8;VTI1B;WNK3;CFTR;WNK2;SGK1
prerank,"phosphatidylinositol-3,5-bisphosphate binding (GO:0080025)",-0.4080788609619776,-1.1737378713922038,0.2316831683168317,0.6487581655912822,1.0,8/23,19.12%,HIP1;CLVS2;CLVS1;HIP1R;SNX14;ATP13A2;GBF1;JPH2
prerank,tropomyosin binding (GO:0005523),0.4856906616659312,1.1718615719266037,0.28,0.7653424500452013,1.0,3/16,4.14%,TNNT2;CALD1;NEBL
prerank,metal ion binding (GO:0046872),-0.24721489862424295,-1.1709412544117448,0.030456852791878174,0.6509418243653041,1.0,110/477,18.47%,CSGALNACT1;SLIT2;LTBP4;SPOCK2;ADGRL3;MAP3K5;ITPR2;ACER3;RASGRP3;ESYT2;STK38;TPD52;PITPNM2;THBS1;TPT1;CDH1;IQGAP1;CALM1;GSN;SPARCL1;CDH11;AGRN;S100A6;CDH2;CDC42BPA;MT1E;MT1F;MT1G;MT1B;MT1M;MT1A;MT1H;MT1X;MCTP1;ASPN;TGM2;STK38L;CAMKK2;NUDT3;CALR;HPRT1;HSP90B1;ADPRH;GNAI1;CEMIP2;MT2A;PDE2A;CLEC3B;CHP1;RPH3A;NOTCH4;ATP2A2;NRXN1;RYR2;DYSF;SNN;CCDC47;NUCB1;C2CD5;PIR;MARK1;CERK;BNIP2;S100A1;IDS;HSPA5;STIM2;MAP2K7;GRIN1;S100A16;PCLO;RHEB;MSH2;SYT10;CDH13;S100A10;MARK2;SYT4;SDF4;CALU;PPP3CA;PITPNM3;TKT;RET;SRPK1;CANX;SPOCK1;ITPR3;MT3;IRAK3;AASDHPPT;KCNIP2;PLA2G4A;AOC3;TPM4;DSG2;CALM2;TPPP;TOP2A;PGP;TUBB4A;SYT7;CETN2;UBA2;LETM1;DSPP;SYT2;S100A11;PINK1;SPARC
prerank,phosphatidylinositol kinase activity (GO:0052742),-0.4654212873587813,-1.170761567760358,0.2459349593495935,0.6461073595124387,1.0,6/15,17.15%,PIK3C2B;PIK3CD;PIK3C2A;PIK3C3;PI4KB;PIK3R3
prerank,transition metal ion transmembrane transporter activity (GO:0046915),-0.3914431390429113,-1.1703914795750674,0.25327510917030566,0.641865121860917,1.0,12/30,24.70%,SLC39A10;SLC40A1;SLC30A5;SLC31A1;SLC39A8;SLC39A7;SLC30A1;TMEM165;SLC39A14;SLC11A1;SLC39A6;SLC25A28
prerank,N-acyltransferase activity (GO:0016410),0.4141311127891594,1.1699482234156244,0.23175182481751824,0.7646142351358436,1.0,10/32,16.89%,NMT2;NAA80;CERS6;CERS5;CERS1;SMARCE1;SAT2;ESCO1;NAT8;NAT14
prerank,fibroblast growth factor receptor binding (GO:0005104),0.4498608771988817,1.169921908859128,0.2829076620825147,0.7585366824093507,1.0,5/21,10.36%,KL;FRS2;FGF1;FGF9;FGF20
prerank,inhibitory extracellular ligand-gated ion channel activity (GO:0005237),-0.47812388335039757,-1.169069093121156,0.30268199233716475,0.6400989920624445,1.0,6/13,25.22%,GABRG3;GLRA3;GABRA5;GABRE;GABRG2;GLRA1
prerank,syntaxin binding (GO:0019905),0.3687202018635846,1.1684122016954832,0.24143556280587275,0.756718197067114,1.0,11/61,11.44%,UNC13C;STXBP4;DAPK1;ABCA1;SYT12;LRRK2;STX16;SNAP47;GOLGA2;ABL1;STX8
prerank,monocarboxylic acid transmembrane transporter activity (GO:0008028),0.4286849583361043,1.1676631305765068,0.29213483146067415,0.7529757880771851,1.0,4/26,3.87%,SLC6A13;SLC16A12;SLC6A12;SLC6A1
prerank,single-stranded DNA binding (GO:0003697),0.3376697512820897,1.1659599793940478,0.23809523809523808,0.7520286845080789,1.0,24/93,18.52%,POLR2D;RBMS1;RAD51B;SSBP2;RNF138;RAD51AP2;TDP2;DMC1;BLM;WDR48;FUBP1;SSBP1;BRCA2;PCBP2;RAD23B;POLR3C;MLH1;MCM2;RAD51;STN1;REXO4;XPC;PURA;MCM7
prerank,"phosphatidylinositol-3,4,5-trisphosphate binding (GO:0005547)",-0.3706298103497252,-1.1655882956293975,0.2398286937901499,0.6445644993370484,1.0,7/34,7.26%,CYTH3;ARAP2;MYO10;IQGAP1;ARAP3;FERMT2;HIP1R
prerank,mechanosensitive ion channel activity (GO:0008381),-0.4805298348919469,-1.1596243501606456,0.2991967871485944,0.6558006595410356,1.0,3/12,8.12%,PIEZO2;PIEZO1;TMC6
prerank,"oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor (GO:0016628)",0.4706071385502564,1.157487719879294,0.29141716566866266,0.7707310732277604,1.0,2/17,6.87%,DPYD;PTGR1
prerank,hexose transmembrane transporter activity (GO:0015149),-0.4774499442264427,-1.1557473540822563,0.3036750483558994,0.6612436021799998,1.0,1/12,0.78%,SLC2A1
prerank,transcription cis-regulatory region binding (GO:0000976),0.28365430368166766,1.1553583563695204,0.15756035578144853,0.7706384207782916,1.0,59/406,12.90%,RORA;SOX5;TCF7L2;OSR1;AEBP1;EPAS1;NPAS3;ARID5B;MXI1;SMAD6;CUX1;PRDM5;SATB1;ZBTB20;DMRT1;SCX;NR1I2;ASCL2;SOX6;TBL1XR1;HIF3A;NFYB;BBX;VSX2;ZFP90;TEAD1;ASH2L;ARID4A;GLI3;ZFP37;BCOR;SMAD3;XRCC5;RFXAP;GABPB1;GABPB2;TCF12;RBL2;ARNT;PER3;CREB3L2;NFYC;HDAC1;AGO2;SNAI1;TFAP2A;HOXC8;TFAP2B;ZNF568;ZNF177;RXRA;E2F6;NONO;MLXIP;FOXK2;AR;HSF1;SOX13;PSPC1
prerank,RNA methyltransferase activity (GO:0008173),0.45496010539280646,1.1515637247651627,0.2923076923076923,0.7758579340719186,1.0,6/19,9.61%,TRMT9B;METTL4;FTSJ3;METTL8;TRDMT1;LCMT2
prerank,actin binding (GO:0003779),-0.2734302803133448,-1.151455167632531,0.1557632398753894,0.6675010422896671,1.0,32/170,9.04%,UTRN;MYRIP;TMSB4X;SYNE1;NOS3;ACTN4;KLHL2;FXYD5;PARVB;MICAL2;ABLIM1;GSN;MAP1B;ITGB1;PTK2;CORO2B;KCNMA1;TMSB10;EPS8L2;FERMT2;CCDC88A;SMTN;CAP2;CEACAM1;HNRNPU;PDLIM7;ADD2;MYH9;MICAL1;EPS8;SSH2;LDB3
prerank,polyubiquitin modification-dependent protein binding (GO:0031593),-0.3394609380711184,-1.1508876876917469,0.23349056603773585,0.6639063859493263,1.0,18/49,22.36%,OTUD7A;MINDY2;UBXN1;MINDY1;BAG6;ZRANB1;UBQLN4;AGAP3;TAB3;ZFAND2B;FAAP20;SPRTN;SHARPIN;RNF168;OTUD7B;UBL7;HDAC6;VCP
prerank,myosin V binding (GO:0031489),-0.45071482536285656,-1.1492942504711923,0.2851153039832285,0.6628987355113977,1.0,6/15,25.20%,RAB3C;RAB3B;RAB8A;RAB3A;RAB14;RAB6B
prerank,proton transmembrane transporter activity (GO:0015078),-0.3439551874115082,-1.1490063157704813,0.2689655172413793,0.658639600452598,1.0,16/39,28.07%,COX4I1;CLCN5;NDUFA4;UQCRH;COX6A1;UQCR11;COX8A;COX5A;UQCRQ;UQCRC1;CLCN3;UQCR10;NDUFA4L2;ATP6V1B2;COX15;COX4I2
prerank,peptidase activator activity involved in apoptotic process (GO:0016505),-0.45426351585688907,-1.148811578041285,0.27521008403361347,0.6540358731279301,1.0,6/14,14.62%,MAL;RACK1;NOD1;ATP2A3;RPS27L;CASP8AP2
prerank,secondary active transmembrane transporter activity (GO:0015291),0.369213469154192,1.1483279939484774,0.2670157068062827,0.7794030443074815,1.0,14/51,12.56%,SLC22A4;SLC5A5;SLC20A2;SLCO1B1;SLC28A3;MCU;SLC20A1;SLC25A11;SLC35E2B;SLC35E2A;SLC22A6;CLCN4;SLC35A1;SLC46A2
prerank,manganese ion binding (GO:0030145),0.36839064409904076,1.1477459036800377,0.2551369863013699,0.7753185622266975,1.0,16/48,18.79%,LARGE1;PPM1M;B4GALT1;TDP2;NEK4;HMGCL;MPPED2;XYLT2;ABL1;PRIMPOL;WRN;XPNPEP3;POMGNT1;XXYLT1;GALNT3;PCK2
prerank,"exodeoxyribonuclease activity, producing 5'-phosphomonoesters (GO:0016895)",0.5114003156813439,1.1475787264422272,0.3144016227180527,0.7699878997445617,1.0,5/10,14.26%,MGME1;DCLRE1A;DCLRE1B;TATDN1;APEX1
prerank,kinase binding (GO:0019900),-0.24540628463686154,-1.1466736440982996,0.08522727272727272,0.6548872632514957,1.0,84/434,11.54%,UTRN;FRMD5;SLC12A2;SLC12A7;CAV1;PTPRJ;ACTB;EEF1A1;ESR1;TIAM1;DLG2;MSN;TFRC;NSF;BCAR3;ADAM10;ACVRL1;RAC1;IQGAP1;CALM1;GSN;HSP90AB1;UNC5C;PTK2;FBXO7;TTC28;PLCG2;CSPG4;EEF2;PDE8A;CAV2;NBEA;DAB2IP;RPS7;PIK3IP1;RPS3;RPS19;PKD1;TRIM14;FLNA;HSPB1;RPS6;LIMS1;CIT;BCAR1;AP2A2;WARS1;STX1A;IKBKB;RHOB;MTCP1;FERMT2;CTNNB1;BCL2L1;FAF1;PTPRC;ACTA2;CEACAM1;GSK3B;CHP1;SPRED2;CDC37;ADD2;LRRC14;PDCD10;EMP2;SRCIN1;CHEK2;PAK2;APC;RHOA;MAP3K1;CDKN1B;CRK;MAP2K7;ATF4;CEP68;DUSP3;PTPN1;PIH1D1;TOLLIP;STAT3;SLC12A4;MSH2
prerank,clathrin adaptor activity (GO:0035615),-0.45574885532084214,-1.1464655126374192,0.2953667953667954,0.6505475413972223,1.0,5/15,8.97%,HIP1;STON2;AP2A2;HIP1R;AP2M1
prerank,ADP binding (GO:0043531),0.42848397063321964,1.1435069474312927,0.30868761552680224,0.7754730583208219,1.0,5/25,12.41%,PRKAG2;MYO18A;MYO9B;MYH10;PRKAG1
prerank,sequence-specific double-stranded DNA binding (GO:1990837),0.27279463226820583,1.1428876296585841,0.13768961493582263,0.7714062749762228,1.0,93/597,13.72%,CREB5;SOX5;MAF;TCF7L2;TCF4;OSR1;ARNT2;ZIC1;HLF;HOXC4;HOXB4;ARID5B;ESRRG;SMAD6;CUX1;PRDM5;ZBTB20;DMRT1;NR1I2;ASCL2;SOX6;TBL1XR1;NFYB;ZIC5;BBX;PKNOX2;VSX2;NFAT5;ELF4;TEAD1;ASH2L;HOXA7;NFIB;ARID4A;TEF;GMEB1;ZNF250;GLI3;IRF8;ZBTB32;TCF7L1;BCOR;ZNF23;SMAD3;XRCC5;EN1;GABPB1;GABPB2;NR6A1;TCF12;ARNT;PER3;KDM5B;CEBPG;CREB3L2;IRF3;MBD4;ZSCAN29;NFYC;ABL1;HOXB6;IRX1;ZIC4;NEUROD2;SNAI1;TFAP2A;HOXC8;TFAP2B;ZNF568;NPAS2;ZNF177;RXRA;ZBTB37;HIVEP1;GLI2;ORC2;NONO;FOXK2;GMEB2;BATF;AR;HSF1;SOX13;PSPC1;NFATC4;TSPYL2;KLF5;HOXA6;CLOCK;NR1I3;HOXD4;MEIS2;HOXB9
prerank,kinase activator activity (GO:0019209),0.4103953502641417,1.1424702730479157,0.27440147329650094,0.7669248030302319,1.0,1/30,0.09%,PRKAG2
prerank,cell-cell adhesion mediator activity (GO:0098632),-0.3416652002836105,-1.1423942053991698,0.25379609544468545,0.6569371413114194,1.0,15/42,21.30%,STXBP6;BSG;ESAM;CD200;ROBO4;BAIAP2L1;PPP1CA;CNTN6;CD47;NTNG1;DSCAML1;S100A11;NPTN;PLXNB3;JAM3
prerank,hormone receptor binding (GO:0051427),-0.4493595180682788,-1.1394392236271638,0.272552783109405,0.6601834131983865,1.0,5/14,25.34%,SOCS2;PTHLH;JAK1;ADCYAP1;NPPC
prerank,mRNA 5'-UTR binding (GO:0048027),-0.3818714693521537,-1.13751605558774,0.2648870636550308,0.6603031258243874,1.0,7/24,11.21%,RPL41;RPS7;RPL26;RPS14;GNL3;RPL5;RSL1D1
prerank,calcium ion binding (GO:0005509),-0.24934718375887696,-1.1366538053651483,0.084,0.6577703518759369,1.0,60/323,13.63%,SLIT2;LTBP4;SPOCK2;ADGRL3;ITPR2;ACER3;RASGRP3;ESYT2;TPD52;PITPNM2;THBS1;TPT1;CDH1;IQGAP1;CALM1;GSN;SPARCL1;CDH11;AGRN;S100A6;CDH2;MCTP1;ASPN;TGM2;CAMKK2;CALR;HSP90B1;CEMIP2;CLEC3B;CHP1;RPH3A;NOTCH4;ATP2A2;NRXN1;RYR2;DYSF;CCDC47;NUCB1;C2CD5;BNIP2;S100A1;IDS;HSPA5;STIM2;GRIN1;S100A16;PCLO;SYT10;CDH13;S100A10;SYT4;SDF4;CALU;PPP3CA;PITPNM3;TKT;RET;CANX;SPOCK1;ITPR3
prerank,calcium-dependent phospholipase A2 activity (GO:0047498),0.46683669024133484,1.1325394998646128,0.322,0.7892909786223294,1.0,4/15,14.96%,PLA2G10;PLA2G4B;PLA2G4C;PLA2G12A
prerank,zinc ion transmembrane transporter activity (GO:0005385),-0.4046339732032489,-1.1311457809537948,0.2837301587301587,0.6678166585085408,1.0,5/20,9.85%,SLC39A10;SLC30A5;SLC39A8;SLC39A7;SLC30A1
prerank,CoA hydrolase activity (GO:0016289),0.46465928624290465,1.1298537667685489,0.30982905982905984,0.7913149529124797,1.0,8/16,23.38%,ACOT4;ACAA2;ACOT1;HIBCH;NUDT7;ACOT13;ACOT11;ACOT6
prerank,GTPase inhibitor activity (GO:0005095),-0.4571961862620114,-1.1292662246760772,0.3047808764940239,0.6678501697725713,1.0,2/13,2.21%,SLIT2;IQGAP1
prerank,transmembrane receptor protein tyrosine kinase adaptor activity (GO:0005068),0.49906581231007513,1.1285392360781825,0.336283185840708,0.7894441856008728,1.0,6/12,20.13%,FRS2;PIK3R1;GAB2;BLNK;SHC1;IRS1
prerank,MAP kinase kinase kinase activity (GO:0004709),-0.46931637458051867,-1.1284838426794817,0.3136094674556213,0.6653466659332332,1.0,4/11,24.76%,MAP3K5;MAP3K1;MAP3K6;MAP3K15
prerank,tau protein binding (GO:0048156),-0.34023591889350563,-1.1265405610744048,0.2809734513274336,0.6654832081304355,1.0,16/40,23.15%,ACTB;HSP90AA1;HSP90AB1;FYN;LGMN;GSK3B;MARK1;MARK2;BIN1;CLU;CDK5;TTBK2;DCTN1;HDAC6;MAP1A;BRSK2
prerank,chemorepellent activity (GO:0045499),-0.3878936864337099,-1.126465191249289,0.30131004366812225,0.6610218689165308,1.0,11/25,11.12%,SEMA6A;SEMA7A;SEMA6D;SEMA3C;SEMA4D;SEMA3E;SEMA4B;SEMA5B;DPP4;SEMA6C;SEMA3G
prerank,endopeptidase activity (GO:0004175),0.287042158890153,1.1222538731073297,0.24074074074074073,0.8016345784440881,1.0,26/257,8.92%,ADAMTS12;ADAMTS9;TRABD2B;CORIN;ADAMTS5;THSD4;ADAMTS10;KLK2;ADAMTS15;MMP2;CTSH;USP11;PCSK9;ADAMTS7;ACE;TPP1;NRDC;MMP19;PSMA2;USP24;PSMA3;MMP9;USP25;ADAMTSL4;USP7;USP34
prerank,protein serine/threonine kinase activator activity (GO:0043539),0.3989976770697659,1.1209252333071613,0.29159212880143115,0.7996204696182825,1.0,8/34,10.90%,LTF;ALS2;IGF2;FAM20A;RICTOR;CCNT2;CCNT1;MLST8
prerank,"DNA binding, bending (GO:0008301)",-0.4424069447573594,-1.1190992082286502,0.3187250996015936,0.6758339811659159,1.0,3/14,16.53%,LEF1;HHEX;TOP2A
prerank,protein heterodimerization activity (GO:0046982),0.2972364466256038,1.118925206391814,0.2303448275862069,0.7998847220264382,1.0,25/178,11.68%,ATP1A2;BMP6;TCF4;ARNT2;EPAS1;BDKRB2;NPAS3;TPM1;BCL2;IRAK2;TOP2B;ZHX2;PAFAH1B3;ITGA3;ALG2;ARNT;PAFAH1B1;BCL2L2;PGLYRP3;MICU1;NEUROD2;UBA3;TFAP2B;ERBB2;FXR1
prerank,small GTPase binding (GO:0031267),-0.2630198203753709,-1.1184529874990643,0.17708333333333334,0.6727963528986715,1.0,52/169,22.70%,UNC13B;FGD5;CAV1;FGD6;TBC1D30;IQGAP1;SH3BP4;EXOC4;ARHGDIB;NCKAP1;RIN3;RABGAP1L;FLNA;YBX3;SOD1;EHD1;PEX5L;SGSM1;CYRIB;PAK1;EPS8;PAK2;EXOC5;RANBP1;KCTD13;EVI5;RANGAP1;WHAMM;ARHGEF2;MYO5A;PPP6R1;MLPH;DMXL2;RCC2;BICD1;BICDL1;CDC42EP5;RAF1;TRIP11;RTKN;CDC42EP2;KIF3B;RABGAP1;RABGGTB;IFT20;ARFIP2;RABGGTA;PEX5;EXOC8;RAB8A;SIKE1;RAP1GAP
prerank,1-acylglycerol-3-phosphate O-acyltransferase activity (GO:0003841),0.47808194636504797,1.1148063200630876,0.36726546906187624,0.8060563109851223,1.0,1/13,0.83%,AGPAT4
prerank,phosphoric ester hydrolase activity (GO:0042578),0.36477935824756613,1.1143528514822723,0.3238255033557047,0.8017392142353418,1.0,8/49,8.96%,ATP1A2;PXYLP1;LHPP;DUSP10;EPHX2;ACP3;MPPED2;HDHD2
prerank,Notch binding (GO:0005112),0.41347497663778626,1.1096772739698144,0.33455882352941174,0.8085549504885933,1.0,2/22,3.23%,SNED1;MEGF10
prerank,thyroid hormone receptor binding (GO:0046966),0.40273609687262685,1.108479343858068,0.3236994219653179,0.8065488832570381,1.0,14/28,24.01%,BRD8;NCOA3;NSD1;MED13;MED1;TACC1;ZNHIT3;TRIP6;NCOR1;HMGN3;TRIP12;THRAP3;GTF2H1;MED24
prerank,protein kinase binding (GO:0019901),-0.23465551301078058,-1.1066066429842667,0.08641975308641975,0.6996081677926679,1.0,98/479,13.39%,UTRN;FRMD5;SLC12A2;SLC12A7;CAV1;PTPRJ;ACTB;EEF1A1;TJP2;ESR1;MSN;STK38;TFRC;NSF;ADAM10;ACVRL1;RAC1;HSP90AA1;IQGAP1;CALM1;DUSP16;UNC5C;ITGB1;PTK2;FBXO7;PLCG2;CSPG4;EEF2;CAV2;NBEA;DAB2IP;RPS7;RACK1;RPS3;RPS19;BMPR2;PKD1;TRIB2;ROR2;GCH1;TRIM14;HSPB1;RPS6;LIMS1;CIT;ADCY4;BCAR1;AP2A2;WARS1;IKBKB;RHOB;MTCP1;HDAC5;FERMT2;CCDC88A;BCL2L1;FAF1;CAVIN2;PTPRC;ACTA2;CEACAM1;CSK;GSK3B;KCNQ1;SPRED2;ADD2;PDCD10;RYR2;EMP2;SRCIN1;CHEK2;APPL1;PAK2;APC;RHOA;MAP3K1;CDKN1B;YWHAG;CRK;DUSP8;MAP2K7;ATF4;CEP68;DUSP3;PTPN1;PIH1D1;STAT3;SLC12A4;MSH2;HINT1;USP37;PTPN23;DNM1;MAP3K12;PRKAR1A;IBTK;PICK1;NEDD9
prerank,transaminase activity (GO:0008483),0.4864512982442539,1.1053530477989217,0.35368421052631577,0.8097227788952079,1.0,1/11,1.59%,ABAT
prerank,protein kinase activator activity (GO:0030295),0.3498825169495375,1.104839639505778,0.3118811881188119,0.8059064318683102,1.0,6/60,5.02%,PRKAG2;LTF;ALS2;IGF2;FAM20A;RICTOR
prerank,transforming growth factor beta receptor binding (GO:0005160),0.43823150432689195,1.1045118831857597,0.35403726708074534,0.8015964734965559,1.0,3/18,6.95%,TGFBR3;SMAD6;SMAD3
prerank,voltage-gated sodium channel activity (GO:0005248),0.4247530465762867,1.1043827541897262,0.3582089552238806,0.7966463086890725,1.0,1/22,0.08%,SCN7A
prerank,double-stranded DNA binding (GO:0003690),0.2652474656903948,1.1043567369741571,0.21194379391100704,0.7915152704128443,1.0,81/531,13.79%,CREB5;MAF;TCF4;OSR1;ARNT2;ZIC1;HLF;HOXC4;RBMS1;HOXB4;ESRRG;CUX1;SATB1;ZBTB20;DMRT1;NR1I2;ASCL2;RAD51B;ZIC5;BBX;PKNOX2;VSX2;NFAT5;ELF4;TEAD1;HOXA7;NFIB;RAD51AP2;TEF;CAMTA1;GMEB1;ZNF250;GLI3;IRF8;DMC1;DDX60;ZBTB32;TCF7L1;ZNF23;XRCC5;EN1;NR6A1;TCF12;ARNT;WDR48;KDM5B;MAU2;CEBPG;ZBP1;IRF3;ZSCAN29;ABL1;HOXB6;PRKDC;IRX1;ZIC4;NEUROD2;SNAI1;TFAP2A;HOXC8;TFAP2B;NPAS2;ZNF177;RXRA;ZBTB37;CRY1;CGGBP1;HIVEP1;GLI2;GMEB2;BATF;HSF1;NFATC4;KLF5;HOXA6;CLOCK;NR1I3;HOXD4;MEIS2;HOXB9;MRE11
prerank,cholesterol binding (GO:0015485),0.3568643941582845,1.1021399988809928,0.2979452054794521,0.7923361830378397,1.0,4/47,3.73%,SIDT1;OSBPL8;ABCA1;GRAMD1C
prerank,symporter activity (GO:0015293),0.494169027182027,1.0978928659371818,0.3467741935483871,0.7990761668402879,1.0,3/10,12.56%,SLC5A5;SLC28A3;SLC46A2
prerank,transforming growth factor beta binding (GO:0050431),-0.38606303816193904,-1.097854155516365,0.334020618556701,0.717667905170872,1.0,8/23,12.08%,LTBP4;THBS1;ACVRL1;ENG;TGFBR2;CD109;LTBP1;NRROS
prerank,solute:anion antiporter activity (GO:0140323),0.47505751568968146,1.0975241305164023,0.3854166666666667,0.7949620027563818,1.0,1/14,0.12%,SLC7A11
prerank,"inositol 1,4,5 trisphosphate binding (GO:0070679)",-0.45934359091710053,-1.0974013292939433,0.3568627450980392,0.7139754457743389,1.0,7/11,14.92%,ITPR2;TRPC3;TRPC6;RPH3A;TRPC4;ITPR3;TRPC1
prerank,G protein-coupled receptor binding (GO:0001664),0.30351113572124244,1.0967188707214905,0.3037037037037037,0.7921306204469177,1.0,17/132,7.96%,WNT4;RNF43;WNT6;PRKN;TULP3;GNAS;ADM;NDP;ZNRF3;ACE;TAFA5;GNAQ;ARHGEF11;WNT5B;GRK3;CCL19;RYK
prerank,UDP-glycosyltransferase activity (GO:0008194),0.3314975287008801,1.0965256923788709,0.30082644628099175,0.7876869016607927,1.0,8/70,7.76%,B3GALT1;LARGE1;GXYLT2;B3GNT5;B4GALT1;CHSY1;HAS1;EXTL1
prerank,histone deacetylase binding (GO:0042826),-0.2885935210466938,-1.095306985489794,0.27419354838709675,0.714695578411923,1.0,28/88,24.45%,LEF1;MEF2C;MEF2D;HSP90AA1;HSP90AB1;HES1;HDAC5;YWHAB;SFPQ;SP2;HEY2;MAPK8;MEF2B;TAL1;AKAP8;BRMS1;TOP2A;KCTD21;RAD9A;SMG5;TFAP4;SPI1;HDAC9;HDAC6;NACC1;HSPA1B;RELA;SATB2
prerank,transmitter-gated ion channel activity (GO:0022824),-0.3574771020706697,-1.093971428404839,0.32967032967032966,0.7136467190488095,1.0,12/29,24.46%,GABRB3;GRIK4;GABRB1;GABRG3;GLRA3;GRIA2;GABRA5;GRIK2;GRID2;GABRE;CHRNB1;GABRG2
prerank,kinase activity (GO:0016301),-0.273932090138952,-1.0923861161481003,0.250814332247557,0.71327980640124,1.0,36/109,24.55%,DGKH;PSTK;DGKB;PRKD3;PGM2L1;NADK;DGKI;PIK3C2B;GSK3B;NMRK1;MTOR;CERK;PAPSS2;PIK3CD;PIK3C2A;DGKZ;DGKG;MASTL;PIK3C3;CKB;RFK;ITPKB;PI4KB;PRKD1;ETNK1;IRAK1;PINK1;SEPHS2;CDK5;PANK2;AKT1;DGKQ;DGKE;TRIB3;SEPHS1;IDNK
prerank,lysophosphatidic acid acyltransferase activity (GO:0042171),0.4529062454061922,1.09043081189239,0.3958333333333333,0.7990563503786828,1.0,1/15,0.83%,AGPAT4
prerank,superoxide-generating NAD(P)H oxidase activity (GO:0016175),0.4930299726752644,1.0882679841778193,0.34444444444444444,0.7997060240811089,1.0,3/10,13.92%,DUOX2;NCF2;DUOX1
prerank,purinergic nucleotide receptor activity (GO:0001614),-0.4171580524169497,-1.0860594839493538,0.3643724696356275,0.7254468073979436,1.0,12/15,50.52%,GPR34;P2RY12;PTAFR;P2RY1;P2RX3;P2RX7;P2RX5;P2RX6;GPR171;P2RX1;GPR87;P2RY13
prerank,transcription coactivator binding (GO:0001223),0.42272157824612583,1.0858158976534187,0.336,0.8016145140257447,1.0,4/20,8.08%,RORA;VGLL4;SMAD3;CCNT2
prerank,platelet-derived growth factor receptor binding (GO:0005161),-0.43315988729897426,-1.0851933160083993,0.3528225806451613,0.7229230437767297,1.0,5/13,7.98%,PTPRJ;ITGA5;PDGFC;IL1R1;VEGFA
prerank,lipase activity (GO:0016298),0.3548825908569175,1.084590822908684,0.3411764705882353,0.799758763938235,1.0,6/43,7.82%,CEL;LIPA;PLA2G10;LIPC;LIPH;DAGLB
prerank,protein phosphatase regulator activity (GO:0019888),0.34805112538291916,1.083512100173642,0.32554257095158595,0.7975310979492436,1.0,6/53,5.46%,RCAN2;PPP2R2B;PPP4R4;DMPK;PTPA;PTN
prerank,acidic amino acid transmembrane transporter activity (GO:0015172),0.4515678163326193,1.0832323594871895,0.3661417322834646,0.7934170404376851,1.0,5/15,11.83%,SLC1A3;SLC25A18;SLC1A5;SLC25A22;SLC38A7
prerank,snoRNA binding (GO:0030515),-0.34282449148355765,-1.0820606914338025,0.3378076062639821,0.7267177983735318,1.0,13/30,28.95%,IMP3;BMS1;NUDT4;DHX37;WDR3;NUDT1;TBL3;NHP2;TSR1;RRP9;NUDT16;NOP10;BYSL
prerank,transition metal ion binding (GO:0046914),0.26542763023907767,1.0799593381227939,0.27044025157232704,0.7972373856299785,1.0,86/397,16.10%,MOXD1;PAPPA;HEPH;KDM7A;AGMO;PRKN;KMT2A;UPB1;LARGE1;ZEB1;SOD3;PPM1M;LTF;LOXL3;LACC1;B4GALT1;RNF2;BAZ1B;KDM2B;IKZF4;TDP2;SORD;ACE;TET1;CXXC5;ZBTB32;RABIF;ZFP37;NAPEPLD;PHF8;THAP1;ENPP2;SMAD3;NPEPPS;NEK4;BLM;MMP9;HMGCL;CHD4;MPPED2;BBOX1;KDM2A;ZKSCAN5;SLC30A8;SLU7;DPYS;COX17;KDM5B;TRAF7;XYLT2;MDM2;NSD1;ABL1;CCS;DCT;MYCBP2;PAM;ZNF8;ATP7B;KMT2B;EEA1;RXRA;ENPP3;GLI2;ITGB1BP2;CYLD;S100A9;RCHY1;SHMT1;PRIMPOL;ESCO1;NUDT12;TRIM24;KDM5C;CBLB;MNAT1;ACO2;BIRC2;ZMYM2;PHF2;WRN;XPNPEP3;POMGNT1;SEC24A;SIRT3;SKI
prerank,cytochrome-c oxidase activity (GO:0004129),-0.4208119032074158,-1.078990174267243,0.362,0.7306410832370984,1.0,8/15,28.07%,COX4I1;NDUFA4;COX6A1;COX8A;COX5A;NDUFA4L2;COX15;COX4I2
prerank,serotonin receptor activity (GO:0099589),-0.38462734987528,-1.0785003246898013,0.3674321503131524,0.7179354315858818,1.0,12/22,39.74%,CHRM3;HTR2A;HRH1;HRH2;HTR2C;CHRM1;HTR1F;HTR1A;HTR1B;CHRM5;HRH3;HTR6
prerank,G protein-coupled serotonin receptor activity (GO:0004993),-0.38462734987528,-1.0785003246898013,0.3674321503131524,0.7179354315858818,1.0,12/22,39.74%,CHRM3;HTR2A;HRH1;HRH2;HTR2C;CHRM1;HTR1F;HTR1A;HTR1B;CHRM5;HRH3;HTR6
prerank,G protein-coupled amine receptor activity (GO:0008227),-0.38462734987528,-1.0785003246898013,0.3674321503131524,0.7179354315858818,1.0,12/22,39.74%,CHRM3;HTR2A;HRH1;HRH2;HTR2C;CHRM1;HTR1F;HTR1A;HTR1B;CHRM5;HRH3;HTR6
prerank,Toll-like receptor binding (GO:0035325),-0.4605297963424305,-1.0780290922768818,0.37335834896810505,0.7145416023154516,1.0,7/11,32.31%,DAB2IP;TOLLIP;MYD88;TIRAP;TLR6;CD36;TLR1
prerank,telomeric DNA binding (GO:0042162),0.37383853100908637,1.0778597270148784,0.3553875236294896,0.7977492188255704,1.0,17/32,25.35%,ACD;XRCC5;BLM;APEX1;WRN;STN1;TELO2;UPF2;PURA;HNRNPA2B1;RAD50;UPF3A;TERF2;SMG1;KDM1A;NCL;SMG7
prerank,methylated histone binding (GO:0035064),0.3356194275730113,1.0777395329857433,0.3516295025728988,0.7932576785304577,1.0,15/62,15.47%,KDM7A;PYGO1;L3MBTL2;DPF2;PHF8;CBX8;MTF2;CBX2;KAT8;MBTD1;MORC3;RRP8;TRIM24;PHF1;PHF2
prerank,alanine transmembrane transporter activity (GO:0022858),-0.4432391599316744,-1.0775473233948867,0.3764478764478765,0.7113239333440924,1.0,6/12,16.42%,SLC6A6;SLC38A5;SLC3A2;SLC36A1;SLC1A4;SLC36A4
prerank,intracellular ligand-gated ion channel activity (GO:0005217),0.48847915782308154,1.0768975720498086,0.3958762886597938,0.7908292335856623,1.0,1/11,0.76%,ITPR1
prerank,lipoprotein particle receptor binding (GO:0070325),-0.3678440506412647,-1.0764610406820245,0.344017094017094,0.7097601032875438,1.0,8/27,12.92%,DNAJA1;HSP90B1;APBB1;AP2M1;RELN;APBB3;MESD;CLU
prerank,semaphorin receptor activity (GO:0017154),0.48411229109968795,1.0753726116027704,0.3760504201680672,0.7901048906958413,1.0,2/11,4.34%,PLXNA2;PLXNC1
prerank,"3',5'-cyclic-AMP phosphodiesterase activity (GO:0004115)",-0.4430421947356732,-1.0739972911756388,0.3946869070208729,0.7119328671595313,1.0,5/12,7.62%,PDE4D;PDE3A;PDE8A;PDE2A;PDE8B
prerank,phosphatidylinositol monophosphate phosphatase activity (GO:0052744),-0.40565669799635273,-1.069771872167705,0.3673036093418259,0.719086213373057,1.0,7/16,17.31%,SYNJ1;MTM1;MTMR6;MTMR9;SACM1L;MTMR12;INPP5F
prerank,NADP binding (GO:0050661),0.3821177025246981,1.068803850102737,0.37389770723104054,0.8030490708989791,1.0,3/32,2.60%,DPYD;GMDS;HSD17B1
prerank,phosphotyrosine residue binding (GO:0001784),-0.3361844005524389,-1.0685045794382675,0.37100213219616207,0.7178081019254424,1.0,10/37,20.18%,BCAR3;SHE;PLCG2;CRK;NCK2;SAMSN1;PIK3R3;SHB;YES1;SHC3
prerank,ionotropic glutamate receptor binding (GO:0035255),-0.4589745308904294,-1.0669784888617166,0.376984126984127,0.7173915215647939,1.0,2/10,1.67%,SHANK3;NSF
prerank,iron ion binding (GO:0005506),0.34422027731750404,1.0656148641154104,0.37076648841354726,0.8070715329218284,1.0,8/48,10.44%,HEPH;KDM7A;AGMO;LTF;TET1;PHF8;PHYH;CDO1
prerank,tubulin binding (GO:0015631),-0.23591730397335411,-1.065089756252298,0.2510460251046025,0.7179559442665429,1.0,91/295,24.34%,DNM3;MTUS1;SGIP1;TTLL7;STARD9;MAP1B;UNC5C;REEP3;REEP1;FYN;MAP4;RPS3;MID1;CLIP1;MAP6;BLOC1S2;CLIP2;CCDC88A;EML6;RP1;EFHC2;KIF26A;PRUNE1;MDM1;CHP1;STMN2;DNM2;MAP1LC3B;GAPDH;PAK1;APPL1;APC;NAV3;KIF1A;ARL8A;RMDN3;GIT1;WHAMM;DNM1;ARHGEF2;KIF13A;RAB11FIP5;STMN1;ALDOA;MTCL1;RCC2;TOGARAM1;NDE1;CCDC66;GAS2L3;CCDC88C;HOOK1;RMDN1;KIF21B;FHDC1;APC2;TPPP;STMN4;TPPP3;CEP295NL;CCDC69;KIF3B;RABGAP1;STMN3;GAS2L1;MID2;CDK5;CKAP5;IRAG2;POLB;GABARAPL1;HAUS6;DCTN1;KIF15;NUMA1;B9D2;MAST1;HDAC6;TRIM36;FMR1;SPAG5;MAP1A;VAPA;TRAPPC14;CLASP2;SPEF1;TTLL6;CEP295;SAXO2;KIFC1;KIF1B
prerank,DNA-binding transcription factor binding (GO:0140297),0.2809057809243485,1.064759606385047,0.31900138696255204,0.8047629748016467,1.0,36/189,14.36%,TCF7L2;RBPJ;FHL2;PPARA;PRRX1;RUNX1T1;BCL2;PRDM5;SCX;NFYB;FIZ1;SIK1;TLE3;CXXC5;TTC8;SMAD3;TEAD3;CHD4;TCF12;RBL2;PIAS1;TLE1;LYAR;WWP2;BBS7;HDAC1;CGGBP1;CRTC3;CRTC1;AR;IFI27;GTF2I;CREBBP;RERE;MTDH;SRF
prerank,death receptor activity (GO:0005035),-0.43604965770794857,-1.063051097841324,0.4178498985801217,0.7188064798093039,1.0,4/11,19.29%,TNFRSF11A;TNFRSF1B;FAS;TNFRSF10B
prerank,lysophospholipase activity (GO:0004622),-0.3768101053840995,-1.0626402018020804,0.3868312757201646,0.7155104305440845,1.0,6/20,15.57%,MGLL;GDPD1;GDPD3;LYPLA2;PNPLA6;PLA2G4A
prerank,"steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0033764)",0.4193383734120919,1.0622184410030777,0.3962962962962963,0.8066977096444441,1.0,4/18,15.42%,HSD17B1;HSD17B10;DHRS11;HSD17B14
prerank,"phosphotransferase activity, alcohol group as acceptor (GO:0016773)",-0.2806539196986636,-1.0601889119417058,0.33248081841432225,0.7174928503631034,1.0,20/74,16.27%,DGKH;PKM;DGKB;PGM2L1;NADK;DGKI;HK1;PIK3C2B;FAM20C;NMRK1;PAPSS2;PIK3CD;PIK3C2A;DGKZ;DGKG;PIK3C3;RFK;PI4KB;CLP1;ETNK1
prerank,protein serine/threonine kinase activity (GO:0004674),0.2669808382830394,1.0586087887413402,0.32205513784461154,0.8113687712488892,1.0,49/334,11.96%,MAPK4;ROCK2;OXSR1;NRK;WNK4;CDK8;DAPK1;PDPK1;CAMK1D;MYLK;BMP2K;MAP4K5;DMPK;CDK7;FAM20A;IRAK2;SRPK2;ARAF;MAPK9;SIK1;LRRK2;PRKAA2;PRKCZ;PRKCB;STK17B;TTK;PRKCA;NEK4;GRK3;PRKAA1;NRBP1;CAMK2D;GRK5;PIK3R4;PKN2;CDK1;MAP3K2;NEK10;VRK2;SBK3;LATS1;STKLD1;PRKDC;RPS6KB1;IKBKE;PRKD2;BMPR1A;MAPKAPK2;HIPK3
prerank,WW domain binding (GO:0050699),-0.3510744669699537,-1.0568986664284854,0.3646288209606987,0.7219393889304301,1.0,14/26,41.44%,NDFIP2;TCEAL8;TCEAL9;WBP1;NDFIP1;TCEAL5;PRRG4;TCEAL1;SCNN1A;TCEAL3;TCEAL6;NFE2;LITAF;CDC25C
prerank,phosphatase activity (GO:0016791),0.3191166912556698,1.0563617388504811,0.3768595041322314,0.81276825499525,1.0,8/73,7.06%,ATP1A2;PXYLP1;PLPP3;LHPP;DUSP10;EPHX2;ACP3;NT5M
prerank,inorganic cation transmembrane transporter activity (GO:0022890),0.35033435566467,1.0552237361582026,0.3739424703891709,0.8110365904066519,1.0,4/48,4.37%,TRPM3;NALCN;SLC41A1;MMGT1
prerank,5'-3' RNA polymerase activity (GO:0034062),0.377094673886185,1.054889384811785,0.3690909090909091,0.8072614978524218,1.0,6/27,13.56%,POLR2D;POLR2A;TENT2;POLR1F;POLR1A;POLR1D
prerank,protein kinase inhibitor activity (GO:0004860),-0.3236634155544616,-1.0539892152802246,0.3883720930232558,0.7252732578466576,1.0,20/42,33.60%,RACK1;CIT;NCK1;YWHAB;SPRED2;CDKN1B;SPRY4;IBTK;SMCR8;CAMK2N1;PRKRIP1;INKA2;CDKN1A;SOCS1;SPRY2;RPTOR;GMFB;CEP43;MAPK8IP1;NPM1
prerank,organic anion transmembrane transporter activity (GO:0008514),0.2934464226937654,1.0535798291389713,0.3722304283604136,0.8063143637524102,1.0,28/134,13.05%,SLC6A13;SLC13A3;SLC16A12;SLC38A3;SLC6A9;SLC1A3;PDPN;SLC6A1;SLC25A18;GJA1;SLCO1B1;SLC38A9;SLC13A5;SLC2A10;ABCC2;SLC1A5;SLC25A22;SLC27A1;SLC19A2;SLC19A1;SLC22A6;SLC36A2;SLC35A1;SLC38A7;SLC25A2;SLC38A2;SLC25A38;OCA2
prerank,peptide hormone receptor binding (GO:0051428),-0.44290757223651644,-1.0535494173156215,0.40234375,0.7221762150905403,1.0,6/11,44.81%,PTHLH;GNRH1;ADCYAP1;PSMC5;VIP;UCN2
prerank,epidermal growth factor receptor binding (GO:0005154),0.39267498493661,1.0515402060691257,0.3840304182509506,0.8068649714099478,1.0,3/25,3.44%,EFEMP1;FER;FAM83B
prerank,histone methyltransferase activity (H3-K36 specific) (GO:0046975),0.4621580839867394,1.0511309530899449,0.4072494669509595,0.8034293326235521,1.0,4/10,19.85%,ASH1L;NSD1;SETD2;NSD3
prerank,G protein-coupled peptide receptor activity (GO:0008528),0.31826514159009384,1.0509860646011697,0.36333878887070375,0.7994414502825417,1.0,5/73,6.98%,NPR3;LGR4;BDKRB2;KISS1R;PTH2R
prerank,protein tyrosine/serine/threonine phosphatase activity (GO:0008138),-0.36849367266460975,-1.0505342366804589,0.3934782608695652,0.7257705578881309,1.0,12/22,29.63%,DUSP16;DUSP8;DUSP3;SBF1;DUSP1;DUSP12;DUSP6;DUSP4;CDKN3;PPM1F;DUSP18;DUSP7
prerank,phosphatase binding (GO:0019902),-0.2661376666700595,-1.048998839258996,0.3216216216216216,0.7254878767678573,1.0,23/105,15.18%,MAP3K5;IQGAP1;PTK2;RACK1;PXN;PPME1;NFATC2;CTNNB1;HSP90B1;MET;CEACAM1;FLT4;CHCHD3;CDKN1B;MAP2K7;STAT3;SPTBN4;PPP6R1;MTMR9;JUP;TERF2IP;VRK3;FBXL2
prerank,actin monomer binding (GO:0003785),-0.36674219031144906,-1.047836585774661,0.421505376344086,0.7243001034774106,1.0,3/22,3.89%,TMSB4X;NOS3;TMSB10
prerank,GABA-A receptor activity (GO:0004890),-0.3861575504885669,-1.0448997748183493,0.42190669371196754,0.7276879530373079,1.0,6/18,24.46%,GABRB3;GABRB1;GABRG3;GABRA5;GABRE;GABRG2
prerank,bHLH transcription factor binding (GO:0043425),0.4281933906345849,1.0447740355182085,0.41700404858299595,0.811356263872138,1.0,4/19,7.83%,FHL2;SCX;SMAD3;TCF12
prerank,phosphatidylinositol binding (GO:0035091),-0.2697686758536509,-1.043330045197535,0.32545931758530183,0.7276525291519299,1.0,30/91,21.39%,PITPNC1;HIP1;EPB41;MCF2L;ITPR2;ESYT2;PITPNM2;SCARB1;TNFAIP8L3;DENND1B;CCDC88A;HIP1R;RPH3A;SNX16;APPL1;MTM1;RNF34;ITPR3;WDFY3;PLEKHN1;PITPNA;SNX1;SNAP91;PITPNB;MREG;PLEKHF2;THY1;SNX2;EXOC8;NUMA1
prerank,chloride channel inhibitor activity (GO:0019869),-0.45656975618461576,-1.0424189626466904,0.4421906693711968,0.7259001686721259,1.0,7/10,16.40%,STX7;STX1A;VAMP8;VTI1B;WNK3;CFTR;WNK2
prerank,solute:sodium symporter activity (GO:0015370),0.3768152716646493,1.0421141399171194,0.38198198198198197,0.8138134982362413,1.0,6/27,9.21%,SLC20A2;SLC13A5;SLC34A3;SLC28A3;SLC20A1;SLC4A9
prerank,U6 snRNA binding (GO:0017070),-0.4185261098019365,-1.041415034427663,0.4222222222222222,0.7246227851236846,1.0,6/14,26.10%,LARP7;DDX39B;PRPF4;EIF5A;RBM22;LSM8
prerank,thioesterase binding (GO:0031996),-0.43806260197183244,-1.0414115094071745,0.40535372848948376,0.7205971029841086,1.0,2/11,14.46%,RAC1;TRAF1
prerank,sodium channel activity (GO:0005272),0.36046800261101253,1.0394858145278207,0.41025641025641024,0.8160287893035026,1.0,2/37,2.96%,SCN7A;SHROOM2
prerank,potassium channel regulator activity (GO:0015459),-0.30341375519476055,-1.0391123080650089,0.375,0.7224650250390787,1.0,12/49,17.01%,ABCC9;NEDD4L;KCNS3;FLNA;KCNAB1;WNK3;CHP1;KCNMB4;ADRB2;KCNIP2;WNK2;SGK1
prerank,purine ribonucleoside triphosphate binding (GO:0035639),-0.22138379870399225,-1.0391118821925984,0.33707865168539325,0.7184954369894134,1.0,138/431,25.04%,MAP3K5;EEF1A1;RAP1A;RHOJ;STK38;HSPA8;KRAS;RPS6KA5;ATP1A1;ACVRL1;RAC1;HSP90AA1;HSP90AB1;RASL12;CDC42BPA;PRAG1;RAB31;RAB27A;MINK1;TGM2;CDK11B;GCH1;STK38L;PRPS2;NRAS;ATP5F1A;RERG;RHOB;TUBB3;GBP4;ATP5F1D;ARF5;RHOT1;SCG5;GNAI1;WNK3;MRAS;GNL3;HNRNPU;ARF1;DNM2;MYH9;HSPA14;RAB28;MARK1;RAB38;RHOA;ARHGEF5;EIF4G1;PXK;BMS1;RALB;TUBB4B;HSPA5;ARL8A;PEAK1;CDK6;GBP5;NDUFA13;TUBA1B;RHEB;ABCD3;ATP1A3;MSH2;PDK2;LMTK2;GUK1;MARK2;OAS2;PFKM;KCNJ8;IDE;SRPK1;TUBB2A;PFKP;GBP3;SYN2;ABCD2;TUBA1A;STK36;IRAK3;RABL3;CLP1;RHOG;EIF2B2;ATL2;RPS6KA4;WNK2;PEX1;RRAS;TUBB4A;MTHFD1L;RRAGB;UBA2;AK6;PINK1;ABCD4;ACVR1;LIG4;RAB1B;ACLY;RIT2;HSPA9;RAB39A;INSR;TLK2;ABCA2;MTREX;MKNK2;AKT1;ARFIP2;UHMK1;MAP3K6;NUAK2;ABCG1;MAST1;SIK2;SMC4;RAB8A;TUBD1;HSPA1B;TSR1;BRSK2;PYGL;NEK11;AARS2;GEM;DDX25;SEPHS1;RAB14;ARL4A;KIFC1;ERN1;NUDT16;HRAS;DRG2;TUBB2B;CDC42BPB
prerank,protein serine/threonine kinase inhibitor activity (GO:0030291),0.3744894081019415,1.0388421552103373,0.40373831775700936,0.813412164437983,1.0,1/29,0.09%,PRKAG2
prerank,hexosyltransferase activity (GO:0016758),0.29549803615485376,1.0380130213419254,0.3847376788553259,0.811127014680719,1.0,12/101,8.14%,B3GALT1;TMTC4;LARGE1;TMTC1;B3GNT5;A4GALT;B4GALT1;ALG6;CHSY1;HAS1;EXTL1;ALG9
prerank,methylation-dependent protein binding (GO:0140034),0.3281057717940118,1.0378929423835839,0.3925549915397631,0.8070941263739436,1.0,14/57,15.47%,KDM7A;PYGO1;L3MBTL2;PHF8;CBX8;MTF2;CBX2;KAT8;MBTD1;MORC3;RRP8;TRIM24;PHF1;PHF2
prerank,mRNA binding (GO:0003729),-0.23258621358198997,-1.0364789876004803,0.3629032258064516,0.721161795346648,1.0,77/249,22.10%,RPL41;NOVA2;HNRNPK;TARDBP;ADARB1;RPS7;RPS3;PKM;RBFOX1;QKI;RPL26;IREB2;RBFOX3;RPS14;LUC7L2;HNRNPAB;G3BP1;PABPC1;RBFOX2;RBM47;YBX3;CALR;SRSF1;SRRM3;GNL3;RPL5;HNRNPU;PUM2;RPS2;PPIE;SF3B1;DDX5;EIF4G3;RBM14;ZC3H12C;SRSF5;EIF4G1;EIF3D;SSB;RPL7;CPEB1;RSL1D1;CPSF6;RBM8A;ZFP36L1;YTHDF3;KHDRBS3;RNPS1;SRSF6;RPS26;GRSF1;SHFL;RPS5;RIDA;HNRNPA0;RPL13A;SERBP1;N4BP1;EIF2A;CSTF2;ZC3H12A;PCBP1;CSTF2T;PCF11;YTHDC1;MRPL13;EDC3;RPL35;HNRNPLL;PTBP1;PCBP4;METTL3;SNIP1;EIF3A;TRA2B;RBM24;FMR1
prerank,four-way junction DNA binding (GO:0000400),0.4115389702888658,1.0363544751916571,0.4166666666666667,0.806582675801271,1.0,4/17,10.22%,RAD51B;RAD51C;BLM;ABL1
prerank,ATPase regulator activity (GO:0060590),-0.31538296830358215,-1.036031730620216,0.41043083900226757,0.718421985310638,1.0,10/38,17.54%,FNIP2;ATP1B1;DNAJA1;BAG1;SIL1;DNAJC1;DNAJC10;ATP5IF1;PLN;DNAJB1
prerank,protease binding (GO:0002020),0.3013291440557381,1.0360128182438932,0.3894080996884735,0.8032449661076583,1.0,16/99,10.34%,BDKRB2;TIMP3;STIM1;PRKN;BCL2;ECM1;COL1A2;CCBE1;A2ML1;ITGA3;NOL3;PTEN;AMFR;ADAMTSL4;BRCA2;DVL3
prerank,phosphate ion binding (GO:0042301),-0.4549663967629807,-1.0354979885920108,0.4542124542124542,0.7157999204098865,1.0,5/10,35.54%,PDE2A;RPH3A;RELA;CHST14;ADSS1
prerank,extracellular ligand-gated ion channel activity (GO:0005230),-0.4510653352918431,-1.0349369812708646,0.4423791821561338,0.7134690050771678,1.0,5/10,34.07%,GABRG3;GABRA5;GABRE;GABRG2;GABRG1
prerank,transmembrane receptor protein serine/threonine kinase activity (GO:0004675),-0.3823236525509126,-1.034166441169313,0.4228456913827655,0.7116098324405108,1.0,5/18,5.03%,LTBP4;ACVRL1;ENG;BMPR2;TGFBR2
prerank,cation channel activity (GO:0005261),0.30214635265908263,1.0334376335100282,0.38522012578616355,0.8057426192438153,1.0,4/94,1.71%,TRPM3;SLC24A3;KCNQ4;NALCN
prerank,tumor necrosis factor receptor superfamily binding (GO:0032813),-0.35009893182213025,-1.032705448284164,0.43137254901960786,0.7115536040120338,1.0,11/28,31.81%,DAB2IP;EDA;TMBIM1;TRAF1;MADD;CASP8AP2;MYD88;STAT1;BID;FADD;PIDD1
prerank,BMP binding (GO:0036122),-0.4349307664872113,-1.0303359396880045,0.44550669216061184,0.7134118749030888,1.0,2/11,3.97%,ENG;BMPR2
prerank,metal ion transmembrane transporter activity (GO:0046873),-0.34804569410898545,-1.0300150900109168,0.42250530785562634,0.7104883257728037,1.0,8/27,12.61%,SLC12A2;ITPR2;SLC9B2;MAGT1;ATP2A3;SLC4A8;KCNA1;ATP2B1
prerank,non-membrane spanning protein tyrosine kinase activity (GO:0004715),-0.32191805052184685,-1.0295467956738307,0.3930232558139535,0.7079208141422475,1.0,10/35,20.24%,PTK2;FYN;PTK2B;BMX;CSK;PEAK1;STYK1;YES1;SLA;TXK
prerank,ionotropic glutamate receptor activity (GO:0004970),-0.38533373630503265,-1.0294464550033302,0.42827868852459017,0.7044513152495746,1.0,6/17,19.38%,PTK2B;GRIK4;GRIN3A;GRIN1;GRIA2;GRIK2
prerank,GABA receptor activity (GO:0016917),-0.36549561294732114,-1.028500802637295,0.41821946169772256,0.7030662325439154,1.0,7/21,26.01%,GABRB3;GABRB1;GABRG3;GABRA5;GABRE;GABRG2;GABBR1
prerank,myosin II binding (GO:0045159),-0.4484490825194303,-1.0274342762065138,0.45294117647058824,0.7019738024909546,1.0,3/10,7.96%,SHROOM4;GSN;SHROOM1
prerank,carboxylic acid binding (GO:0031406),-0.31581493173076897,-1.0267696018141912,0.38839285714285715,0.69986839958265,1.0,8/38,10.80%,NOS3;SESN3;GRM7;PSAP;GRIN3A;SESN2;NOS1;GRIN1
prerank,platelet-derived growth factor binding (GO:0048407),0.46743482552166926,1.0262863009757355,0.41875,0.8193594029635395,1.0,3/11,3.77%,PDGFRB;COL1A2;PDGFRA
prerank,hyaluronic acid binding (GO:0005540),0.471330480885884,1.026252504880954,0.43452380952380953,0.8151416909276459,1.0,1/10,0.66%,CEMIP
prerank,neutral amino acid transmembrane transporter activity (GO:0015175),-0.323398341656954,-1.0255294228423824,0.40700218818380746,0.6991881385684133,1.0,9/32,12.02%,SLC6A6;SLC7A5;SFXN1;SLC1A1;SLC38A5;SLC3A2;SLC43A2;SLC36A1;SLC1A4
prerank,adenyl-nucleotide exchange factor activity (GO:0000774),-0.4306878322998343,-1.0219714132770543,0.47058823529411764,0.7006837985981116,1.0,2/11,8.63%,BAG1;SIL1
prerank,adenyl nucleotide binding (GO:0030554),-0.4306878322998343,-1.0219714132770543,0.47058823529411764,0.7006837985981116,1.0,2/11,8.63%,BAG1;SIL1
prerank,MAP kinase phosphatase activity (GO:0033549),-0.41255787457126014,-1.0218128477074275,0.4267161410018553,0.6974904775991434,1.0,7/12,29.63%,DUSP16;DUSP8;DUSP3;DUSP1;DUSP6;DUSP4;DUSP7
prerank,phosphatidylinositol phosphate binding (GO:1901981),-0.26178809925600866,-1.021624426466836,0.39766081871345027,0.694456458794156,1.0,14/100,7.60%,CERT1;HIP1;CYTH3;ARAP2;MYO10;IQGAP1;ARAP3;DAB2IP;DENND1B;CLVS2;CLVS1;FERMT2;HIP1R;RPH3A
prerank,pre-mRNA binding (GO:0036002),0.3704674533197689,1.0209897945339617,0.4411214953271028,0.8247289420489666,1.0,1/28,0.19%,CELF2
prerank,adenylate cyclase binding (GO:0008179),0.4688015596509821,1.0207272495910682,0.43125,0.8211542426315317,1.0,1/10,0.40%,ADCY5
prerank,RNA polymerase II-specific DNA-binding transcription factor binding (GO:0061629),0.271151909688424,1.0200976882586545,0.4157142857142857,0.8185243399442123,1.0,34/181,14.26%,TCF7L2;RBPJ;ARNT2;PPARA;PRRX1;NR1I2;NCOA2;FIZ1;SETD6;TTC8;SMAD3;NCOA3;TEAD3;CHD4;NCOA7;RBL2;ARNT;PIAS1;WWP2;BBS7;MED1;HDAC1;TACC1;PARP9;SMARCE1;RXRA;CRY1;SMARCB1;AR;IFI27;GTF2I;CREBBP;RERE;MTDH
prerank,calcium-activated potassium channel activity (GO:0015269),-0.4266404487388016,-1.0184464941928986,0.4280155642023346,0.6980276569817119,1.0,3/11,12.06%,KCNMA1;KCNMB4;KCNN2
prerank,protein-cysteine S-palmitoyltransferase activity (GO:0019706),-0.3520224812036511,-1.0178470894947267,0.4472049689440994,0.6959794387405552,1.0,9/24,24.55%,ZDHHC14;ZDHHC15;GOLGA7;ZDHHC2;ZDHHC7;ZDHHC4;ZDHHC8;ZDHHC20;ZDHHC17
prerank,cysteine-type endopeptidase inhibitor activity involved in apoptotic process (GO:0043027),-0.38361751516402953,-1.0178468655244453,0.42362525458248473,0.6925509685989761,1.0,5/18,13.88%,GAS6;SERPINB9;BIRC3;RPS6KA1;MT3
prerank,"3',5'-cyclic-nucleotide phosphodiesterase activity (GO:0004114)",0.38838442385953387,1.0148935659080869,0.4373795761078998,0.8276187383547866,1.0,4/21,6.86%,PDE1A;PDE7B;PDE7A;PDE5A
prerank,acetylgalactosaminyltransferase activity (GO:0008376),0.36696265040442694,1.0103037286480314,0.43853211009174314,0.8351442934843095,1.0,3/26,5.43%,B3GALT1;B3GNT5;CHSY1
prerank,sodium channel regulator activity (GO:0017080),0.3557106447131613,1.0100601711015094,0.4499054820415879,0.8315043907954632,1.0,8/37,11.92%,SNTA1;GPD1L;NEDD4;PCSK9;CAMK2D;PTPN3;SCN3B;SCN2B
prerank,palmitoyltransferase activity (GO:0016409),-0.3379967585750861,-1.0084638479639951,0.4620253164556962,0.7109636789138825,1.0,11/28,26.41%,ZDHHC14;ZDHHC15;GOLGA7;ZDHHC2;ZDHHC7;HHAT;ZDHHC4;ZDHHC8;ZDHHC20;ZDHHC17;ZDHHC5
prerank,sodium ion transmembrane transporter activity (GO:0015081),0.3701373341487022,1.0071358005390316,0.47547169811320755,0.8348590346528952,1.0,3/27,3.10%,SLC8A3;SLC41A1;SLC8A1
prerank,potassium ion antiporter activity (GO:0022821),0.419685600071256,1.0051571038162879,0.45841784989858014,0.8356926945568962,1.0,1/15,0.37%,SLC24A3
prerank,serine-type endopeptidase inhibitor activity (GO:0004867),-0.30829956813498816,-1.004922081578945,0.43400447427293065,0.7157565293150107,1.0,9/38,13.62%,SERPINE2;SERPINI1;SERPINB9;APP;SERPINF1;A2M;FURIN;SPINT2;SPOCK1
prerank,aminoacyl-tRNA ligase activity (GO:0004812),-0.31619721827139713,-1.0045174950817677,0.44719101123595506,0.7134048086626456,1.0,13/37,30.27%,WARS2;LARS2;WARS1;SARS1;YARS1;IARS1;NARS1;FARSA;AARS2;CARS1;KARS1;MARS2;GARS1
prerank,SUMO transferase activity (GO:0019789),0.40509129520296705,1.0036262661418458,0.4525691699604743,0.8355044681310653,1.0,5/16,19.35%,PIAS1;MDM2;CBX4;HDAC4;PIAS3
prerank,voltage-gated ion channel activity (GO:0005244),-0.38709127531465437,-1.0023798607484347,0.46,0.7149744084154595,1.0,4/14,18.32%,CACNA1E;CACNA1H;HCN1;KCND2
prerank,calcium-dependent phospholipid binding (GO:0005544),-0.28941951327262827,-1.002235374118099,0.4357142857142857,0.7119289360180501,1.0,23/49,29.85%,ESYT2;MCTP1;CPNE8;RPH3A;CPNE3;DYSF;C2CD5;CPNE2;PCLO;SYT10;SYT4;PLA2G4A;CPNE9;SYT7;SYT2;SYT15;PLA2G4F;ANXA8;CPNE5;DOC2B;SYT17;ESYT3;SYT1
prerank,hexosaminidase activity (GO:0015929),0.4431108571867344,1.0021536005246692,0.4686868686868687,0.8350390616433208,1.0,4/12,15.55%,CEMIP;HEXD;SPAM1;HYAL1
prerank,transforming growth factor beta-activated receptor activity (GO:0005024),-0.4148751645121569,-0.9982209367989985,0.4727626459143969,0.7177809009404146,1.0,5/12,5.03%,LTBP4;ACVRL1;ENG;BMPR2;TGFBR2
prerank,endopeptidase inhibitor activity (GO:0004866),0.29429086174459684,0.9971010868200525,0.45527156549520764,0.8437511658757831,1.0,7/82,3.85%,TFPI;TIMP3;ITIH2;PROS1;SERPIND1;LTF;A2ML1
prerank,low-density lipoprotein particle receptor binding (GO:0050750),-0.35651289949572146,-0.9968662691955232,0.48851774530271397,0.7177739593452971,1.0,7/22,12.92%,DNAJA1;HSP90B1;APBB1;AP2M1;APBB3;MESD;CLU
prerank,titin binding (GO:0031432),0.42322511403628255,0.996775764658771,0.46540880503144655,0.8404091249074012,1.0,3/13,12.97%,TRIM63;CAMK2D;ACTN2
prerank,cyclic-nucleotide phosphodiesterase activity (GO:0004112),0.37343477619603693,0.996302897863958,0.4680451127819549,0.8374133876554496,1.0,4/23,6.86%,PDE1A;PDE7B;PDE7A;PDE5A
prerank,ubiquitin binding (GO:0043130),-0.2649643143251636,-0.9958956457438937,0.46715328467153283,0.7165356488205515,1.0,31/73,29.91%,FBXO7;MVB12B;UBXN1;HSPB1;BUB3;UBAP1;FAF1;UCHL1;TOLLIP;NSFL1C;OTUB1;UCHL3;MVB12A;TOP2A;UBAP1L;N4BP1;AUP1;SPRTN;RNF19B;SHARPIN;RNF168;USP5;PLAA;RBCK1;TNFAIP3;USP33;RNF31;VPS36;CKS2;TOM1L1;VPS28
prerank,mitogen-activated protein kinase binding (GO:0051019),-0.32192308133049763,-0.9953464631929915,0.4668192219679634,0.714592870334165,1.0,4/29,5.40%,PTPRJ;DUSP16;GCH1;NFATC1
prerank,receptor tyrosine kinase binding (GO:0030971),-0.2799126910534997,-0.9898092373275058,0.48552338530066813,0.7241016436359565,1.0,14/56,14.03%,GRB14;PITPNM2;GAS6;PTPN14;CBL;RACK1;NCK1;TOB1;SOCS5;CPNE3;DUSP3;PTPN1;PITPNM3;NRG3
prerank,protein phosphatase activator activity (GO:0072542),-0.39949942808234673,-0.9897646325741091,0.4768339768339768,0.7208084587851653,1.0,6/13,24.75%,CALM1;PPP2R5C;CALM2;PPP2R5A;PPP1R15A;CALM3
prerank,delayed rectifier potassium channel activity (GO:0005251),-0.31341407920099845,-0.9889227998014591,0.4901098901098901,0.7191383167188837,1.0,7/32,10.77%,KCNQ3;KCNB2;KCNS3;KCNB1;KCNQ1;KCNQ5;KCNA1
prerank,protein phosphorylated amino acid binding (GO:0045309),-0.3032023139731819,-0.9884415406460128,0.4967462039045553,0.7167996203132637,1.0,11/42,20.18%,BCAR3;SHE;PLCG2;YWHAB;CRK;NCK2;SAMSN1;PIK3R3;SHB;YES1;SHC3
prerank,phosphatase activator activity (GO:0019211),-0.3875804683835066,-0.985253230604653,0.4866920152091255,0.7206525375137512,1.0,7/14,24.75%,CALM1;PPP2R5C;BMP2;CALM2;PPP2R5A;PPP1R15A;CALM3
prerank,phosphatidylinositol-4-phosphate binding (GO:0070273),0.3670380757310955,0.9845187600945374,0.48713235294117646,0.862892511513671,1.0,5/24,11.29%,OSBPL8;GSDMA;PLEKHF1;GSDMD;PLEKHA8
prerank,cAMP binding (GO:0030552),-0.4110412186272524,-0.9805414577920271,0.4838095238095238,0.7285038475173276,1.0,3/11,12.14%,PDE4D;PDE2A;HCN1
prerank,pentosyltransferase activity (GO:0016763),0.3427202872509978,0.9797250064853752,0.5053763440860215,0.8709992968855241,1.0,10/36,19.51%,LARGE1;LACC1;PARP4;PARP10;PARP9;UPP2;SIRT3;QPRT;TIPARP;PARP14
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides (GO:0016812)",0.4449636069102282,0.9781845295198212,0.48187633262260127,0.8707419475608965,1.0,2/10,8.48%,DPYSL3;DPYS
prerank,mannosyltransferase activity (GO:0000030),0.37982938340503375,0.9774054547041694,0.48975409836065575,0.8683534332391699,1.0,5/21,10.06%,TMTC4;TMTC1;ALG2;ALG9;PIGV
prerank,DNA-directed 5'-3' RNA polymerase activity (GO:0003899),0.35010036546619216,0.9750181222755323,0.47549909255898365,0.8700980970401926,1.0,6/27,13.65%,POLR2D;POLR2A;POLR1F;POLR1A;POLR1D;PRIMPOL
prerank,filamin binding (GO:0031005),0.44039450559145865,0.9749869467774652,0.4895397489539749,0.866011002989421,1.0,2/11,4.14%,DPYSL3;NEBL
prerank,calcium ion transmembrane transporter activity (GO:0015085),-0.27405868264234357,-0.9739653824519289,0.4769585253456221,0.7399172524614014,1.0,20/55,20.09%,ITPR2;TRPC3;PKD1;ATP2C1;ATP2A3;SLC24A2;ATP2A2;RYR2;GRIN1;CACNB2;ATP2B1;TRPV2;PANX1;TRPC1;SLC24A5;ORAI1;TMEM165;ATP2B2;ATP2B4;PSEN1
prerank,growth factor receptor binding (GO:0070851),0.2824055057309177,0.973582516666379,0.5078369905956113,0.8653624455764446,1.0,14/95,10.36%,EFEMP1;PDGFRB;KL;FER;FAM83B;PDGFRA;PDGFD;FRS2;FGF1;IL6;VEGFB;FGF9;JAK2;FGF20
prerank,protein homodimerization activity (GO:0042803),0.2326862718052633,0.9723190408075228,0.5470383275261324,0.8643533166281053,1.0,60/589,8.36%,MAPK4;CPQ;DPYD;NPR3;MTUS2;APPL2;FGFR2;NR2F2;KIT;NADK2;TPM1;KMT2A;JAML;UPB1;FBLN5;SNX6;LHPP;CBS;BCL2;TNNC1;GSTM2;HSD17B1;CRYL1;SOX6;TPST1;TRIM5;ALS2;IRAK2;PDGFRA;ZHX2;RBPMS;CRPPA;PAFAH1B3;CBY1;PTPA;GLIPR2;LRRK2;NDP;SNX9;EPHX2;THAP1;PDCD6;BNIP3;ACP3;SMAD3;HOGA1;PGRMC1;BLM;RPE;NR6A1;NRBP1;ZDHHC3;ARNT;CSF1;KLHL7;MYO9B;SLC30A8;MUC13;CAMK2D;SRR
prerank,microtubule binding (GO:0008017),-0.2229154419246993,-0.9720428654844038,0.503448275862069,0.7410883280530224,1.0,80/222,26.87%,DNM3;MTUS1;SGIP1;STARD9;MAP1B;REEP3;REEP1;MAP4;RPS3;MID1;CLIP1;MAP6;CLIP2;CCDC88A;EML6;RP1;KIF26A;MDM1;CHP1;DNM2;MAP1LC3B;GAPDH;APC;NAV3;KIF1A;RMDN3;WHAMM;DNM1;ARHGEF2;KIF13A;MTCL1;RCC2;TOGARAM1;NDE1;CCDC66;GAS2L3;CCDC88C;HOOK1;RMDN1;KIF21B;FHDC1;APC2;TPPP;CEP295NL;CCDC69;KIF3B;GAS2L1;MID2;CDK5;CKAP5;IRAG2;POLB;HAUS6;TTBK2;MAPRE1;DCTN1;KIF15;NUMA1;MAST1;HDAC6;KNSTRN;FMR1;SPAG5;MAP1A;VAPA;CLASP2;CAMSAP3;SPEF1;CEP295;SAXO2;KIFC1;KIF1B;KIFC2;EZR;REEP2;KIF14;CAMSAP1;TRPV4;NEFM;CETN3
prerank,glycine binding (GO:0016594),-0.4057497519923048,-0.9701758825096144,0.5018587360594795,0.7419168394547695,1.0,7/11,30.84%,GRIN3A;GRIN1;GLRA3;GLRA1;GLDC;GRIN2B;GNMT
prerank,transcription coregulator binding (GO:0001221),0.31061316967813224,0.9678120798810665,0.4991304347826087,0.8720574676763289,1.0,10/50,12.84%,RORA;USP11;VGLL4;SMAD3;MTF2;CCNT2;PER3;CHD6;CNOT2;AR
prerank,potassium channel activity (GO:0005267),-0.24840401716646254,-0.965385946421286,0.5316091954022989,0.7495813878756246,1.0,19/89,14.90%,KCNK5;ABCC9;KCNQ3;KCNB2;KCNMA1;KCNS3;KCNB1;GRIK4;KCNK13;KCNQ1;KCNT1;KCNMB4;KCNQ5;KCNA1;KCNN2;HCN1;TMEM38B;KCNH7;KCNQ2
prerank,phosphatidylinositol-3-phosphate binding (GO:0032266),0.3265964451445526,0.963464893845495,0.5325342465753424,0.8790182705172436,1.0,9/38,16.93%,SNX21;PARD3;SH3PXD2B;WIPI1;PLEKHF1;ZFYVE26;SNX12;RUFY4;DENND1A
prerank,calcium channel activity (GO:0005262),0.28322280712208914,0.9625417757652517,0.5194174757281553,0.8771358688537035,1.0,8/84,8.07%,CACNA2D3;SLC24A3;CACNA1D;CACNB4;CACNG7;TMC2;CACNA2D1;MCU
prerank,steroid hydroxylase activity (GO:0008395),0.3893363027213667,0.9623027595617321,0.49145299145299143,0.873662738551442,1.0,1/16,1.12%,CYP27A1
prerank,calcium channel regulator activity (GO:0005246),0.3254891476410118,0.9618399415586659,0.4836488812392427,0.8707657820942779,1.0,4/37,5.03%,ITPR1;STIM1;CACNG1;CACNG7
prerank,ATP binding (GO:0005524),0.24674704991560392,0.9617109135834733,0.5160875160875161,0.8671190134727131,1.0,44/266,14.87%,PRKAG2;ATP1A2;OXSR1;KSR1;WNK4;DAPK1;CLPX;MAP4K5;DMPK;ABCA1;SRPK2;SPHK1;PTPA;SIK1;STK17B;MYO18A;SARS2;TRNT1;BLM;MYO9B;SRR;PMVK;GALK1;HSPA1L;NOL9;ABL1;LATS1;MYH10;ATP7B;SMARCA5;RTEL1;BMPR1A;PRKAG1;PRKACB;ABCB8;PPIP5K2;NLK;PRKCI;STK26;CDKL5;HACL1;SIK3;TAP2;NIM1K
prerank,cysteine-type endopeptidase activator activity involved in apoptotic process (GO:0008656),-0.397343122935259,-0.9544485123386447,0.5414141414141415,0.7716024473405896,1.0,5/12,14.62%,RACK1;NOD1;ATP2A3;RPS27L;CASP8AP2
prerank,adenyl ribonucleotide binding (GO:0032559),0.2421045495269357,0.9530524514264636,0.5446540880503145,0.8841207287285907,1.0,48/291,14.87%,PRKAG2;ATP1A2;OXSR1;KSR1;WNK4;DAPK1;PRKAG3;CLPX;MAP4K5;DMPK;ABCA1;SRPK2;SPHK1;PTPA;SIK1;STK17B;MYO18A;SARS2;TRNT1;RAPGEF4;BLM;MPPED2;MYO9B;SRR;PMVK;GALK1;HSPA1L;NOL9;ABL1;LATS1;SLC19A1;MYH10;ATP7B;SMARCA5;RTEL1;BMPR1A;PRKAG1;PRKACB;ABCB8;PPIP5K2;NLK;PRKCI;STK26;CDKL5;HACL1;SIK3;TAP2;NIM1K
prerank,protein kinase C activity (GO:0004697),-0.3743060761702837,-0.9517437974507753,0.5281124497991968,0.774257858112534,1.0,6/14,20.25%,PRKCH;PRKD3;PRKD1;PRKCE;PRKCG;PRKCD
prerank,cysteine-type endopeptidase inhibitor activity (GO:0004869),-0.3157434090790444,-0.9515700181344066,0.5227272727272727,0.7712741082500995,1.0,9/30,16.38%,GAS6;CST3;SERPINB9;BIRC3;RPS6KA1;SPOCK1;PTTG1;MT3;CARD16
prerank,mitogen-activated protein kinase kinase kinase binding (GO:0031435),0.4437878403364036,0.9505533103132074,0.5316455696202531,0.8862298142563697,1.0,1/11,0.41%,SASH1
prerank,phosphatase inhibitor activity (GO:0019212),-0.3456075286806086,-0.9479315065438105,0.5429769392033543,0.7763691882239004,1.0,9/20,28.94%,PPME1;PPP1R2;SET;LMTK2;BOD1;URI1;MGAT5;ARPP19;SAG
prerank,nucleosomal DNA binding (GO:0031492),0.36341463680203834,0.9414234707391013,0.5193370165745856,0.9039841277274752,1.0,7/21,14.47%,RBBP4;HNRNPC;CHD4;HDAC1;SMARCE1;SMARCB1;SMARCC1
prerank,phosphoric diester hydrolase activity (GO:0008081),-0.2952285896724776,-0.9413125589442712,0.5711060948081265,0.7879370785857743,1.0,9/35,13.71%,GPCPD1;PLCB4;SMPD4;GDPD1;PLCB3;GDPD3;PLCXD3;PLD3;PDE11A
prerank,low-density lipoprotein particle binding (GO:0030169),-0.35844003569200933,-0.9411846058692663,0.5298969072164949,0.7847672357840975,1.0,5/16,5.13%,PLTP;THBS1;SCARB1;SCARF1;STAB1
prerank,metallocarboxypeptidase activity (GO:0004181),0.346696384316029,0.9390759258522086,0.5478424015009381,0.9058163003412063,1.0,3/26,7.30%,AEBP1;CPXM1;AGBL2
prerank,magnesium ion binding (GO:0000287),0.25674465273837316,0.9389522501480926,0.5680119581464873,0.9020720571929005,1.0,32/135,17.29%,OXSR1;EYA2;SRPK2;SPHK1;SIK1;TDP2;LRRK2;EPHX2;PDCD6;HMGCL;IDH2;SRR;XYLT2;ABL1;LATS1;CLYBL;RAP2A;IDH3G;FOXK2;THTPA;PRKACB;NUDT12;NLK;STK26;HACL1;SIK3;NIM1K;BRSK1;WRN;PI4K2A;NEK6;XXYLT1
prerank,acyl-CoA hydrolase activity (GO:0047617),0.37394290094460214,0.9369721125150146,0.5347368421052632,0.9028025536368116,1.0,7/17,24.65%,ACOT4;ACAA2;ACOT1;ACOT13;ACOT11;ACOT6;PPT1
prerank,actinin binding (GO:0042805),0.36141163950557764,0.9361716733963958,0.549800796812749,0.9008062636504004,1.0,3/21,4.86%,KCNA5;CSRP3;CACNA1D
prerank,glucose transmembrane transporter activity (GO:0005355),-0.3533317590379379,-0.9356691013953156,0.5492957746478874,0.7939859868069653,1.0,1/17,0.78%,SLC2A1
prerank,carboxylic ester hydrolase activity (GO:0052689),0.271937805239588,0.9351522073485231,0.5579937304075235,0.8989974502378913,1.0,9/85,7.82%,CEL;LIPA;PLA2G10;PAFAH2;PAFAH1B3;ENPP2;H6PD;LIPC;DAGLB
prerank,glucuronosyltransferase activity (GO:0015020),0.36893424282047693,0.9350991402369024,0.5359223300970873,0.895167156915017,1.0,3/19,7.76%,LARGE1;CHSY1;EXTL1
prerank,m7G(5')pppN diphosphatase activity (GO:0050072),-0.3949964459309828,-0.9350014508994637,0.5581395348837209,0.792106603884042,1.0,5/11,24.72%,NUDT3;NUDT4;NUDT1;DCPS;NUDT16
prerank,nucleotidyltransferase activity (GO:0016779),0.36605229350825086,0.9342312615191477,0.548582995951417,0.8932608338967416,1.0,9/19,23.15%,CRPPA;REV1;TENT2;TUT1;MOCS3;TUT4;TUT7;THG1L;PAPSS1
prerank,protein tyrosine/threonine phosphatase activity (GO:0008330),-0.39839088272260903,-0.9341378010304592,0.5661764705882353,0.7872764741166255,1.0,6/10,29.63%,DUSP16;DUSP8;DUSP1;DUSP6;DUSP4;DUSP7
prerank,MAP kinase tyrosine/serine/threonine phosphatase activity (GO:0017017),-0.39839088272260903,-0.9341378010304592,0.5661764705882353,0.7872764741166255,1.0,6/10,29.63%,DUSP16;DUSP8;DUSP1;DUSP6;DUSP4;DUSP7
prerank,active ion transmembrane transporter activity (GO:0022853),-0.28888087589032413,-0.9339007834825109,0.5790697674418605,0.7843305503449702,1.0,16/37,22.83%,SLCO1C1;SLCO2A1;SLCO2B1;COX4I1;SLCO3A1;NDUFA4;UQCRH;COX6A1;UQCR11;COX8A;COX5A;UQCRQ;SLCO4A1;UQCRC1;UQCR10;NDUFA4L2
prerank,"DNA-binding transcription repressor activity, RNA polymerase II-specific (GO:0001227)",0.24768444410807672,0.9330473220020943,0.5796460176991151,0.8921919002200482,1.0,30/173,13.14%,AEBP1;PPARA;ZEB2;KCNIP3;MXI1;ZEB1;PRDM5;SATB1;ZBTB20;ASCL2;VSX2;ZFP90;IRF8;ZBTB32;MXD1;ZFP37;THAP1;EN1;MITF;IRX1;SNAI1;TFAP2A;ZNF177;ZBTB37;E2F6;ZBTB39;FOXK2;HSF1;SOX13;NFATC4
prerank,NAD+ binding (GO:0070403),0.4093770027365822,0.9307476799689122,0.5548387096774193,0.8938704288948999,1.0,3/12,16.06%,CRYL1;PARP9;SIRT3
prerank,acetylglucosaminyltransferase activity (GO:0008375),0.30106255115183866,0.9304497246575009,0.5668449197860963,0.8906696587775235,1.0,3/46,2.79%,B3GALT1;LARGE1;B3GNT5
prerank,lipoprotein particle binding (GO:0071813),-0.33325173699506905,-0.9297103725968426,0.540084388185654,0.7902407216323504,1.0,7/20,12.87%,PLTP;THBS1;SCARB1;SCARF1;STAB1;CDH13;HSPD1
prerank,transcription regulatory region nucleic acid binding (GO:0001067),0.24757552141019123,0.9272909847966755,0.6087591240875913,0.8938799446163065,1.0,29/188,12.90%,SOX5;TCF7L2;ARID5B;SMAD6;PRDM5;ZBTB20;SOX6;TBL1XR1;NFYB;ASH2L;ARID4A;BCOR;SMAD3;XRCC5;GABPB1;GABPB2;TCF12;PER3;CREB3L2;NFYC;TFAP2A;ZNF568;RXRA;NONO;FOXK2;AR;HSF1;SOX13;PSPC1
prerank,ligand-gated cation channel activity (GO:0099094),-0.2510281846484344,-0.9244583557969157,0.6174863387978142,0.7988452596957135,1.0,28/75,34.56%,KCNJ2;PTK2B;GRIK4;GRIN3A;GRIN1;KCNN2;KCNJ8;KCNJ15;GRIA2;TRPM4;GRIK2;KCNH2;CHRNB1;KCNJ6;MCOLN1;TRPM2;KCNJ16;GRIA1;KCNJ10;SCNN1A;GRIN2B;ASIC1;GRIK1;TRPM8;P2RX3;P2RX7;P2RX5;P2RX6
prerank,"DNA-binding transcription activator activity, RNA polymerase II-specific (GO:0001228)",0.23658812919635414,0.9243656508723667,0.6348993288590604,0.8966487909682547,1.0,46/254,15.71%,TCF4;RBPJ;PPARA;HLF;HOXC4;PRRX1;MEIS1;MYBL1;SCX;NR1I2;HOXB3;NFYB;NFAT5;ELF4;HOXA7;NFIB;GMEB1;SMAD3;RFXAP;TCF12;MITF;NFIA;CEBPG;MDM2;IRF3;NFYC;TFAP2A;TFAP2B;MYB;MLXIP;FOXK2;AR;GTF2I;KLF5;CLOCK;NR1I3;HOXD4;MEIS2;SRF;TFDP2;HOXD8;NKRF;SOX12;SMARCD3;BARX2;SMAD4
prerank,endopeptidase activator activity (GO:0061133),-0.40040308438857597,-0.9207113751355006,0.58125,0.8037544176884208,1.0,4/10,28.49%,PSME3;PSME1;VSIR;NLRC4
prerank,FMN binding (GO:0010181),-0.39268778158691775,-0.9197732685024207,0.5845864661654135,0.8023622582063887,1.0,6/11,32.85%,NOS3;NOS1;PPCDC;PNPO;NOS2;POR
prerank,tRNA methyltransferase activity (GO:0008175),0.36937212977832934,0.9197019607673335,0.5532319391634981,0.9037422020789533,1.0,4/16,14.72%,TRMT9B;TRDMT1;LCMT2;THUMPD3
prerank,exonuclease activity (GO:0004527),0.30421193795688894,0.9178386791004757,0.5672913117546848,0.9041675945898668,1.0,14/46,18.02%,REXO5;APEX2;ENPP2;EXOSC8;DCLRE1B;ENPP3;ISG20L2;MRE11;ERI1;APEX1;WRN;CNOT7;REXO4;EXOSC3
prerank,histone demethylase activity (H3-K9 specific) (GO:0032454),0.3994535813013812,0.9173146050913521,0.5479744136460555,0.901537224752943,1.0,3/12,8.91%,KDM7A;PHF8;KDM3B
prerank,heparan sulfate sulfotransferase activity (GO:0034483),0.3723065523214714,0.9171638468909947,0.5323590814196242,0.8980488237781558,1.0,2/15,2.21%,HS3ST3A1;HS3ST3B1
prerank,voltage-gated cation channel activity (GO:0022843),0.2630131844468575,0.9139731299079089,0.6006240249609984,0.9017632248305054,1.0,9/97,7.01%,CACNA2D3;KCNQ4;KCNA5;KCND3;CACNA1D;CACNB4;CACNG7;TMC2;CACNA2D1
prerank,aspartic-type peptidase activity (GO:0070001),-0.3953445771044489,-0.9112969442231393,0.5881226053639846,0.8173064340463205,1.0,3/10,27.00%,CTSD;PSEN1;CTSE
prerank,nuclear receptor binding (GO:0016922),0.2580654315697647,0.9083172170352208,0.6321483771251932,0.9110625069269815,1.0,21/111,12.11%,TCF7L2;BRD8;NR1I2;PPARGC1B;STAT5B;NCOA2;GRIP1;WIPI1;PRKCB;SMAD3;NCOA3;NCOA7;NSD1;MED13;MED1;LATS1;TACC1;SMARCE1;RXRA;RNF14;CRY1
prerank,K63-linked polyubiquitin modification-dependent protein binding (GO:0070530),-0.3186319162518541,-0.9076089994238703,0.5945378151260504,0.821999986256503,1.0,8/22,21.06%,OTUD7A;MINDY2;ZRANB1;TAB3;FAAP20;SPRTN;RNF168;OTUD7B
prerank,phosphatidylinositol phospholipase C activity (GO:0004435),-0.30670876125239327,-0.907138559883672,0.6254980079681275,0.8194538323033059,1.0,5/23,9.09%,EDNRA;PLCG2;PLCB4;CHRM3;PLCB3
prerank,carboxy-lyase activity (GO:0016831),-0.31209297153471727,-0.9070082688654197,0.5778688524590164,0.8163242019609828,1.0,7/23,17.62%,DDC;AMD1;AZIN1;GAD1;PPCDC;CSAD;UROD
prerank,"acyltransferase activity, transferring groups other than amino-acyl groups (GO:0016747)",0.27952598148328556,0.9067125278997648,0.6039279869067103,0.9106859134534613,1.0,15/69,14.53%,LPGAT1;ZDHHC1;SPHK1;CERS6;CERS5;DBT;ZDHHC3;KAT8;KAT6B;CERS1;SOAT2;CREBBP;ESCO1;PLA2G4C;AWAT2
prerank,peptidase activator activity (GO:0016504),-0.31407606150869954,-0.9065161094630789,0.5916114790286976,0.8138309653464045,1.0,8/22,23.27%,CAV1;MAL;PSME3;PSME1;CASP8AP2;PINK1;VCP;VSIR
prerank,ribonuclease P activity (GO:0004526),-0.3780744599111328,-0.905693274171102,0.6145038167938931,0.8122472113247399,1.0,7/11,33.82%,POP5;RPP21;POP4;RPP30;PRORP;POP7;RPP40
prerank,protein kinase A regulatory subunit binding (GO:0034237),0.35224831362345177,0.9053493028032975,0.6003787878787878,0.9098959682900353,1.0,5/21,9.82%,AKAP7;WASF1;WASF3;ARFGEF2;AKAP8L
prerank,tau-protein kinase activity (GO:0050321),0.3573962554413274,0.9028900383289046,0.5910852713178295,0.9116539484607251,1.0,1/20,0.38%,ROCK2
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines (GO:0016813)",0.40732218454618735,0.9014315740251077,0.5631929046563193,0.9112795703735704,1.0,1/11,1.80%,AGMAT
prerank,ubiquitin conjugating enzyme binding (GO:0031624),0.3324581331269803,0.9006965315086319,0.5698324022346368,0.9091539472043092,1.0,5/27,8.71%,PPARA;PRKN;RNF217;SIAH2;RNF180
prerank,calcium channel inhibitor activity (GO:0019855),0.40936078116707914,0.8999098150937127,0.5963488843813387,0.9072384653895427,1.0,1/11,0.76%,ITPR1
prerank,myosin binding (GO:0017022),-0.2553794970642229,-0.8989974465871109,0.6389548693586699,0.8228537489694149,1.0,11/55,13.66%,MYRIP;SHROOM4;GSN;RAB3C;NKD2;MYOC;SHROOM1;RHOA;RAB3B;LMTK2;MLPH
prerank,ligand-gated calcium channel activity (GO:0099604),0.3574227257098228,0.898353167442906,0.5996168582375478,0.9070186058791058,1.0,1/19,0.76%,ITPR1
prerank,zinc ion binding (GO:0008270),0.22488022103266966,0.8924490647036447,0.7293333333333333,0.9171666930300132,1.0,56/293,14.28%,PAPPA;KDM7A;PRKN;KMT2A;UPB1;ZEB1;RNF2;BAZ1B;KDM2B;IKZF4;SORD;ACE;TET1;CXXC5;ZBTB32;RABIF;ZFP37;NAPEPLD;PHF8;THAP1;ENPP2;SMAD3;NPEPPS;BLM;MMP9;CHD4;BBOX1;KDM2A;ZKSCAN5;SLC30A8;SLU7;DPYS;KDM5B;TRAF7;MDM2;NSD1;MYCBP2;PAM;ZNF8;KMT2B;EEA1;RXRA;ENPP3;GLI2;ITGB1BP2;CYLD;S100A9;RCHY1;SHMT1;PRIMPOL;ESCO1;NUDT12;TRIM24;KDM5C;CBLB;MNAT1
prerank,protein serine/threonine phosphatase inhibitor activity (GO:0004865),0.4011911830941395,0.8922902115534243,0.5883620689655172,0.9138414189181807,1.0,1/11,2.10%,PPP1R1A
prerank,voltage-gated potassium channel activity (GO:0005249),0.2631817736690507,0.891341350025197,0.6577708006279435,0.9123291231000608,1.0,5/80,4.29%,KCNK2;KCNQ4;KCNA5;KCNT2;KCND3
prerank,tRNA binding (GO:0000049),-0.2636515301595081,-0.889909480754814,0.6376146788990825,0.8389259505885193,1.0,17/43,29.74%,EEF1A1;PSTK;SARS1;SSB;RPUSD4;ALKBH8;EIF2A;DALRD3;ELP5;TRMT10C;AARS2;YRDC;MRPS27;CARS1;KARS1;PUS1;TRNAU1AP
prerank,ubiquitin-specific protease binding (GO:1990381),0.34719199554882163,0.8839822151522249,0.5889101338432122,0.9249438356858467,1.0,3/19,8.31%,PRKN;PTEN;AMFR
prerank,H4 histone acetyltransferase activity (GO:0010485),0.403770390921676,0.883938925848241,0.5961123110151187,0.9213607317607478,1.0,5/10,21.45%,KAT8;BRCA2;NAA60;NAA50;MSL3
prerank,cysteine-type peptidase activity (GO:0008234),-0.2396406531742764,-0.8828910526984821,0.7331670822942643,0.8502739163165386,1.0,39/73,39.56%,USP38;LGMN;USP29;CTSB;CAPN2;UCHL1;USP50;USP37;CTSZ;CASP8;USP28;USP8;ATG4A;USP9X;OTUD7B;CTSC;USP5;CTSL;OTULIN;USP49;CASP1;USP33;USP2;USP10;USP9Y;ATG4D;BLMH;CTSF;USP35;ESPL1;ATG4B;CASP9;USP26;USP30;GGH;CTSO;CTSK;USP40;ATG4C
prerank,dynactin binding (GO:0034452),0.389362107944438,0.8813285018821303,0.6015325670498084,0.9233392750949264,1.0,3/12,14.29%,SNX6;PAFAH1B1;BICD2
prerank,nuclear receptor coactivator activity (GO:0030374),0.28681864014925695,0.8812300104702588,0.6466552315608919,0.9198958531769106,1.0,10/52,10.55%,BRD8;PPARGC1B;NCOA2;ZMIZ1;PRKCB;NCOA3;NCOA7;MED13;MED1;TACC1
prerank,phosphatidylinositol-3-phosphatase activity (GO:0004438),-0.34197550506255114,-0.8789804687912115,0.6430020283975659,0.8548057383899041,1.0,6/14,23.16%,SYNJ1;MTM1;MTMR6;MTMR9;MTMR12;MTMR1
prerank,Lys48-specific deubiquitinase activity (GO:1990380),-0.3487597498680396,-0.8783141706279758,0.6460348162475822,0.8526244135437915,1.0,3/14,5.02%,ATXN3;MINDY2;MINDY1
prerank,peptide N-acetyltransferase activity (GO:0034212),0.40043286126359323,0.8764061697908789,0.6334745762711864,0.9266917498871305,1.0,3/10,20.19%,NAA80;NAA60;NAA50
prerank,DNA replication origin binding (GO:0003688),-0.3016703763104118,-0.8743465691512675,0.659043659043659,0.8574991524302463,1.0,10/23,33.63%,HSPD1;MCM4;MCM8;POLA1;MCM5;MCM10;ORC1;DHX9;MCM6;CDC6
prerank,serine-type endopeptidase activity (GO:0004252),0.25539982156720764,0.8723677331069035,0.678125,0.9318869118200017,1.0,5/80,3.86%,CORIN;KLK2;MMP2;CTSH;PCSK9
prerank,calmodulin-dependent protein kinase activity (GO:0004683),0.3305018533385886,0.8711577820931667,0.5957854406130269,0.9307029568700682,1.0,4/24,11.87%,DAPK1;CAMK1D;CAMK2D;MAPKAPK2
prerank,excitatory extracellular ligand-gated ion channel activity (GO:0005231),-0.31078022131958455,-0.8699021271687714,0.6488222698072805,0.8632723291277836,1.0,16/21,56.45%,GRIK2;CHRNB1;P2RX3;P2RX7;P2RX5;P2RX6;CHRNA9;CHRNA5;CHRNA4;GLRB;CHRNA3;P2RX1;CHRNB4;TRPV1;CHRNA1;P2RX2
prerank,ion channel inhibitor activity (GO:0008200),0.304382881317857,0.8692194573500787,0.6431034482758621,0.9311669873833809,1.0,8/35,12.80%,ITPR1;WNK4;NEDD4;PCSK9;CAMK2D;SCN3B;STX8;PACSIN3
prerank,G protein-coupled receptor activity (GO:0004930),0.2241409905743107,0.8691854504952206,0.7688172043010753,0.9276455365171331,1.0,16/239,8.44%,ADGRV1;NPR3;LGR4;BDKRB2;ADGRL1;LPAR1;CXCR5;PDGFRB;CXCR6;LPAR2;SSTR2;ADRA1D;KISS1R;PTH2R;GPR143;F2RL2
prerank,ATPase activator activity (GO:0001671),-0.3140254230426466,-0.8663768023750682,0.6653061224489796,0.8668398135971892,1.0,6/20,21.59%,ATP1B1;DNAJA1;DNAJC1;DNAJC10;DNAJB1;DNAJA2
prerank,cyclin-dependent protein serine/threonine kinase activity (GO:0004693),0.3318587269614428,0.8645658393858844,0.648854961832061,0.9303803680805407,1.0,5/21,15.36%,CDK8;CDK7;CDK1;CDK15;CDK4
prerank,cyclin-dependent protein kinase activity (GO:0097472),0.3318587269614428,0.8645658393858844,0.648854961832061,0.9303803680805407,1.0,5/21,15.36%,CDK8;CDK7;CDK1;CDK15;CDK4
prerank,protein serine/threonine/tyrosine kinase activity (GO:0004712),0.3151435137137499,0.8623386148943519,0.6437007874015748,0.9316227298989277,1.0,5/28,10.49%,MAP2K6;LRRK2;PRKAA2;TTK;RPS6KB1
prerank,nuclear localization sequence binding (GO:0008139),-0.3150338551754941,-0.8622130826339761,0.678646934460888,0.8714383711678109,1.0,9/18,34.92%,NFKBIA;KPNA4;POM121;KPNA3;CABP1;NUP153;TNPO2;KPNA2;IPO4
prerank,nucleotide diphosphatase activity (GO:0004551),0.3690043568606507,0.8621436309014417,0.6004056795131846,0.9284913273486557,1.0,4/14,13.94%,FHIT;NUDT13;NUDT6;NUDT12
prerank,DNA secondary structure binding (GO:0000217),0.305659404568199,0.8618229708434068,0.6831501831501832,0.9256942867789268,1.0,6/31,10.22%,KMT2A;RAD51B;RAD51C;BLM;CLSPN;ABL1
prerank,phospholipase C activity (GO:0004629),-0.2896471184005289,-0.8613880616786314,0.7057613168724279,0.8695646670527292,1.0,5/25,9.09%,EDNRA;PLCG2;PLCB4;CHRM3;PLCB3
prerank,RNA polymerase binding (GO:0070063),0.3429243807055329,0.8606886019551733,0.62890625,0.924510028051732,1.0,4/18,8.76%,NEDD4;CCNT2;CCNT1;PKN2
prerank,"phosphatidylinositol-3,4-bisphosphate binding (GO:0043325)",0.320452339568114,0.8602556003759934,0.6318785578747628,0.9219570667154663,1.0,2/25,2.13%,PLEKHA2;ADAP2
prerank,ferrous iron binding (GO:0008198),-0.30708239148707484,-0.8593183404064527,0.6799163179916318,0.8702370497070058,1.0,5/21,12.19%,FTH1;FTL;EGLN3;ISCU;EGLN2
prerank,growth factor activity (GO:0008083),0.25754299925062596,0.8586296637082959,0.7004909983633388,0.9218093856066394,1.0,13/74,13.39%,DKK1;IGF2;ARTN;PTN;FGF1;IL6;CSF1;VEGFB;FGF9;FGF20;TGFA;AREG;GDNF
prerank,1-phosphatidylinositol binding (GO:0005545),-0.3309673431762976,-0.8585932095082427,0.6659919028340081,0.8681669743315586,1.0,2/15,2.38%,EPB41;SCARB1
prerank,NF-kappaB binding (GO:0051059),-0.2983685048095192,-0.8582233001324663,0.6780383795309168,0.8655001081845253,1.0,12/24,36.43%,NFKBIA;FAF1;GSK3B;COMMD7;BRMS1;RNF25;RELA;HIF1AN;HDAC3;NPM1;CDK5RAP3;ANXA4
prerank,adenylyltransferase activity (GO:0070566),0.33106237543171213,0.8549122197492269,0.6653992395437263,0.9260153878371443,1.0,7/21,14.90%,NMNAT2;TENT2;ABL1;TUT1;NMNAT1;FLAD1;PAPOLB
prerank,neuropeptide receptor activity (GO:0008188),0.3070818108855354,0.8536061169307081,0.6424682395644283,0.9252037661761462,1.0,7/29,16.09%,SSTR2;KISS1R;GPR143;NTSR1;TACR3;HCRTR2;NPY2R
prerank,death domain binding (GO:0070513),-0.35915995593234923,-0.85328038422587,0.6613861386138614,0.8717390975911332,1.0,3/11,6.08%,RACK1;DAPL1;BCL2L1
prerank,retinoic acid receptor binding (GO:0042974),-0.31757307483830294,-0.8520667273892416,0.6774847870182555,0.8705048021216218,1.0,4/17,16.23%,ACTN4;ARID5A;NRIP1;NR4A2
prerank,ribonuclease P RNA binding (GO:0033204),-0.36690427889652083,-0.8508119484834821,0.6602687140115163,0.8696852581337615,1.0,4/10,17.54%,POP5;RPP21;POP4;RPP30
prerank,voltage-gated chloride channel activity (GO:0005247),-0.36550378701050745,-0.8502816337003265,0.6751968503937008,0.8673318333855468,1.0,2/10,5.88%,ANO1;CLCN5
prerank,"oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor (GO:0050664)",0.358719140612733,0.84794354526865,0.6336842105263157,0.9338141279405657,1.0,5/14,18.25%,DUOX2;NCF2;DUOX1;CYB5R4;AIFM1
prerank,neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential (GO:0099529),-0.3140474795594144,-0.8474511420836724,0.6610526315789473,0.869474365137709,1.0,11/19,34.93%,GRIK4;GABRG3;GABRA5;GRIK2;GRID2;GABRE;CHRNB1;GABRG2;GRIK1;GABRG1;GRID1
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines (GO:0016814)",-0.36108783780756604,-0.842761087723578,0.6793168880455408,0.8748751885412434,1.0,5/10,25.30%,ADARB2;GDA;CDA;ADA;DCTD
prerank,mRNA methyltransferase activity (GO:0008174),-0.3429749179642406,-0.8400765989259387,0.6616541353383458,0.8764342118186601,1.0,5/12,23.63%,TRMT61B;METTL3;CMTR2;TRMT10C;PCIF1
prerank,galactosyltransferase activity (GO:0008378),0.3730577214294378,0.838405758344101,0.6666666666666666,0.9501819164473269,1.0,4/11,12.36%,A4GALT;B4GALT1;B3GALT6;B4GALT2
prerank,DNA polymerase binding (GO:0070182),-0.3131103048720253,-0.8365256646050273,0.7018867924528301,0.8795175714539282,1.0,2/18,2.29%,HSP90AA1;HSP90AB1
prerank,high voltage-gated calcium channel activity (GO:0008331),0.3707044225416713,0.8291705252050214,0.6652078774617067,0.9650273037775405,1.0,2/10,4.95%,CACNA1D;CACNB4
prerank,protein phosphatase 2A binding (GO:0051721),-0.29087611415151904,-0.8263127334239642,0.7244444444444444,0.8944244178746344,1.0,7/23,18.15%,DAB2IP;PPME1;GRIN3A;FOXO1;MASTL;BOD1;SMG5
prerank,single-stranded RNA binding (GO:0003727),-0.24670531597775738,-0.8251650205259767,0.7733333333333333,0.8931266383298783,1.0,22/43,35.55%,ADARB2;HNRNPU;STRBP;SNRPC;EIF4H;IFIH1;POLR2G;EXOSC10;PTBP1;AGO3;EIF4B;FMR1;HNRNPF;CNBP;TLR7;PUS1;JMJD6;DHX9;RBM11;ZFR;HNRNPA1;TLR8
prerank,carbohydrate:cation symporter activity (GO:0005402),0.36541911301925384,0.8232234711107632,0.6694915254237288,0.9735337628727305,1.0,1/11,6.15%,SLC2A10
prerank,ligand-gated channel activity (GO:0022834),-0.2697866485311888,-0.8224293238624264,0.7048458149779736,0.8944451122967949,1.0,8/29,22.14%,GRIK4;GABRB1;GRIN3A;GRIN1;GRIA2;GRIK2;GRID2;CHRNB1
prerank,MAP kinase kinase activity (GO:0004708),0.3324575978085066,0.815366912662979,0.6833013435700576,0.9848182506393814,1.0,2/15,5.17%,MAP2K6;LRRK2
prerank,signaling receptor complex adaptor activity (GO:0030159),0.28061668429253106,0.8152654040187715,0.7170818505338078,0.9814251388357026,1.0,13/38,20.73%,SORBS1;GRIP1;LRRK2;FRS2;PIK3R1;GAB2;MAGI2;AXIN1;BLNK;PTPN11;SHC1;IRS1;LAT
prerank,protein kinase C binding (GO:0005080),-0.25243871111278826,-0.8151613117057197,0.7536231884057971,0.9032133871024799,1.0,15/43,20.71%,RACK1;HSPB1;ADCY4;HDAC5;CCDC88A;CAVIN2;YWHAG;HINT1;PICK1;TOP2A;DSP;ADAM9;HDAC7;HDAC9;TIRAP
prerank,ligand-gated ion channel activity (GO:0015276),-0.264866587694744,-0.8139454176257979,0.7165178571428571,0.9017648308063814,1.0,8/30,22.14%,GRIK4;GABRB1;GRIN3A;GRIN1;GRIA2;GRIK2;GRID2;CHRNB1
prerank,chemokine receptor binding (GO:0042379),0.28856092781275666,0.8128773929926625,0.7334558823529411,0.9822790826106658,1.0,6/35,14.90%,CXCL13;CCL19;ITCH;CCL4;CKLF;CX3CL1
prerank,ion channel activity (GO:0005216),0.24276249088067428,0.8111701542010373,0.7944785276073619,0.9819146289160715,1.0,5/80,7.63%,TRPM3;NALCN;TMC2;GRIK5;TMEM120B
prerank,voltage-gated anion channel activity (GO:0008308),-0.3169722549164572,-0.8110277852231934,0.7318548387096774,0.9032970605688011,1.0,2/15,5.88%,ANO1;CLCN5
prerank,nucleotidase activity (GO:0008252),-0.30500244640756036,-0.8105504976080133,0.6984126984126984,0.9007647346948231,1.0,8/15,34.05%,NT5C2;NT5C;BPNT2;NT5E;NT5DC1;NT5C1A;NT5DC3;NT5DC2
prerank,CXCR chemokine receptor binding (GO:0045236),0.3643938057276029,0.8103642793526715,0.6638115631691649,0.9798298680299196,1.0,2/11,9.63%,CXCL13;ITCH
prerank,voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization (GO:0086008),0.34757706796218474,0.8102261372831729,0.7045454545454546,0.9765530772116078,1.0,2/14,4.29%,KCNA5;KCND3
prerank,kinase inhibitor activity (GO:0019210),-0.2557578155774869,-0.8059540337989446,0.8086021505376344,0.9049866004292106,1.0,13/33,33.60%,WARS1;NCK1;YWHAB;CDKN1B;SPRY4;SMCR8;PRKRIP1;CDKN1A;SOCS1;AHSG;GMFB;MAPK8IP1;NPM1
prerank,cadherin binding involved in cell-cell adhesion (GO:0098641),-0.2865228668744718,-0.7980115879221431,0.751984126984127,0.914794835525443,1.0,3/18,10.25%,STXBP6;BAIAP2L1;PPP1CA
prerank,poly(A)-specific ribonuclease activity (GO:0004535),-0.3252026152132561,-0.7976515479460299,0.7355212355212355,0.9120474578324181,1.0,2/12,8.27%,PAN2;CNOT6L
prerank,serine-type peptidase activity (GO:0008236),0.22804572946071255,0.7971665435504375,0.837245696400626,0.9966554717863122,1.0,7/96,7.38%,CORIN;KLK2;MMP2;CTSH;PCSK9;TPP1;MMP9
prerank,lysine N-methyltransferase activity (GO:0016278),0.3134887749754639,0.7933860520031635,0.7044145873320538,0.9998260425162947,1.0,5/20,19.84%,SETD7;SETD6;EEF1AKMT1;SETD2;SETD4
prerank,"oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen (GO:0016702)",-0.30204251454028375,-0.7927489228352109,0.7616033755274262,0.9165898195143379,1.0,7/16,32.59%,PIR;ALOX12;ETHE1;HGD;ALOXE3;HAAO;ADI1
prerank,microtubule motor activity (GO:0003777),0.25885685195670394,0.7869449588562313,0.7854671280276817,1.0,1.0,5/51,6.91%,KIF13B;KIF2A;KIF6;DNAH2;KIF27
prerank,cysteine-type endopeptidase activity involved in execution phase of apoptosis (GO:0097200),0.34897762238745694,0.784822795326648,0.7197452229299363,1.0,1.0,2/10,11.35%,CASP12;CFLAR
prerank,chemokine activity (GO:0008009),0.28481407507741696,0.7828238988038745,0.7462406015037594,1.0,1.0,6/31,18.35%,CXCL13;CCL19;CCL4;CKLF;CX3CL1;CCL28
prerank,carboxypeptidase activity (GO:0004180),0.271633661712367,0.7814915952462218,0.7715289982425307,1.0,1.0,4/35,7.30%,AEBP1;SCPEP1;CPXM1;AGBL2
prerank,ubiquitin-like protein conjugating enzyme binding (GO:0044390),0.2751032717513001,0.7804257044753216,0.7403508771929824,1.0,1.0,5/33,8.71%,PPARA;PRKN;RNF217;SIAH2;RNF180
prerank,motor activity (GO:0003774),0.24808220317610954,0.7797579621878696,0.8073701842546064,1.0,1.0,6/60,6.91%,KIF13B;KIF2A;KIF6;DYNC2H1;DNAH2;KIF27
prerank,core promoter sequence-specific DNA binding (GO:0001046),-0.24761126297845554,-0.7793026646590442,0.8296943231441049,0.9335814259630203,1.0,9/35,26.82%,FOXP1;H3-3A;PIH1D1;RRN3;ZBTB17;KLF10;TAF4;RELA;STAT1
prerank,metalloendopeptidase inhibitor activity (GO:0008191),-0.3053548742729476,-0.7786793076567674,0.7598425196850394,0.9310939422926224,1.0,7/14,26.16%,SPOCK2;NGF;SPOCK1;BST2;TIMP2;SPOCK3;TIMP1
prerank,histone-lysine N-methyltransferase activity (GO:0018024),0.2529292272140375,0.7705464606082089,0.8051001821493625,1.0,1.0,8/44,11.84%,KMT2A;ASH2L;SETD7;SETD1A;ASH1L;NSD1;KMT2B;SMYD3
prerank,adrenergic receptor binding (GO:0031690),0.3214475057107501,0.7701614831099711,0.716796875,1.0,1.0,5/16,16.23%,GNAS;NEDD4;DLG4;MAGI2;GRK2
prerank,pseudouridine synthase activity (GO:0009982),-0.3128176473397692,-0.7685678719727047,0.7692307692307693,0.9422665803296303,1.0,7/13,29.07%,RPUSD4;RPUSD1;TRUB2;PUS7;PUSL1;RPUSD2;PUS1
prerank,mRNA 3'-UTR AU-rich region binding (GO:0035925),0.2949034031037436,0.7674950390443778,0.7552816901408451,1.0,1.0,3/22,8.06%,RBMS3;CPEB2;EXOSC8
prerank,ubiquitin-ubiquitin ligase activity (GO:0034450),0.3470948510146064,0.7642901969504698,0.7257383966244726,1.0,1.0,5/11,22.95%,AMFR;UBE4A;PPIL2;UBE4B;UBE2K
prerank,ATP hydrolysis activity (GO:0140603),-0.2327917294423028,-0.7634399798631768,0.8594847775175644,0.9461168999504792,1.0,12/41,16.80%,HSP90AA1;SMCHD1;KIF26A;ABCB10;TOR1B;TOR3A;ATP2B1;CLU;ABCD2;CFTR;ABCA3;RUVBL1
prerank,microtubule plus-end binding (GO:0051010),0.2977615579173833,0.7631302082348578,0.7495291902071564,1.0,1.0,3/20,8.78%,STIM1;MAPRE2;PAFAH1B1
prerank,calcium-release channel activity (GO:0015278),0.3126127259155116,0.7628918909442938,0.7490421455938697,1.0,1.0,3/17,11.59%,ITPR1;MCOLN3;PKD2
prerank,SH2 domain binding (GO:0042169),0.27128394020647706,0.761356232185068,0.786618444846293,1.0,1.0,10/31,20.13%,AFAP1;SH3PXD2B;ABL1;JAK2;PAG1;NLK;RUFY1;BLNK;DAG1;IRS1
prerank,signal sequence binding (GO:0005048),-0.2358080248066074,-0.7549740047493839,0.8477272727272728,0.9543721579312113,1.0,19/35,35.38%,NFKBIA;TOMM20;PEX5L;AP2M1;KCNIP2;KPNA4;AP2B1;TIMM22;POM121;PEX5;KPNA3;CAT;CABP1;NUP153;KDELR3;TNPO2;KPNA2;IPO4;SEC61A2
prerank,Hsp70 protein binding (GO:0030544),0.2686766006235134,0.7538842557271538,0.8019417475728156,1.0,1.0,2/31,4.25%,PRKN;HDAC8
prerank,endodeoxyribonuclease activity (GO:0004520),-0.2751805294164659,-0.7530324742908128,0.8104166666666667,0.9535612701260646,1.0,9/20,35.33%,RPS3;EXOG;RBBP8;APLF;ERCC5;EXO1;FEN1;DNA2;DCLRE1C
prerank,"hydrolase activity, hydrolyzing O-glycosyl compounds (GO:0004553)",0.2700822788059974,0.7502542310346992,0.8059701492537313,1.0,1.0,8/29,16.16%,MGAM;HEXD;GANC;CTBS;GBA2;MOGS;PGGHG;GLA
prerank,protein kinase regulator activity (GO:0019887),0.21545400664599798,0.7499071686803139,0.9059561128526645,1.0,1.0,14/95,16.29%,PRKAG2;PRKAG3;MBIP;CCNT2;CCNT1;GPRC5C;PARVA;PRKAG1;CCNE1;GPRC5B;CDKN1C;CCNL1;DUS2;TAOK3
prerank,phosphatidylinositol-5-phosphate binding (GO:0010314),0.3128739685314732,0.7490339468200495,0.753061224489796,1.0,1.0,3/15,13.46%,SH3PXD2B;PLEKHF1;VEPH1
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides (GO:0016811)",-0.2143236446922254,-0.7477461979589355,0.9166666666666666,0.9573847763760626,1.0,15/54,23.69%,ACER3;ACER2;GLS;TGM2;HDAC5;HINT1;SIRT4;HDAC11;NIT1;HDAC9;HINT3;SIRT7;HDAC6;SIRT6;AMDHD2
prerank,methyl-CpG binding (GO:0008327),0.28380232756211965,0.7439240233558637,0.783427495291902,1.0,1.0,3/22,10.88%,TET1;CXXC5;ZBTB38
prerank,cholesterol transfer activity (GO:0120020),0.30323529848626685,0.7426259433719189,0.7755102040816326,1.0,1.0,2/16,3.73%,ABCA1;GRAMD1C
prerank,water transmembrane transporter activity (GO:0005372),0.3202541614769491,0.7413225735736507,0.7189409368635438,1.0,1.0,1/11,3.58%,PDPN
prerank,ribosomal small subunit binding (GO:0043024),-0.27882301546376215,-0.740847455877384,0.828752642706131,0.9628447093127421,1.0,11/17,38.90%,EIF1B;ERAL1;EIF4H;DHX29;EIF1;EIF4B;MTIF3;NME1;NPM1;PIM1;UNG
prerank,sterol transfer activity (GO:0120015),0.29890381785166853,0.7374396805135911,0.7820773930753564,1.0,1.0,2/17,3.73%,ABCA1;GRAMD1C
prerank,cysteine-type endopeptidase activity involved in apoptotic process (GO:0097153),0.32340907475185915,0.7372578292763241,0.7698744769874477,1.0,1.0,4/11,22.62%,CASP12;CFLAR;PYCARD;CASP4
prerank,channel activity (GO:0015267),-0.22095403196505126,-0.7362080864287555,0.9114470842332614,0.9651375792276085,1.0,12/41,26.52%,AQP11;AQP4;TMEM266;TRPV2;MCUB;PANX1;TMEM120A;TRPA1;SLC14A1;CHRNB1;BAX;TRPV4
prerank,sequence-specific mRNA binding (GO:1990825),-0.31780984259484757,-0.7359747856756587,0.7944954128440367,0.9620121262711986,1.0,6/10,31.11%,SSB;SHFL;RBM24;FMR1;ETF1;DHX9
prerank,phospholipase A2 activity (GO:0004623),0.2718786050925986,0.7353199856923232,0.8245283018867925,1.0,1.0,4/26,14.96%,PLA2G10;PLA2G4B;PLA2G4C;PLA2G12A
prerank,cyclic nucleotide binding (GO:0030551),-0.2555226688756511,-0.7302910807103427,0.8326612903225806,0.9654212709644324,1.0,4/21,13.71%,PDE4D;PDE2A;HCN1;PDE11A
prerank,neuropeptide hormone activity (GO:0005184),-0.256356705916925,-0.728978480180236,0.8560157790927022,0.9634811261201082,1.0,15/22,55.93%,SPX;NPY;PNOC;ADCYAP1;PENK;NMB;VIP;CRH;GAL;PPY;CALCB;UCN;NPPA;GHRH;HCRT
prerank,5'-nucleotidase activity (GO:0008253),-0.29257884247119653,-0.7285331413935375,0.839458413926499,0.9606239533152678,1.0,7/13,34.05%,NT5C2;NT5C;NT5E;NT5DC1;NT5C1A;NT5DC3;NT5DC2
prerank,RNA polymerase II complex binding (GO:0000993),0.25708512269721895,0.7273988531471719,0.828996282527881,1.0,1.0,14/32,23.57%,NCOA3;RPRD1B;AGO2;RPRD2;CDC73;SCAF1;CTR9;RECQL5;ELP2;PAF1;AGO1;BRD4;SUPT4H1;WAC
prerank,protein phosphatase inhibitor activity (GO:0004864),-0.2457081449458795,-0.7251710983679329,0.8739837398373984,0.9613475962068204,1.0,6/26,16.71%,PPME1;PPP1R2;SET;PPP1R14A;LMTK2;BOD1
prerank,antiporter activity (GO:0015297),0.2835380547938422,0.7242240779668789,0.8072289156626506,1.0,1.0,7/20,16.77%,SLC25A11;SLC35E2B;SLC35E2A;CLCN4;SLC35A1;TMEM241;SLC35D2
prerank,protein-lysine N-methyltransferase activity (GO:0016279),0.2504778106319981,0.7216234198162498,0.8398576512455516,1.0,1.0,9/34,19.85%,SETD7;SETD6;CAMKMT;EEF1AKMT1;SMYD3;N6AMT1;SETD2;SETD4;NSD3
prerank,phosphatidate phosphatase activity (GO:0008195),0.30762634275308975,0.7213232771139761,0.7780126849894292,1.0,1.0,1/13,1.84%,PLPP3
prerank,vitamin D receptor binding (GO:0042809),0.2963410126862043,0.7187619805589439,0.8045738045738046,1.0,1.0,3/14,11.73%,MED13;MED1;RXRA
prerank,SUMO binding (GO:0032183),0.3101543593862155,0.7171370301942668,0.768172888015717,1.0,1.0,5/13,18.33%,USP25;SIMC1;CBX4;PML;USPL1
prerank,alpha-actinin binding (GO:0051393),0.26637122450113215,0.710962600430435,0.8424015009380863,1.0,1.0,7/24,20.39%,KCNA5;CACNA1D;PKD2;PALLD;PDLIM5;DAG1;PKD2L1
prerank,basic amino acid transmembrane transporter activity (GO:0015174),0.3083623613390622,0.7101475301542951,0.7911877394636015,1.0,1.0,1/13,1.21%,SLC38A3
prerank,Lys63-specific deubiquitinase activity (GO:0061578),0.3219017782106206,0.704301228984055,0.8177966101694916,1.0,1.0,3/10,17.36%,USP27X;CYLD;DESI2
prerank,NADPH binding (GO:0070402),-0.28865993483458585,-0.703327567446722,0.8615071283095723,0.9824031223705766,1.0,3/13,16.48%,KCNAB1;LBR;QDPR
prerank,"oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0016616)",0.20829823748374335,0.6950755709260058,0.9481361426256077,1.0,1.0,14/75,16.03%,CRYL1;EHHADH;SORD;HSD17B10;PTGR1;H6PD;BDH1;DHRS3;UGDH;DHDH;BDH2;DHRS11;ME3;RDH11
prerank,O-methyltransferase activity (GO:0008171),0.3196082786208456,0.6944688720266263,0.7946058091286307,1.0,1.0,3/10,15.18%,FTSJ3;LRTOMT;ASMT
prerank,protein phosphatase 1 binding (GO:0008157),-0.24406645195547816,-0.6943417795030874,0.8805031446540881,0.9883693095593555,1.0,3/21,7.36%,PPP1R16B;AKAP11;KCNQ1
prerank,"catalytic activity, acting on a tRNA (GO:0140101)",0.23784940757766887,0.6932798330701544,0.8696428571428572,1.0,1.0,11/35,24.43%,TRMT9B;TRDMT1;LCMT2;DTWD1;DUS2;GATC;AARS1;TARS2;ELAC2;DUS1L;GATB
prerank,cardiolipin binding (GO:1901612),0.31337130265352664,0.6920817993594468,0.8075221238938053,1.0,1.0,3/10,13.62%,GSDMD;GSDME;NME4
prerank,chemoattractant activity (GO:0042056),-0.23352495929505315,-0.6917321679114933,0.9017094017094017,0.9875911853770651,1.0,11/26,36.86%,VEGFA;FGF7;SCG2;MIF;BMP4;CXCL10;FGF2;NTF3;GPNMB;VEGFC;CCL5
prerank,ubiquitin conjugating enzyme activity (GO:0061631),0.2530022896437505,0.6905458681492866,0.8860759493670886,1.0,1.0,6/31,17.12%,UBE2E2;UBE2L3;BIRC6;UBE2A;UBE2H;UBE2E1
prerank,ribosomal large subunit binding (GO:0043023),0.31013781205106333,0.6871372989814799,0.8354166666666667,1.0,1.0,3/11,13.15%,CPEB2;LTN1;NEMF
prerank,R-SMAD binding (GO:0070412),0.2719771471671434,0.686579032070542,0.845213849287169,1.0,1.0,5/18,15.77%,SMAD6;SMAD3;LDLRAD4;SMAD4;PMEPA1
prerank,DNA-(apurinic or apyrimidinic site) endonuclease activity (GO:0003906),-0.2955660633584801,-0.686185148112026,0.8560606060606061,0.9895587619573833,1.0,5/11,22.52%,RPS3;NEIL1;NEIL3;APLF;NTHL1
prerank,peptide alpha-N-acetyltransferase activity (GO:0004596),0.3075036019675521,0.685500523412028,0.8309278350515464,1.0,1.0,2/11,13.55%,NAA80;NAA60
prerank,aminopeptidase activity (GO:0004177),0.2579679285688743,0.6851415400634637,0.8703339882121808,1.0,1.0,6/26,20.78%,CTSH;NPEPPS;XPNPEP3;NAALADL1;MMP14;MMP17
prerank,nucleoside diphosphate kinase activity (GO:0004550),-0.2748063011502583,-0.6838624180613324,0.884990253411306,0.9883798499479599,1.0,9/14,46.52%,CMPK1;AK5;NME2;AK9;NME1;NME6;DTYMK;AK1;NME3
prerank,CCR chemokine receptor binding (GO:0048020),0.2479220653099104,0.6811706807055979,0.8529980657640233,1.0,1.0,4/28,14.90%,CXCL13;CCL19;CCL4;CX3CL1
prerank,3'-5' DNA helicase activity (GO:0043138),0.28198576108198714,0.6798626392788443,0.8410462776659959,1.0,1.0,6/16,20.67%,HELQ;BLM;MCM2;WRN;MCM7;RECQL5
prerank,I-SMAD binding (GO:0070411),0.2891890605262317,0.6752844065218312,0.8492871690427699,1.0,1.0,5/13,19.08%,SMAD6;SMAD3;AXIN1;SMAD4;SMAD2
prerank,S-adenosylmethionine-dependent methyltransferase activity (GO:0008757),0.22717654803350762,0.6729251451245449,0.9221014492753623,1.0,1.0,11/40,17.88%,METTL4;METTL8;PRMT7;DPH5;AS3MT;RRP8;LRTOMT;THUMPD3;ASMT;N6AMT1;NNMT
prerank,nuclease activity (GO:0004518),0.2158090278878106,0.6699577207673605,0.9278688524590164,1.0,1.0,10/52,17.21%,REXO5;RNASEL;SND1;ISG20L2;MRE11;APEX1;PARN;WRN;RNASEH2A;REXO4
prerank,transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential (GO:1904315),-0.22450470156170493,-0.6675244420914592,0.9387308533916849,0.9993361848753495,1.0,8/28,24.46%,GRIK4;GABRG3;GABRA5;GRIK2;GRID2;GABRE;CHRNB1;GABRG2
prerank,calcium-dependent cysteine-type endopeptidase activity (GO:0004198),0.2860556944522099,0.6672655639629416,0.8543307086614174,1.0,1.0,1/14,2.76%,CAPN9
prerank,RNA stem-loop binding (GO:0035613),0.2979102499060342,0.6663819117776112,0.8436213991769548,1.0,1.0,3/12,11.70%,RC3H2;MYH10;LARP6
prerank,basal RNA polymerase II transcription machinery binding (GO:0001099),0.23312564801171498,0.6642531637937973,0.9202226345083488,1.0,1.0,14/33,23.57%,NCOA3;RPRD1B;AGO2;RPRD2;CDC73;AR;CTR9;RECQL5;ELP2;PAF1;AGO1;DRAP1;SUPT4H1;WAC
prerank,gamma-tubulin binding (GO:0043015),-0.23152747552567537,-0.6625078373522505,0.9269311064718163,0.9999566812889767,1.0,4/21,13.42%,BLOC1S2;PAK1;GIT1;RAB11FIP5
prerank,"endoribonuclease activity, producing 5'-phosphomonoesters (GO:0016891)",-0.2184423408776565,-0.662269508036542,0.9434782608695652,0.9967750877529334,1.0,13/28,33.82%,POP5;RPP21;POP4;RPP30;EDC3;AGO3;PRORP;NUDT16;EXO1;POP7;DROSHA;FEN1;RPP40
prerank,histone methyltransferase activity (GO:0042054),-0.21287440732727092,-0.6613908243802982,0.9288793103448276,0.994237160081867,1.0,12/32,33.94%,PRMT8;MEN1;KMT2E;SMYD1;FBL;EHMT2;DOT1L;EED;SUZ12;TTLL12;KMT5A;SMYD2
prerank,endoribonuclease activity (GO:0004521),0.23263678154168793,0.6529849733998855,0.9239543726235742,1.0,1.0,6/32,15.12%,RNASEL;ZC3H12B;SND1;AGO2;DICER1;NYNRIN
prerank,NAD+ ADP-ribosyltransferase activity (GO:0003950),0.2427076558578494,0.6510070167306956,0.9028571428571428,1.0,1.0,10/25,25.71%,PARP4;PARP10;PARP9;SIRT3;TIPARP;PARP14;TNKS2;SIRT5;ART4;PARP2
prerank,alpha-tubulin binding (GO:0043014),-0.2100617536369388,-0.6483387314583652,0.9414316702819957,1.0,1.0,4/31,10.46%,TTLL7;FYN;EFHC2;ARL8A
prerank,"exoribonuclease activity, producing 5'-phosphomonoesters (GO:0016896)",0.23254511029661906,0.6476587513973786,0.9211409395973155,1.0,1.0,12/33,23.00%,ERI3;ERI2;DCP2;ERI1;PARN;CNOT7;CNOT8;EXOSC3;XRN1;PDE12;EXOSC4;DIS3L
prerank,cyclin-dependent protein serine/threonine kinase inhibitor activity (GO:0004861),-0.281620132541763,-0.6454977050249395,0.9153846153846154,0.9996087688930659,1.0,4/10,29.95%,CDKN1B;CDKN1A;CDKN2D;INCA1
prerank,neuropeptide receptor binding (GO:0071855),0.26181818150310243,0.644016972715171,0.8589473684210527,1.0,1.0,2/14,11.14%,APLN;AGRP
prerank,retinoid X receptor binding (GO:0046965),-0.27242951098738694,-0.6383815328369995,0.9005847953216374,1.0,1.0,3/11,16.23%,ARID5A;NRIP1;NR4A2
prerank,GABA receptor binding (GO:0050811),0.2822408925576101,0.6362249579896101,0.8758465011286681,1.0,1.0,3/11,15.88%,ARFGEF2;TRAK1;TRAK2
prerank,cysteine-type endopeptidase activity (GO:0004197),0.19061326096442413,0.6313260783011244,0.9871382636655949,1.0,1.0,8/78,8.92%,CAPN9;CTSH;USP11;CASP12;USP24;USP25;USP7;USP34
prerank,intracellular cyclic nucleotide activated cation channel activity (GO:0005221),-0.2627936608038078,-0.6212066829666684,0.9219712525667351,1.0,1.0,2/11,17.90%,HCN1;HCN2
prerank,RNA polymerase core enzyme binding (GO:0043175),0.22090006366978146,0.6206732014101508,0.9378427787934186,1.0,1.0,13/33,23.57%,NCOA3;RPRD1B;AGO2;RPRD2;ERBB2;CDC73;CTR9;RECQL5;ELP2;PAF1;AGO1;SUPT4H1;WAC
prerank,phospholipase activity (GO:0004620),0.18775419567827115,0.6175483764884979,0.9855072463768116,1.0,1.0,13/67,18.10%,PLA2G10;FAM83B;NAPEPLD;ENPP2;LIPC;LIPH;PLA2G4B;PLCL1;PLA2G4C;PLA2G12A;PLCE1;ABHD16A;ABHD12
prerank,G protein-coupled photoreceptor activity (GO:0008020),0.26446955430006297,0.6129116405547917,0.902127659574468,1.0,1.0,12/12,73.57%,GPR88;OPN1MW;OPN1MW3;RRH;OPN4;GNAT2;OPN1SW;OPN5;RHO;ELOVL4;GPR52;OPN3
prerank,methyltransferase activity (GO:0008168),0.199865662235022,0.6091391841853456,0.9563025210084034,1.0,1.0,12/46,18.74%,METTL4;FTSJ3;PRMT7;EEF1AKMT1;AS3MT;RRP8;LRTOMT;METTL27;ASMT;N6AMT1;NNMT;NSUN3
prerank,ubiquitin-like protein conjugating enzyme activity (GO:0061650),0.21773636165639057,0.6081731726383096,0.9463327370304114,1.0,1.0,6/34,17.12%,UBE2E2;UBE2L3;BIRC6;UBE2A;UBE2H;UBE2E1
prerank,ribonuclease activity (GO:0004540),0.19143672418053986,0.6073135627931415,0.9731993299832495,1.0,1.0,17/56,22.70%,RNASEL;ZC3H12B;EXOSC8;SND1;AGO2;DICER1;NYNRIN;CNOT7;RNASEH2A;EXOSC3;NOB1;AGO1;PIWIL4;SAMHD1;ELAC2;EXOSC4;PPP1R8
prerank,RNA 7-methylguanosine cap binding (GO:0000340),0.2627977574587656,0.6039519592433109,0.9111969111969112,1.0,1.0,4/12,18.90%,AGO2;EIF4E3;LARP1;GEMIN5
prerank,exopeptidase activity (GO:0008238),-0.17601751839307098,-0.6020446126573732,0.9849246231155779,1.0,1.0,22/50,39.94%,FAP;NAALAD2;DPP4;ACE2;CTSZ;PRCP;RCE1;ENPEP;NUDT16;LTA4H;JMJD7;BLMH;DPP9;CPB1;PM20D2;CPA2;DPEP1;KDM8;DPP10;DPP6;GGH;DPEP3
prerank,single-stranded DNA helicase activity (GO:0017116),-0.22111639898632207,-0.6007142088704674,0.9427966101694916,1.0,1.0,10/19,35.62%,WRNIP1;POLQ;MCM5;RFC5;DHX9;MCM6;PIF1;HELB;DNA2;RFC2
prerank,cyclin-dependent protein serine/threonine kinase regulator activity (GO:0016538),-0.18184040622443923,-0.5930028880321121,0.9813519813519813,1.0,1.0,20/42,42.18%,CCNY;CCNYL1;CDKN1B;CCNF;CCNL2;CCNG2;CDKN1A;CDKN2D;CCNB2;CKS2;CCNQ;INCA1;CDK5R2;CCND1;CCNA2;CCND3;CCNB1;CKS1B;CDKN2C;CCNC
prerank,N-methyltransferase activity (GO:0008170),-0.21747460940713795,-0.5913527777600588,0.9468503937007874,1.0,1.0,2/20,6.70%,TFB2M;TRMT11
prerank,mannose binding (GO:0005537),-0.2447027302901899,-0.5900667856678261,0.9383697813121272,1.0,1.0,4/12,27.41%,LMAN2;LMAN2L;CLN5;ACR
prerank,"intramolecular oxidoreductase activity, transposing C=C bonds (GO:0016863)",-0.23918915948415684,-0.5875747537276662,0.939453125,1.0,1.0,4/13,24.23%,SREBF2;MIF;IDI1;DDT
prerank,endonuclease activity (GO:0004519),0.19117479481860702,0.587406004846657,0.9838998211091234,1.0,1.0,9/49,15.12%,RNASEL;ZC3H12B;SND1;MBD4;AGO2;DICER1;MRE11;APEX1;NYNRIN
prerank,cGMP binding (GO:0030553),0.2586167037029227,0.5848803589688442,0.9230769230769231,1.0,1.0,4/11,22.23%,PDE5A;CNGA3;CNGB3;RAPGEF2
prerank,histone deacetylase activity (GO:0004407),-0.21383285560566484,-0.5804191543355534,0.9685534591194969,1.0,1.0,10/19,38.06%,HDAC5;HDAC11;HDAC9;SIRT7;HDAC6;SIRT6;HDAC3;MIER1;HDAC10;SUDS3
prerank,sulfuric ester hydrolase activity (GO:0008484),0.2552780322710521,0.5794290463206367,0.9198396793587175,1.0,1.0,4/12,20.66%,SULF1;ARSG;ARSK;GALNS
prerank,tRNA-specific ribonuclease activity (GO:0004549),0.2505309764910587,0.5783370667667654,0.9363449691991786,1.0,1.0,3/14,12.98%,RPP14;TSEN34;TSEN2
prerank,postsynaptic neurotransmitter receptor activity (GO:0098960),0.2215941209723009,0.5762339262811744,0.9671179883945842,1.0,1.0,21/21,77.87%,CHRNE;CHRNB2;ANXA9;CHRNA7;CHRFAM7A;DRD4;CHRNA2;CHRNA6;DRD1;CHRNA1;DRD5;GRM5;CHRNB3;CHRNB4;CHRNA3;CHRNG;CHRNA4;CHRNA5;GRM1;GRIA1;CHRNB1
prerank,polynucleotide adenylyltransferase activity (GO:0004652),0.25175992509032624,0.5746555955473661,0.93713163064833,1.0,1.0,4/12,19.12%,TENT2;TUT1;PAPOLB;PAPOLG
prerank,5'-3' exonuclease activity (GO:0008409),0.24403058355945734,0.5734589533598322,0.9436619718309859,1.0,1.0,4/14,13.79%,DCLRE1A;DCLRE1B;DCP2;MRE11
prerank,muscle alpha-actinin binding (GO:0051371),-0.2215284730881132,-0.5716233971584748,0.9510204081632653,1.0,1.0,2/15,9.04%,PDLIM7;LDB3
prerank,acetylcholine-gated cation-selective channel activity (GO:0022848),-0.24302437394319693,-0.5672331854120817,0.9668508287292817,1.0,1.0,7/11,53.94%,CHRNB1;CHRNA9;CHRNA5;CHRNA4;CHRNA3;CHRNB4;CHRNA1
prerank,snRNA binding (GO:0017069),-0.17344936116653167,-0.566991404713341,0.9951456310679612,1.0,1.0,11/42,28.13%,HNRNPU;LARP7;DDX39B;MEPCE;SNRPC;PRPF4;EIF5A;RBM22;SNRNP35;LSM8;LSM11
prerank,"racemase and epimerase activity, acting on carbohydrates and derivatives (GO:0016857)",0.2585104772841864,0.566567027615646,0.9334719334719335,1.0,1.0,3/10,16.59%,RPE;RENBP;DSEL
prerank,NAD-retinol dehydrogenase activity (GO:0004745),0.23706680060271204,0.5604055546677394,0.9323770491803278,1.0,1.0,14/14,76.31%,DHRS3;RDH11;SDR16C5;ADH1A;RDH5;ADH7;ADH4;SDR9C7;HSD17B6;RDH16;DHRS9;RDH12;RDH10;AKR1A1
prerank,nucleobase-containing compound kinase activity (GO:0019205),-0.21254625676655092,-0.5577490509971965,0.9681908548707754,1.0,1.0,6/17,30.14%,CMPK1;CLP1;AK5;NME2;AK9;NME1
prerank,single-stranded telomeric DNA binding (GO:0043047),-0.23995299638141573,-0.5548371140762285,0.9648148148148148,1.0,1.0,6/11,40.88%,RPA1;TERF2IP;RPA2;HNRNPA1;TERF1;CTC1
prerank,3'-5'-exoribonuclease activity (GO:0000175),0.19725338017316693,0.5514718837997832,0.9608177172061328,1.0,1.0,11/34,23.00%,ERI3;ERI2;CNOT2;ERI1;PARN;CNOT7;CNOT8;EXOSC3;PDE12;EXOSC4;DIS3L
prerank,miRNA binding (GO:0035198),-0.1790626669198688,-0.5445589120924222,0.9936575052854123,1.0,1.0,8/30,23.96%,PUM2;YBX1;ZC3H7A;ZC3H12A;SOX2;AGO3;FMR1;ZNF346
prerank,ubiquitin-like protein-specific protease activity (GO:0019783),-0.19985458038949577,-0.5404158889765642,0.9735234215885947,0.9985115683963735,1.0,6/20,26.88%,EIF3F;USP50;OTUB1;USP9X;YOD1;SENP5
prerank,RNA cap binding (GO:0000339),-0.20334089498398242,-0.5295214043901381,0.9770833333333333,0.9983028283156736,1.0,4/16,22.72%,EIF3D;DCPS;CYFIP2;EIF4E
prerank,voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization (GO:1902282),0.2407595637549667,0.526900510309452,0.951271186440678,1.0,1.0,1/11,4.29%,KCND3
prerank,3'-5' exonuclease activity (GO:0008408),0.17553005134995975,0.5223331932163392,0.9883720930232558,1.0,1.0,16/45,23.00%,ERI3;ERI2;TATDN1;MRE11;ERI1;APEX1;PARN;WRN;CNOT7;CNOT8;REXO4;EXOSC3;RAD50;PDE12;EXOSC4;DIS3L
prerank,deoxyribonuclease activity (GO:0004536),-0.19824547541888465,-0.5130880663029485,0.9810606060606061,0.9991528039516339,1.0,1/14,3.62%,RPS3
prerank,damaged DNA binding (GO:0003684),0.17174826763560266,0.5095160288978324,0.993127147766323,1.0,1.0,9/44,15.90%,DDB2;AUNIP;DCLRE1A;DCLRE1B;MPG;CUL4B;CREBBP;APEX1;RAD18
prerank,protein-arginine N-methyltransferase activity (GO:0016274),0.2311224748218686,0.5060721761648158,0.9604989604989606,1.0,1.0,3/11,19.75%,PRMT7;FBXO11;CARM1
prerank,RNA polymerase II core promoter sequence-specific DNA binding (GO:0000979),-0.20607520443496957,-0.5055848510961704,0.9849624060150376,0.9975027753140889,1.0,3/12,26.82%,H3-3A;RELA;STAT1
prerank,regulatory RNA binding (GO:0061980),0.16841719569473437,0.49999282871095824,0.9929078014184397,1.0,1.0,11/38,22.04%,ZC3H7B;AGO2;DICER1;RBM10;HNRNPA2B1;TUT4;RBM4;AGO1;TUT7;ELAVL1;PIWIL4
prerank,"endodeoxyribonuclease activity, producing 5'-phosphomonoesters (GO:0016888)",0.21131270010672354,0.496997638409034,0.966,1.0,1.0,13/13,78.89%,ZGRF1;DICER1;DNASE1L3;FAN1;DNASE1L2;SLX4;DNASE1;ENDOV;DNASE1L1;DNA2;FEN1;EXO1;GEN1
prerank,neuropeptide binding (GO:0042923),0.19816686497551037,0.4921176227780734,0.9747081712062257,1.0,1.0,1/18,5.58%,SSTR2
prerank,telomerase RNA binding (GO:0070034),0.18683358497595787,0.4863485684138199,0.9925093632958801,1.0,1.0,4/22,15.46%,HNRNPC;TEP1;DCP2;PARN
prerank,metalloaminopeptidase activity (GO:0070006),0.19480797978124798,0.47096983303028905,0.9860557768924303,1.0,1.0,4/16,20.78%,NPEPPS;XPNPEP3;MMP14;MMP17
prerank,aspartic-type endopeptidase activity (GO:0004190),0.20094161958568743,0.4676401868009718,0.9813278008298755,1.0,1.0,12/12,79.92%,SPPL3;BACE1;DDI2;PGC;ASPRV1;BACE2;NAPSA;SPPL2A;SPPL2B;HM13;CTSE;PSEN1
prerank,"phosphotransferase activity, phosphate group as acceptor (GO:0016776)",0.17585308627002896,0.46639653600863606,0.9942857142857143,1.0,1.0,8/24,22.37%,PMVK;NME4;PPIP5K2;ITPKA;AK8;IP6K2;AK4;AK3
prerank,tumor necrosis factor receptor binding (GO:0005164),0.20309786285445033,0.45849818750026133,0.989247311827957,1.0,1.0,3/12,18.30%,BABAM2;TRAP1;TRAF6
prerank,alcohol dehydrogenase (NADP+) activity (GO:0008106),-0.1912865592869334,-0.4535073301377224,0.9885057471264368,1.0,1.0,5/11,38.26%,RDH14;DHRS13;AKR1A1;RDH12;ALDH3A1
prerank,nuclear import signal receptor activity (GO:0061608),0.19005462422301744,0.4526248253644725,0.9860557768924303,1.0,1.0,15/15,81.01%,TNPO1;IPO9;KPNB1;TNPO3;HIKESHI;RANBP6;KPNA6;IPO5;KPNA7;KPNA1;IPO4;KPNA2;TNPO2;KPNA3;KPNA4
prerank,acetylcholine receptor activity (GO:0015464),0.16859055786891458,0.45224339964731736,0.9961538461538462,1.0,1.0,1/22,4.73%,CHRNE
prerank,tRNA (guanine) methyltransferase activity (GO:0016423),-0.18537127533174172,-0.44831359572482377,0.9958592132505176,0.9990743746636604,1.0,3/13,23.81%,TRMT11;TRMT10C;METTL1
prerank,exoribonuclease activity (GO:0004532),0.19635318049902753,0.44351561484451657,0.983739837398374,0.9997036134676662,1.0,4/12,22.48%,EXOSC8;CNOT7;EXOSC3;EXOSC4
prerank,solute:proton symporter activity (GO:0015295),-0.16753125709051694,-0.4418961216882015,0.9980119284294234,0.9965760685545756,1.0,5/16,27.57%,SLC39A8;SLC36A1;SLC25A3;SLC2A9;SLC15A4
prerank,"oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor (GO:0016655)",0.19177652228499686,0.42810621486688205,0.979296066252588,0.9987438399642331,1.0,12/12,80.84%,CRYZ;NQO1;AIFM2;CBR4;CRYZL1;ADH4;DHRS4;AKR1C1;NQO2;CBR1;DCXR;NDUFS7
prerank,nuclear export signal receptor activity (GO:0005049),0.17895926181658417,0.3999992048422326,0.9978902953586498,0.9980426092498713,1.0,11/11,82.12%,NUP214;XPO5;RANBP17;XPO4;EIF4ENIF1;XPO7;XPO1;RAN;XPO6;NUP42;CSE1L
